data_2mxy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.494 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.53 ' HG ' ' HB3' ' A' ' 34' ' ' GLU . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' H ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.408 ' HA ' HG13 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.499 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 119.093 -0.479 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.438 HD22 HG21 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.517 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.517 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.484 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.528 ' HG ' ' HB3' ' A' ' 34' ' ' GLU . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.528 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.42 ' HA ' HG11 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.509 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.42 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.412 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 24.5 m-70 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.6 t30 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 2.0 pm0 -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.524 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.494 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 13.2 m-70 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.461 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.488 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.402 0.144 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 m -65.27 177.26 1.12 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.551 0.74 . . . . 0.0 111.513 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -107.57 24.29 13.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.655 0.782 . . . . 0.0 112.488 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.55 128.62 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 118.214 0.461 . . . . 0.0 111.122 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.6 p -149.97 16.61 0.86 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.537 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -114.26 19.87 15.98 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' H ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.53 14.51 6.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -133.5 47.69 2.8 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.83 138.46 63.5 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.586 2.19 . . . . 0.0 111.069 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -130.99 -23.21 2.5 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.932 0.893 . . . . 0.0 110.693 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.54 154.48 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.201 0.601 . . . . 0.0 110.229 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.41 3.26 28.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.26 0.624 . . . . 0.0 111.611 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 49.05 45.9 22.72 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.312 1.045 . . . . 0.0 111.006 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.78 8.68 10.32 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.135 0.874 . . . . 0.0 113.869 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 57.46 9.3 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.634 1.174 . . . . 0.0 113.927 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.96 -15.63 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.715 0.406 . . . . 0.0 111.706 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.61 5.99 89.15 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -86.57 -23.59 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 117.392 0.596 . . . . 0.0 111.057 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.92 148.93 43.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.33 0.252 . . . . 0.0 110.65 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -121.96 159.61 26.57 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.341 1.056 . . . . 0.0 110.0 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 t -82.78 153.68 25.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -7.66 30.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.491 0.316 . . . . 0.0 111.636 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.91 -7.11 17.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -119.33 14.7 12.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.85 0.86 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.3 mmt -65.73 169.55 6.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.699 0.761 . . . . 0.0 111.499 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.77 -13.72 62.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.199 1.4 . . . . 0.0 112.408 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 113.513 5.313 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.405 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.424 -2.412 1 O4'-C1'-N19 113.155 4.955 . 0.193 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 2 O4'-C1'-N19 112.705 4.505 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.779 1 O4'-C1'-N19 112.623 4.423 . 0.025 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.626 2.426 . 0.161 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 112.238 4.038 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.154 1 O4'-C1'-N19 113.928 5.728 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.371 0.129 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 t -63.28 172.05 2.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.933 0.493 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -108.18 13.55 25.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.196 0.598 . . . . 0.0 112.571 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 7.4 p -120.35 135.43 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 110.231 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.0 p -148.69 10.76 0.84 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.941 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -99.96 18.36 18.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.554 1.07 . . . . 0.0 113.821 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.43 12.59 5.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -134.07 48.3 3.1 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.75 141.46 65.94 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.573 2.182 . . . . 0.0 110.874 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.66 -5.11 2.24 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -99.18 154.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.356 0.662 . . . . 0.0 109.72 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.11 0.58 18.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.38 0.672 . . . . 0.0 112.53 -174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 47.69 47.32 17.98 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.699 0.8 . . . . 0.0 110.849 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 14.13 6.1 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.899 0.761 . . . . 0.0 114.21 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 59.2 5.61 0.6 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.53 -18.08 0.17 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.604 . . . . 0.0 112.292 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.43 10.37 84.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.84 -21.82 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 117.315 0.557 . . . . 0.0 111.145 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.96 150.93 46.18 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 122.352 0.261 . . . . 0.0 110.578 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -114.65 159.59 20.31 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.717 0.807 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.5 t -82.29 157.96 23.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.311 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.73 -8.97 57.44 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.21 0.204 . . . . 0.0 111.202 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -7.9 21.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 111.219 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -119.12 6.17 11.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.468 0.707 . . . . 0.0 110.745 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.22 163.63 26.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.859 0.463 . . . . 0.0 110.225 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 105' ' ' TYR . 3.6 m-85 -85.44 -9.83 56.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.59 1.156 . . . . 0.0 112.848 -170.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 123.513 0.578 . . . . 0.0 111.719 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 1 O4'-C1'-N19 113.464 5.264 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.786 3.586 . 0.231 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 O4'-C1'-N19 112.88 4.68 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.931 1 O4'-C1'-N19 112.666 4.466 . 0.031 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 111.643 -2.572 . 0.15 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.465 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.423 -2.502 1 O4'-C1'-N19 112.736 4.536 . 0.195 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C4'-C3'-C2' 100.099 -2.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.464 0.174 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -63.73 176.23 0.95 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.303 0.641 . . . . 0.0 111.757 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -101.22 9.48 41.81 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.329 0.652 . . . . 0.0 111.731 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.38 125.02 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.238 0.472 . . . . 0.0 111.475 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 66.7 p -148.18 17.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.214 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -118.37 19.73 13.3 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.494 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 13.19 4.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -132.18 46.5 2.2 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.1 141.55 64.08 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.681 2.254 . . . . 0.0 110.978 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -133.67 -11.41 2.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.725 0.81 . . . . 0.0 110.798 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.21 156.07 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.319 0.647 . . . . 0.0 110.212 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -81.89 1.92 32.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.068 0.547 . . . . 0.0 111.82 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 48.51 43.08 19.73 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.91 0.884 . . . . 0.0 110.688 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.2 12.97 4.94 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.06 0.838 . . . . 0.0 113.849 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 58.75 6.13 0.58 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.069 1.348 . . . . 0.0 113.948 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 144.76 24.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.115 0.566 . . . . 0.0 109.574 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.16 3.47 65.96 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.98 -24.37 14.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 123.45 0.7 . . . . 0.0 111.018 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.12 156.61 35.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.8 0.44 . . . . 0.0 111.084 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -119.92 167.51 12.06 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 124.21 1.004 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -72.43 155.4 40.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.484 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.62 29.57 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.237 -0.289 . . . . 0.0 111.25 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.61 -5.9 18.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.76 0.824 . . . . 0.0 111.186 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.11 2.35 9.25 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.206 0.603 . . . . 0.0 111.085 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 55.3 tpp -79.24 -32.6 43.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 110.714 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.4 -10.15 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.709 0.804 . . . . 0.0 111.362 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 1 O4'-C1'-N19 113.541 5.341 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 111.888 3.688 . 0.259 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 O4'-C1'-N19 112.581 4.381 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.808 1 O4'-C1'-N19 113.189 4.989 . 0.035 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 O4'-C1'-N19 110.778 2.578 . 0.169 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 1 O4'-C1'-N19 112.389 4.189 . 0.097 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.919 1 O4'-C1'-N19 112.49 4.29 . 0.615 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -61.36 173.04 0.97 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.327 0.651 . . . . 0.0 111.487 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -111.13 12.1 21.92 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.201 0.6 . . . . 0.0 112.4 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -113.1 129.82 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 118.306 0.503 . . . . 0.0 109.936 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 78.4 p -148.54 20.16 1.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.844 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.27 26.68 9.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.335 0.971 . . . . 0.0 113.338 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.53 ' HG ' ' HB3' ' A' ' 34' ' ' GLU . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.36 13.67 5.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -134.42 45.51 1.54 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.01 143.01 77.38 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.799 2.332 . . . . 0.0 111.306 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.18 6.08 3.86 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.152 0.981 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 p -106.35 154.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.529 0.732 . . . . 0.0 110.348 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.07 0.62 39.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 111.903 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.95 49.44 17.01 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.097 0.959 . . . . 0.0 110.96 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 3.87 23.08 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.418 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 59.07 -2.24 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.306 1.442 . . . . 0.0 114.58 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.88 -29.34 0.06 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.025 0.53 . . . . 0.0 110.689 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.44 88.91 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.8 -24.97 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.374 0.669 . . . . 0.0 111.452 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.61 161.5 29.49 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.061 0.458 . . . . 0.0 111.48 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -89.6 166.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.333 1.053 . . . . 0.0 111.62 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.9 m -80.94 163.66 23.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.369 0.668 . . . . 0.0 109.423 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.06 56.51 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 111.793 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.06 -7.82 35.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.364 0.665 . . . . 0.0 111.51 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -125.01 7.31 7.97 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 123.719 0.808 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.455 ' HA ' ' HE2' ' A' ' 104' ' ' MET . 5.2 tpt -60.4 -21.94 62.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -170.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -138.38 -3.4 1.73 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 C-N-CA 123.612 0.625 . . . . 0.0 111.832 -179.417 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 O4'-C1'-N19 113.405 5.205 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 O4'-C1'-N19 111.933 3.733 . 0.233 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.447 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 112.633 4.433 OUTLIER-DELTA 0.059 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 112.538 4.338 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 O4'-C1'-N19 110.997 2.797 . 0.116 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.468 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.421 -2.651 1 O4'-C1'-N19 112.766 4.566 . 0.095 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.286 1 O4'-C1'-N19 113.546 5.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.286 0.089 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -67.0 179.43 1.14 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.198 0.599 . . . . 0.0 111.048 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -110.79 20.32 17.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.249 0.62 . . . . 0.0 112.342 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -116.33 129.72 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 123.129 0.572 . . . . 0.0 110.825 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.1 p -148.66 19.41 1.03 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 119.14 -0.457 . . . . 0.0 112.064 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -120.86 31.36 6.44 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.64 5.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -134.58 48.41 3.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.94 142.13 67.5 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.783 2.322 . . . . 0.0 110.828 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -135.06 5.21 3.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.245 1.018 . . . . 0.0 111.015 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.03 153.79 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.25 0.62 . . . . 0.0 109.846 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -76.69 2.38 14.37 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.602 0.761 . . . . 0.0 112.47 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 48.6 43.75 20.58 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 123.245 0.618 . . . . 0.0 110.98 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.65 8.15 7.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.29 0.948 . . . . 0.0 114.327 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt 58.69 6.32 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 113.208 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.86 35.91 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.81 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.5 8.14 55.21 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.267 0.461 . . . . 0.0 112.655 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.44 -23.39 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 117.459 0.629 . . . . 0.0 111.526 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -75.28 155.67 36.43 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 122.152 -0.342 . . . . 0.0 110.896 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -110.41 166.29 11.1 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.213 1.005 . . . . 0.0 110.088 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -83.09 156.49 23.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.102 0.561 . . . . 0.0 110.093 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.15 -10.93 60.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.224 0.21 . . . . 0.0 111.299 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.84 -7.1 25.8 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 111.466 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.58 6.83 8.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.862 0.865 . . . . 0.0 110.761 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 tpp -75.23 -32.53 61.17 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.478 0.311 . . . . 0.0 110.714 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.41 -9.83 2.19 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.379 0.672 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 112.147 3.947 . 0.229 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 2 O4'-C1'-N19 112.442 4.242 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 O4'-C1'-N19 110.866 2.666 . 0.464 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 1 O4'-C1'-N19 112.421 4.221 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.019 1 O4'-C1'-N19 113.275 5.075 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -67.87 177.13 2.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.78 0.432 . . . . 0.0 111.05 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -108.23 19.74 19.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.869 0.868 . . . . 0.0 111.679 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 t -118.15 125.88 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.904 -0.498 . . . . 0.0 110.732 -170.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 p -147.92 8.66 0.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -102.55 20.45 17.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.08 1.309 . . . . 0.0 113.898 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' H ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 87' ' ' GLU . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.8 12.65 3.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' C ' HD22 ' A' ' 83' ' ' ASN . 85.3 mt-10 -135.71 48.87 2.97 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.81 144.66 84.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.772 2.315 . . . . 0.0 110.373 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -129.32 0.32 5.1 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.419 0.687 . . . . 0.0 111.168 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.15 156.23 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.965 0.906 . . . . 0.0 110.231 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -73.4 -6.67 47.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.761 0.824 . . . . 0.0 112.043 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 44.9 35.96 1.72 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.32 1.448 . . . . 0.0 113.153 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 95' ' ' ALA . . . -77.63 42.45 2.0 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.255 1.407 . . . . 0.0 113.361 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 61.51 0.24 0.45 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 0.0 113.091 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 93' ' ' GLY . . . -161.84 156.32 22.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 0.0 109.0 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.97 0.03 74.07 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.4 t -83.03 -23.63 8.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 111.337 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -76.39 151.38 36.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.564 0.346 . . . . 0.0 111.152 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.98 173.99 12.75 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.05 0.94 . . . . 0.0 109.924 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -67.46 156.15 37.32 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.55 0.61 2.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -117.1 -4.03 11.49 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.128 0.971 . . . . 0.0 111.023 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.12 11.7 7.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.08 0.952 . . . . 0.0 111.335 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -20.05 64.43 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.928 0.491 . . . . 0.0 111.646 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.33 -11.27 1.43 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.905 1 O4'-C1'-N19 113.921 5.721 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 112.063 3.863 . 0.262 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 1 O4'-C1'-N19 112.961 4.761 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.745 1 O4'-C1'-N19 113.428 5.228 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 C5'-C4'-C3' 111.632 -2.578 . 0.026 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 1 O4'-C1'-N19 113.008 4.808 . 0.154 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 C5'-C4'-C3' 110.907 -3.062 . 0.243 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.465 0.174 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -66.1 177.56 1.36 Allowed 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.248 0.619 . . . . 0.0 111.674 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.48 25.14 12.13 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.328 0.651 . . . . 0.0 111.948 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.56 129.11 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.142 0.428 . . . . 0.0 110.745 -171.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 p -150.08 16.12 0.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.811 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -114.33 19.59 16.15 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.408 ' HA ' HG13 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.499 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -122.43 13.76 10.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 37.0 mt-10 -121.81 46.0 1.06 Allowed Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 57.3 Cg_endo -76.12 29.0 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.115 3.21 . . . . 0.0 111.727 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -69.85 -7.43 39.97 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.026 -0.421 . . . . 0.0 110.421 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 92' ' ' ARG . 12.7 p -90.52 164.57 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.51 1.124 . . . . 0.0 109.596 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -67.86 4.76 1.05 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.027 0.931 . . . . 0.0 112.395 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 90' ' ' VAL . 13.5 ttm180 54.93 6.23 0.12 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.097 2.159 . . . . 0.0 115.201 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.82 -67.71 0.12 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.647 1.594 . . . . 0.0 113.219 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt 59.52 142.45 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.021 2.128 . . . . 0.0 113.333 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.23 163.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.455 1.502 . . . . 0.0 113.943 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.3 6.94 69.74 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.3 t -76.51 -24.69 15.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 123.543 0.737 . . . . 0.0 111.068 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -79.48 160.21 26.65 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.975 0.51 . . . . 0.0 110.846 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -119.04 165.71 13.79 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.834 0.853 . . . . 0.0 110.565 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -76.4 152.94 36.1 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.917 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.08 -6.56 23.46 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.254 -0.279 . . . . 0.0 111.375 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.64 -5.41 20.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.406 0.682 . . . . 0.0 111.472 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -122.88 7.77 9.34 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.359 0.663 . . . . 0.0 111.226 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.86 135.49 46.61 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.33 -0.231 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 52.49 10.61 0.14 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.71 1.604 . . . . 0.0 114.095 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.077 1 O4'-C1'-N19 113.795 5.595 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.02 1 O4'-C1'-N19 112.277 4.077 . 0.174 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 1 O4'-C1'-N19 112.979 4.779 . 0.056 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 O4'-C1'-N19 110.968 2.768 . 0.325 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.621 4.421 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C5'-C4'-C3' 112.956 -1.696 . 0.398 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -61.71 175.78 0.6 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.686 0.794 . . . . 0.0 111.493 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -106.84 21.76 17.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.72 131.81 67.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.756 -0.59 . . . . 0.0 110.499 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.6 p -146.02 6.04 1.01 Allowed 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 123.183 0.593 . . . . 0.0 111.653 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -96.84 -128.97 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.554 0.615 . . . . 0.0 109.762 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.438 HD22 HG21 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.517 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.517 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.95 14.58 6.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -133.52 46.41 2.03 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.37 145.21 82.69 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.791 2.327 . . . . 0.0 111.005 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -142.28 3.38 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.02 155.56 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.154 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.46 0.11 34.94 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.953 0.501 . . . . 0.0 112.104 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 49.03 41.54 19.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.807 0.843 . . . . 0.0 111.156 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.12 9.52 9.33 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.358 0.98 . . . . 0.0 113.845 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 60.66 178.09 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 112.454 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.7 161.37 29.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.732 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.51 -2.41 68.55 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.36 -25.61 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.342 0.657 . . . . 0.0 110.405 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -88.16 151.95 22.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.861 0.465 . . . . 0.0 110.328 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -110.76 160.76 16.44 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.572 0.749 . . . . 0.0 110.539 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 m -80.93 153.7 27.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.567 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.44 -7.85 28.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.9 -5.22 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.684 0.794 . . . . 0.0 111.446 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.01 15.77 11.62 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.711 0.805 . . . . 0.0 110.938 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mmt -71.14 174.13 6.73 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.562 0.696 . . . . 0.0 111.237 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.27 -13.62 62.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 112.617 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 1 O4'-C1'-N19 113.483 5.283 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.734 3.534 . 0.179 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 O4'-C1'-N19 112.16 3.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.888 1 O4'-C1'-N19 112.813 4.613 . 0.036 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.44 -2.707 . 0.162 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.0 3.8 . 0.137 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.726 4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -62.14 173.61 1.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.104 0.562 . . . . 0.0 111.736 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -106.97 25.44 11.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.251 0.62 . . . . 0.0 112.033 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.24 127.13 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 122.786 0.434 . . . . 0.0 110.408 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.2 p -149.59 18.92 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.163 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -120.81 31.15 6.54 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.484 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.42 13.54 5.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -134.23 45.36 1.49 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -62.35 137.09 63.28 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.838 2.359 . . . . 0.0 110.905 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -130.79 -12.25 3.78 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.571 0.748 . . . . 0.0 110.657 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -84.85 154.75 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.261 0.625 . . . . 0.0 109.652 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.46 -1.51 41.91 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.905 0.482 . . . . 0.0 111.948 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 46.92 50.2 13.91 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 123.874 0.87 . . . . 0.0 110.945 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.55 3.41 33.7 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.795 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 56.72 16.73 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 152.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.99 23.29 0.09 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.5 -25.62 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.125 0.97 . . . . 0.0 111.308 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -126.36 161.0 28.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.32 0.648 . . . . 0.0 110.464 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -78.54 168.32 19.96 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.997 0.519 . . . . 0.0 110.046 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.7 t -73.06 150.29 42.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.6 0.36 . . . . 0.0 110.202 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.86 -8.97 40.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.257 -0.277 . . . . 0.0 110.916 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.76 -7.48 21.62 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.801 0.84 . . . . 0.0 111.168 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -117.54 1.39 12.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.49 0.716 . . . . 0.0 111.417 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.63 -179.99 7.18 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.724 0.41 . . . . 0.0 110.54 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -64.56 -14.81 59.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.814 0.845 . . . . 0.0 112.834 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.552 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 113.53 5.33 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.813 3.613 . 0.228 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.82 4.62 . 0.033 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 0 O4'-C1'-N19 111.153 2.953 . 0.119 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 O4'-C1'-N19 112.437 4.237 . 0.09 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.555 0.216 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -72.75 174.56 7.48 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.944 0.402 . . . . 0.0 111.154 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.11 16.44 19.24 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.65 0.78 . . . . 0.0 111.452 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 5.1 p -123.89 135.5 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 11.76 0.95 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.361 0.664 . . . . 0.0 112.028 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -104.02 19.33 20.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.39 9.75 5.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -138.55 58.82 15.09 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.0 103.51 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.31 2.674 . . . . 0.0 110.343 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.55 -11.0 59.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.81 0.444 . . . . 0.0 110.342 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.01 160.2 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.928 . . . . 0.0 110.447 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -91.18 4.87 51.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.222 0.609 . . . . 0.0 111.5 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 48.43 56.08 8.0 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.0 0.92 . . . . 0.0 111.341 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.56 3.23 43.13 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.781 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm 55.91 17.57 2.61 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.63 152.87 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.09 -0.381 . . . . 0.0 111.011 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.21 62.32 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.281 0.467 . . . . 0.0 112.67 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.92 -24.79 19.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 117.428 0.614 . . . . 0.0 110.269 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -81.62 161.25 23.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.419 0.628 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -73.04 167.61 20.75 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.164 0.985 . . . . 0.0 111.002 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.3 m -84.34 154.95 22.59 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.88 -16.0 36.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.94 -6.89 25.9 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.0 0.52 . . . . 0.0 111.797 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.01 14.77 7.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.748 0.819 . . . . 0.0 111.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.1 mmm -63.32 -26.97 69.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.798 0.272 . . . . 0.0 111.087 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.1 -10.15 0.88 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.144 0.577 . . . . 0.0 111.882 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.294 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 113.562 5.362 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 O4'-C1'-N19 112.375 4.175 . 0.141 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 2 C5'-C4'-C3' 108.292 -4.805 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 112.62 4.42 . 0.06 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C5'-C4'-C3' 111.412 -2.725 . 0.162 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.499 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.574 1 O4'-C1'-N19 112.35 4.15 . 0.197 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 111.817 3.617 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -59.73 168.77 1.59 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.548 0.739 . . . . 0.0 111.758 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -109.21 20.23 18.55 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 9.3 p -124.8 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 118.387 0.54 . . . . 0.0 110.125 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.5 p -148.27 19.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.017 0.527 . . . . 0.0 111.857 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -113.44 23.8 12.85 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.528 ' HG ' ' HB3' ' A' ' 34' ' ' GLU . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.74 13.26 5.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -132.92 46.58 2.19 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.78 150.93 79.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.814 2.343 . . . . 0.0 110.804 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.99 -2.39 1.02 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.173 0.589 . . . . 0.0 112.376 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.22 156.89 21.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.151 0.98 . . . . 0.0 110.545 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -75.09 -5.55 44.77 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.524 0.73 . . . . 0.0 112.391 -177.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 45.27 37.34 2.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.378 1.471 . . . . 0.0 112.39 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.6 37.18 0.85 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 126.107 1.813 . . . . 0.0 114.48 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt 61.56 -178.4 0.12 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.652 1.215 . . . . 0.0 112.312 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -19.82 66.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.142 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.02 7.69 82.02 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.07 -27.3 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 117.077 0.438 . . . . 0.0 110.681 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.07 153.19 22.87 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.818 0.447 . . . . 0.0 110.077 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -118.32 154.96 31.47 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.569 0.748 . . . . 0.0 110.689 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.2 t -80.71 152.2 28.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.85 -2.98 5.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.08 -3.99 14.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.619 0.768 . . . . 0.0 111.329 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.01 11.97 9.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.613 0.765 . . . . 0.0 111.431 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 36.5 mtp -74.55 172.81 11.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.317 0.579 . . . . 0.0 111.164 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -75.86 -10.99 59.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.836 0.854 . . . . 0.0 112.131 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.512 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.956 1 O4'-C1'-N19 113.938 5.738 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.42 0 O4'-C1'-N19 111.663 3.463 . 0.189 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 O4'-C1'-N19 112.899 4.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 113.027 4.827 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.032 0 O4'-C1'-N19 110.861 2.661 . 0.552 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.484 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.594 1 O4'-C1'-N19 112.433 4.233 . 0.106 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.026 1 O4'-C1'-N19 114.779 6.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.397 0.141 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -64.88 176.91 1.06 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.211 0.605 . . . . 0.0 111.228 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -112.29 30.73 6.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.407 0.683 . . . . 0.0 112.11 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.94 129.65 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 122.565 0.346 . . . . 0.0 110.372 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.8 p -149.39 22.31 0.93 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.924 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -122.98 32.66 5.63 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.528 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.1 11.42 4.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.49 48.67 3.23 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.72 127.53 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.827 2.351 . . . . 0.0 111.49 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -113.26 -1.1 14.38 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.853 0.861 . . . . 0.0 109.897 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 p -91.82 154.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 123.119 0.568 . . . . 0.0 110.343 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.35 1.01 52.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.217 0.607 . . . . 0.0 111.84 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 49.05 43.27 22.1 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.868 0.867 . . . . 0.0 111.319 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 8.59 7.45 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.203 0.906 . . . . 0.0 114.119 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 57.17 12.79 1.41 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.6 -25.97 0.19 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.76 0.424 . . . . 0.0 111.157 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.21 -1.21 85.94 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.136 0.398 . . . . 0.0 112.162 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.3 t -124.24 -24.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.411 0.684 . . . . 0.0 111.105 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.52 166.22 19.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.147 0.579 . . . . 0.0 110.673 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.79 171.77 14.7 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.527 0.731 . . . . 0.0 110.999 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.6 m -78.44 24.99 0.25 Allowed 'General case' 0 CA--C 1.524 -0.048 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 52.98 6.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.299 1.44 . . . . 0.0 114.63 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.69 -5.48 1.36 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.948 0.899 . . . . 0.0 110.417 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.59 20.43 8.64 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.501 1.12 . . . . 0.0 109.318 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.7 mtp -71.64 176.33 4.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -67.53 -13.3 61.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.49 0.716 . . . . 0.0 112.252 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.604 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.577 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.08 1 O4'-C1'-N19 113.401 5.201 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 O4'-C1'-N19 111.941 3.741 . 0.23 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 112.518 4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 1 O4'-C1'-N19 113.017 4.817 . 0.026 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 O4'-C1'-N19 110.933 2.733 . 0.145 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.502 4.302 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 O4'-C1'-N19 113.371 5.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -86.4 8.34 22.07 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.0 t30 53.97 32.99 16.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.506 0.594 . . . . 0.0 112.33 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 7.8 p -145.67 137.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 O-C-N 122.157 -0.339 . . . . 0.0 110.569 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -150.97 12.24 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.68 0.792 . . . . 0.0 112.063 -173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -112.4 15.05 20.39 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.42 ' HA ' HG11 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.401 ' CE1' " H5'" ' B' ' 6' ' ' ' U' . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.509 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -126.39 13.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -135.99 48.1 2.45 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.31 142.08 71.34 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.742 2.294 . . . . 0.0 110.984 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -137.69 1.01 2.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.722 0.809 . . . . 0.0 111.052 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.0 153.61 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.318 0.647 . . . . 0.0 109.911 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.32 0.88 20.55 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.318 0.647 . . . . 0.0 112.549 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.3 46.93 16.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.049 0.939 . . . . 0.0 111.129 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.03 7.96 7.02 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.807 0.718 . . . . 0.0 113.945 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 59.18 4.7 0.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.085 1.354 . . . . 0.0 114.146 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.76 152.42 28.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.314 0.645 . . . . 0.0 109.672 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.45 -1.17 64.42 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.26 -23.0 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -78.24 152.84 32.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.742 0.417 . . . . 0.0 110.823 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.66 173.16 11.98 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.381 1.072 . . . . 0.0 110.51 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.5 t -72.24 151.82 42.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.76 -2.72 3.94 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.74 13.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.588 0.755 . . . . 0.0 111.396 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.48 7.33 10.62 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.467 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mtp -69.76 -24.82 63.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.077 -0.39 . . . . 0.0 112.052 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -140.16 -3.21 1.4 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.008 0.523 . . . . 0.0 111.904 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 O4'-C1'-N19 113.672 5.472 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 112.049 3.849 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 O4'-C1'-N19 112.195 3.995 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 O4'-C1'-N19 113.108 4.908 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 O4'-C1'-N19 110.664 2.464 . 0.507 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.459 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 112.234 4.034 . 0.12 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.101 1 O4'-C1'-N19 113.246 5.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.346 0.117 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -65.28 175.66 1.61 Allowed 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -106.65 21.5 17.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.9 0.48 . . . . 0.0 112.017 -176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.97 126.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 118.081 0.4 . . . . 0.0 111.035 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.4 p -150.13 16.2 0.84 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -115.13 18.26 16.34 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.483 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.412 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 24.5 m-70 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.93 10.57 6.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.64 57.4 16.17 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 147.67 62.33 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.296 2.664 . . . . 0.0 109.714 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.32 2.85 3.05 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.18 0.592 . . . . 0.0 111.484 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.57 154.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.454 0.702 . . . . 0.0 109.469 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.93 4.63 5.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.763 0.825 . . . . 0.0 112.827 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 49.47 54.01 11.71 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.738 0.815 . . . . 0.0 111.028 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.83 13.45 3.14 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.103 0.859 . . . . 0.0 113.995 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 56.28 -97.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.976 1.311 . . . . 0.0 112.96 178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.52 -13.96 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.86 81.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.5 -30.97 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.62 162.76 14.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.726 0.81 . . . . 0.0 109.186 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.65 166.32 23.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.651 0.262 . . . . 0.0 110.419 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -69.34 159.24 33.51 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.99 -10.65 59.34 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.139 -0.351 . . . . 0.0 111.385 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -98.58 -6.38 30.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.408 0.683 . . . . 0.0 111.001 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.34 17.43 5.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.363 1.065 . . . . 0.0 109.741 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.1 tpt -64.83 -22.72 67.05 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.334 0.654 . . . . 0.0 111.621 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -139.81 -10.68 1.17 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.648 0.379 . . . . 0.0 111.968 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.972 1 O4'-C1'-N19 113.697 5.497 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 O4'-C1'-N19 111.798 3.598 . 0.213 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.458 HO2' ' P ' ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 C5'-C4'-C3' 108.557 -4.629 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.458 ' P ' HO2' ' B' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.445 2 O4'-C1'-N19 112.978 4.778 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.827 0 C5'-C4'-C3' 111.897 -2.402 . 0.343 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 112.82 4.62 . 0.108 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 1 O4'-C1'-N19 112.471 4.271 . 0.577 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.302 0.096 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -74.03 174.45 8.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.844 0.458 . . . . 0.0 111.626 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -113.79 30.38 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.038 0.935 . . . . 0.0 111.526 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.73 140.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -144.82 -8.55 0.63 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.85 0.86 . . . . 0.0 111.084 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -77.59 23.93 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -170.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.6 t30 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 2.0 pm0 -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.45 12.64 4.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -134.62 46.58 1.94 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.1 144.05 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.715 2.277 . . . . 0.0 110.895 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.66 4.94 3.65 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.83 0.852 . . . . 0.0 110.95 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.75 152.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.83 2.44 12.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.718 0.807 . . . . 0.0 112.217 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 48.78 52.06 14.73 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.874 0.869 . . . . 0.0 111.139 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 8.46 7.17 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.006 0.812 . . . . 0.0 113.316 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt 59.62 -5.0 0.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.995 1.718 . . . . 0.0 115.388 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.44 -24.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.864 0.756 . . . . 0.0 111.652 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.78 -0.89 75.81 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.3 t -102.64 -25.43 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.494 0.717 . . . . 0.0 110.707 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -76.46 159.66 30.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.156 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -76.7 164.86 25.48 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.706 0.803 . . . . 0.0 110.885 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -70.21 158.19 36.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.284 0.634 . . . . 0.0 109.653 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.45 -8.75 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.23 -6.84 27.38 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.165 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.39 7.92 6.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.016 0.926 . . . . 0.0 111.146 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -21.89 63.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.478 0.311 . . . . 0.0 111.435 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -140.5 -11.64 1.04 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.656 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 O4'-C1'-N19 113.552 5.352 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.405 4.205 . 0.165 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.455 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.645 1 O4'-C1'-N19 112.844 4.644 OUTLIER-DELTA 0.053 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.781 4.581 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 C5'-C4'-C3' 111.81 -2.46 . 0.108 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.881 3.681 . 0.193 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 O4'-C1'-N19 113.055 4.855 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -80.97 1.61 30.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.83 30.42 13.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.606 0.639 . . . . 0.0 112.383 176.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 12.0 p -142.43 136.38 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.4 p -147.88 10.84 0.93 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -99.71 23.93 8.98 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.264 -0.897 . . . . 0.0 112.727 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' HB3' ' HG ' ' A' ' 46' ' ' CYS . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HE2' " H5'" ' B' ' 1' ' ' ' A' . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.524 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.92 10.12 4.99 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.73 48.33 2.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.81 136.74 46.65 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.525 2.15 . . . . 0.0 110.811 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -129.89 -3.9 4.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.796 0.838 . . . . 0.0 110.201 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.31 156.05 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.582 0.753 . . . . 0.0 109.746 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.57 2.55 47.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.875 0.47 . . . . 0.0 111.926 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mtm105 48.39 40.84 15.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.885 0.874 . . . . 0.0 110.924 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 11.77 9.78 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.626 1.107 . . . . 0.0 113.888 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 59.5 4.81 0.55 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.02 1.328 . . . . 0.0 114.256 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.04 149.63 23.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.078 0.551 . . . . 0.0 109.753 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.29 -1.47 75.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.21 -20.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.014 0.926 . . . . 0.0 110.958 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -71.54 151.17 44.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.642 0.377 . . . . 0.0 111.606 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.84 165.01 13.85 Favored 'General case' 0 CA--C 1.524 -0.033 0 C-N-CA 123.879 0.872 . . . . 0.0 110.081 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 t -75.49 151.74 37.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.13 -5.02 15.67 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.935 -0.478 . . . . 0.0 111.802 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -6.48 22.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.621 0.768 . . . . 0.0 111.038 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.93 7.61 5.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.077 0.951 . . . . 0.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.5 ttm -89.7 160.54 16.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.567 0.747 . . . . 0.0 110.962 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.39 -14.44 62.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.667 1.587 . . . . 0.0 113.135 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.455 " H5'" ' HE2' ' A' ' 50' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.603 0 C3'-C2'-C1' 104.91 3.789 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 N19-C1'-C2' 107.046 -3.972 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 1 O4'-C1'-N19 112.845 4.645 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 O4'-C1'-N19 113.022 4.822 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.736 0 O4'-C1'-N19 110.708 2.508 . 0.125 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.489 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.429 4.229 . 0.157 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 113.16 4.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.3 0.095 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -62.28 173.36 1.19 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.642 0.777 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -109.66 15.67 22.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG21 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -119.02 138.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 118.384 0.538 . . . . 0.0 110.181 -174.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 p -147.0 2.27 0.78 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -87.89 33.05 0.72 Allowed 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.642 -0.661 . . . . 0.0 112.334 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.424 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.494 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.18 13.91 5.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -131.24 50.09 5.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.25 71.11 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.829 3.019 . . . . 0.0 111.586 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.22 -9.18 59.09 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -86.77 155.49 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.095 0.958 . . . . 0.0 109.294 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.79 0.86 51.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.759 0.423 . . . . 0.0 111.62 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 56.48 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.284 1.433 . . . . 0.0 111.337 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.61 -2.55 15.59 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.866 0.746 . . . . 0.0 114.267 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 54.35 11.12 0.37 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.473 1.109 . . . . 0.0 113.893 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.8 -16.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.789 0.436 . . . . 0.0 111.907 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.75 9.24 86.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.49 -21.0 10.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.983 0.513 . . . . 0.0 110.911 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.01 149.75 49.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.95 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.22 154.74 18.46 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.689 0.796 . . . . 0.0 110.263 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 t -85.9 148.94 25.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.9 -6.27 11.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.677 0.391 . . . . 0.0 112.029 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.69 -8.81 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -117.49 8.15 12.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.299 0.64 . . . . 0.0 111.546 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 41.1 mtp -70.68 -26.09 63.27 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.6 -5.02 1.58 Allowed 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.075 0.55 . . . . 0.0 111.988 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 114.298 6.098 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.804 3.604 . 0.25 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.424 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.386 4.186 OUTLIER-DELTA 0.065 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 O4'-C1'-N19 112.39 4.19 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.142 3.942 . 0.089 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.496 ' H3 ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 112.433 4.233 . 0.187 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 O4'-C1'-N19 112.422 4.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -72.85 177.91 4.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.2 0.6 . . . . 0.0 111.553 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -118.04 34.99 4.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.339 1.056 . . . . 0.0 111.259 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.44 136.47 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 111.195 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -152.07 19.13 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.147 1.779 . . . . 0.0 109.37 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -112.97 15.25 19.72 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.536 HD21 ' C5 ' ' B' ' 2' ' ' ' U' . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.8 13.14 5.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -132.86 48.58 3.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.46 139.22 37.33 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.192 1.928 . . . . 0.0 109.325 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.9 3.21 8.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.134 0.574 . . . . 0.0 111.112 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.46 159.1 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 110.049 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 93' ' ' GLY . 3.2 m-80 -74.0 2.74 8.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.765 0.826 . . . . 0.0 111.412 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 63.17 -30.71 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.658 2.383 . . . . 0.0 113.949 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 91' ' ' ASN . . . 63.31 -2.69 1.47 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.441 1.019 . . . . 0.0 114.838 172.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 53.66 5.09 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.57 -20.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.169 0.441 . . . . 0.0 111.2 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.57 -0.51 81.04 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.81 -23.43 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.714 0.806 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.75 151.74 41.98 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.046 -0.409 . . . . 0.0 110.636 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -84.91 161.27 19.91 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.8 m -82.97 152.81 25.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.81 -10.12 44.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.613 0.642 . . . . 0.0 111.789 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.32 -8.21 39.59 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.43 0.692 . . . . 0.0 111.373 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.73 3.03 6.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.706 0.803 . . . . 0.0 110.927 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.9 ttm -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.304 0.641 . . . . 0.0 111.033 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -133.48 -8.95 2.87 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.935 0.494 . . . . 0.0 111.559 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.389 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.434 " H3'" " H5'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C5'-C4'-C3' 110.179 -3.548 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.536 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.366 0 O4'-C1'-N19 112.12 3.92 . 0.144 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.414 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 111.367 3.167 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 O4'-C1'-N19 114.129 5.929 OUTLIER-DELTA 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 111.048 -2.968 . 0.021 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 111.056 2.856 . 0.213 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 1 O4'-C1'-N19 113.821 5.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.316 0.103 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -77.66 -174.15 3.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.842 0.457 . . . . 0.0 110.678 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -118.46 21.34 12.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 111.961 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG12 ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -117.72 129.51 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.533 0.606 . . . . 0.0 110.411 -174.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 56.3 p -148.82 16.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -111.73 17.05 20.23 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HE2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD2' ' C5 ' ' B' ' 2' ' ' ' U' . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HD3' ' C2 ' ' B' ' 2' ' ' ' U' . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.531 ' N ' " H1'" ' B' ' 2' ' ' ' U' . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.27 14.11 5.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -132.78 46.91 2.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.05 144.08 74.56 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.995 2.464 . . . . 0.0 111.383 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -138.34 1.98 2.24 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.123 0.969 . . . . 0.0 111.032 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.61 154.46 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.386 0.675 . . . . 0.0 110.514 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -84.56 2.85 39.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.303 0.641 . . . . 0.0 111.881 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 48.51 51.6 15.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 111.4 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.78 1.92 35.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.399 0.523 . . . . 0.0 113.976 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 55.84 15.13 1.55 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.09 -18.79 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.53 3.14 82.45 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 67.9 t -89.14 -21.4 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.788 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -69.93 151.45 45.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.355 0.262 . . . . 0.0 110.632 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.38 156.55 19.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.792 0.837 . . . . 0.0 110.328 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.9 m -84.14 156.6 22.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -6.15 9.54 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.99 -5.8 15.34 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.385 0.674 . . . . 0.0 110.986 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -123.26 13.83 9.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 110.785 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.0 mmm -62.06 -22.47 65.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -139.72 -6.49 1.31 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.957 0.503 . . . . 0.0 111.822 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.461 " H3'" H5'' ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.285 2 O4'-C1'-N19 113.958 5.758 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.583 ' C5 ' ' CD2' ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.472 1 C5'-C4'-C3' 108.114 -4.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 O4'-C1'-N19 112.662 4.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 113.268 5.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 112.36 -2.093 . 0.333 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 1 O4'-C1'-N19 112.357 4.157 . 0.151 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 110.074 -3.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -72.37 176.98 4.85 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.911 0.485 . . . . 0.0 111.421 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -115.4 19.62 15.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.881 0.872 . . . . 0.0 111.383 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG22 ' H3 ' ' B' ' 6' ' ' ' U' . 6.5 p -123.24 133.53 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.1 p -149.32 18.6 0.95 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.401 0.68 . . . . 0.0 111.76 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.25 17.16 19.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' HA ' ' C2 ' ' B' ' 3' ' ' ' U' . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 13.2 m-70 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.461 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.488 ' HH ' ' CB ' ' A' ' 66' ' ' ALA . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' CB ' ' HH ' ' A' ' 57' ' ' TYR . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.01 13.03 7.27 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 79.3 mt-10 -130.87 45.53 1.81 Allowed Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 83.6 Cg_endo -70.22 81.25 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.178 2.585 . . . . 0.0 110.678 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.53 -7.04 59.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.784 0.434 . . . . 0.0 110.76 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.1 p -90.33 155.48 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.316 0.646 . . . . 0.0 109.345 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -75.88 -8.02 55.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 43.05 66.38 0.79 Allowed 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.123 0.969 . . . . 0.0 111.168 -175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.97 -3.1 20.99 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.919 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' HA ' " H2'" ' B' ' 3' ' ' ' U' . 44.1 mtmt 55.12 7.7 0.2 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.356 1.462 . . . . 0.0 113.991 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.34 -164.39 1.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.233 0.54 . . . . 0.0 110.976 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.07 -2.87 4.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.19 -24.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.74 0.816 . . . . 0.0 111.038 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -83.72 160.18 21.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.375 0.67 . . . . 0.0 111.024 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -98.45 164.48 12.26 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.835 0.854 . . . . 0.0 110.555 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t -77.12 153.68 34.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.248 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.22 -3.32 10.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.36 -4.54 12.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.987 0.915 . . . . 0.0 111.36 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.05 8.32 8.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.316 0.646 . . . . 0.0 111.13 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.467 ' HG3' ' H ' ' A' ' 106' ' ' GLY . 8.2 ptm -115.14 -176.08 2.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.57 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.68 -15.21 51.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.741 0.816 . . . . 0.0 113.148 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' H ' ' HG3' ' A' ' 104' ' ' MET . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 1 O4'-C1'-N19 114.022 5.822 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 112.063 3.863 . 0.243 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.483 ' C2 ' ' HA ' ' A' ' 22' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -2.962 4 O4'-C1'-N19 114.801 6.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.194 0 O5'-C5'-C4' 115.735 3.954 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.899 2.699 . 0.017 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.48 ' H3 ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.128 4.928 . 0.21 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 110.337 -3.442 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.406 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.448 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 28' ' ' VAL . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.499 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.495 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 83' ' ' ASN . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.421 ' HA ' HG13 ' A' ' 67' ' ' VAL . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 119.093 -0.479 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.447 HD21 HG23 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 HD21 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.614 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.433 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 28' ' ' VAL . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.402 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 83' ' ' ASN . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.426 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.543 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.407 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 HD21 HG11 ' A' ' 28' ' ' VAL . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 83' ' ' ASN . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.7 t-20 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.481 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.477 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 83' ' ' ASN . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HA ' HG13 ' A' ' 67' ' ' VAL . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.567 ' HA ' HG12 ' A' ' 28' ' ' VAL . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.45 ' H ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG12 ' A' ' 28' ' ' VAL . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.402 0.144 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 m -65.27 177.26 1.12 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.551 0.74 . . . . 0.0 111.513 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -107.57 24.29 13.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.655 0.782 . . . . 0.0 112.488 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.55 128.62 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 118.214 0.461 . . . . 0.0 111.122 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.6 p -149.97 16.61 0.86 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.537 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -114.26 19.87 15.98 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.53 14.51 6.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -133.5 47.69 2.8 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.83 138.46 63.5 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.586 2.19 . . . . 0.0 111.069 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -130.99 -23.21 2.5 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.932 0.893 . . . . 0.0 110.693 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.54 154.48 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.201 0.601 . . . . 0.0 110.229 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.41 3.26 28.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.26 0.624 . . . . 0.0 111.611 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 49.05 45.9 22.72 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.312 1.045 . . . . 0.0 111.006 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.78 8.68 10.32 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.135 0.874 . . . . 0.0 113.869 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 57.46 9.3 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.634 1.174 . . . . 0.0 113.927 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.96 -15.63 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.715 0.406 . . . . 0.0 111.706 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.61 5.99 89.15 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -86.57 -23.59 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 117.392 0.596 . . . . 0.0 111.057 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.92 148.93 43.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.33 0.252 . . . . 0.0 110.65 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -121.96 159.61 26.57 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.341 1.056 . . . . 0.0 110.0 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 t -82.78 153.68 25.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -7.66 30.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.491 0.316 . . . . 0.0 111.636 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.91 -7.11 17.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -119.33 14.7 12.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.85 0.86 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.3 mmt -65.73 169.55 6.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.699 0.761 . . . . 0.0 111.499 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.77 -13.72 62.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.199 1.4 . . . . 0.0 112.408 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 113.513 5.313 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.426 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.424 -2.412 1 O4'-C1'-N19 113.155 4.955 . 0.193 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 2 O4'-C1'-N19 112.705 4.505 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.779 1 O4'-C1'-N19 112.623 4.423 . 0.025 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.626 2.426 . 0.161 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 112.238 4.038 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.154 1 O4'-C1'-N19 113.928 5.728 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.371 0.129 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 t -63.28 172.05 2.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.933 0.493 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -108.18 13.55 25.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.196 0.598 . . . . 0.0 112.571 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 7.4 p -120.35 135.43 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 110.231 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.0 p -148.69 10.76 0.84 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.941 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -99.96 18.36 18.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.554 1.07 . . . . 0.0 113.821 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.448 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.43 12.59 5.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -134.07 48.3 3.1 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.75 141.46 65.94 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.573 2.182 . . . . 0.0 110.874 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.66 -5.11 2.24 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -99.18 154.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.356 0.662 . . . . 0.0 109.72 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.11 0.58 18.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.38 0.672 . . . . 0.0 112.53 -174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 47.69 47.32 17.98 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.699 0.8 . . . . 0.0 110.849 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 14.13 6.1 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.899 0.761 . . . . 0.0 114.21 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 59.2 5.61 0.6 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.53 -18.08 0.17 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.604 . . . . 0.0 112.292 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.43 10.37 84.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.84 -21.82 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 117.315 0.557 . . . . 0.0 111.145 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.96 150.93 46.18 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 122.352 0.261 . . . . 0.0 110.578 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -114.65 159.59 20.31 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.717 0.807 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.5 t -82.29 157.96 23.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.311 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.73 -8.97 57.44 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.21 0.204 . . . . 0.0 111.202 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -7.9 21.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 111.219 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -119.12 6.17 11.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.468 0.707 . . . . 0.0 110.745 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.22 163.63 26.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.859 0.463 . . . . 0.0 110.225 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 105' ' ' TYR . 3.6 m-85 -85.44 -9.83 56.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.59 1.156 . . . . 0.0 112.848 -170.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 123.513 0.578 . . . . 0.0 111.719 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 1 O4'-C1'-N19 113.464 5.264 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.786 3.586 . 0.231 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 O4'-C1'-N19 112.88 4.68 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.931 1 O4'-C1'-N19 112.666 4.466 . 0.031 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 111.643 -2.572 . 0.15 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.483 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.423 -2.502 1 O4'-C1'-N19 112.736 4.536 . 0.195 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C4'-C3'-C2' 100.099 -2.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.464 0.174 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -63.73 176.23 0.95 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.303 0.641 . . . . 0.0 111.757 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -101.22 9.48 41.81 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.329 0.652 . . . . 0.0 111.731 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.38 125.02 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.238 0.472 . . . . 0.0 111.475 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 66.7 p -148.18 17.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.214 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -118.37 19.73 13.3 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 13.19 4.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -132.18 46.5 2.2 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.1 141.55 64.08 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.681 2.254 . . . . 0.0 110.978 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -133.67 -11.41 2.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.725 0.81 . . . . 0.0 110.798 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.21 156.07 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.319 0.647 . . . . 0.0 110.212 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -81.89 1.92 32.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.068 0.547 . . . . 0.0 111.82 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 48.51 43.08 19.73 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.91 0.884 . . . . 0.0 110.688 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.2 12.97 4.94 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.06 0.838 . . . . 0.0 113.849 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 58.75 6.13 0.58 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.069 1.348 . . . . 0.0 113.948 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 144.76 24.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.115 0.566 . . . . 0.0 109.574 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.16 3.47 65.96 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.98 -24.37 14.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 123.45 0.7 . . . . 0.0 111.018 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 99' ' ' ARG . 75.3 mmtt -75.12 156.61 35.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.8 0.44 . . . . 0.0 111.084 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 98' ' ' LYS . 3.3 mpt_? -119.92 167.51 12.06 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 124.21 1.004 . . . . 0.0 109.869 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -72.43 155.4 40.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.484 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.62 29.57 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.237 -0.289 . . . . 0.0 111.25 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.61 -5.9 18.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.76 0.824 . . . . 0.0 111.186 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.11 2.35 9.25 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.206 0.603 . . . . 0.0 111.085 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 55.3 tpp -79.24 -32.6 43.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 110.714 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.4 -10.15 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.709 0.804 . . . . 0.0 111.362 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 1 O4'-C1'-N19 113.541 5.341 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 111.888 3.688 . 0.259 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 O4'-C1'-N19 112.581 4.381 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.808 1 O4'-C1'-N19 113.189 4.989 . 0.035 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 O4'-C1'-N19 110.778 2.578 . 0.169 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 1 O4'-C1'-N19 112.389 4.189 . 0.097 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.919 1 O4'-C1'-N19 112.49 4.29 . 0.615 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -61.36 173.04 0.97 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.327 0.651 . . . . 0.0 111.487 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -111.13 12.1 21.92 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.201 0.6 . . . . 0.0 112.4 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -113.1 129.82 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 118.306 0.503 . . . . 0.0 109.936 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 78.4 p -148.54 20.16 1.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.844 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.27 26.68 9.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.335 0.971 . . . . 0.0 113.338 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 28' ' ' VAL . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.499 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.36 13.67 5.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -134.42 45.51 1.54 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.01 143.01 77.38 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.799 2.332 . . . . 0.0 111.306 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.18 6.08 3.86 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.152 0.981 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 p -106.35 154.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.529 0.732 . . . . 0.0 110.348 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.07 0.62 39.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 111.903 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.95 49.44 17.01 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.097 0.959 . . . . 0.0 110.96 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 3.87 23.08 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.418 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 59.07 -2.24 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.306 1.442 . . . . 0.0 114.58 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.88 -29.34 0.06 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.025 0.53 . . . . 0.0 110.689 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.44 88.91 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.8 -24.97 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.374 0.669 . . . . 0.0 111.452 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.61 161.5 29.49 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.061 0.458 . . . . 0.0 111.48 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -89.6 166.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.333 1.053 . . . . 0.0 111.62 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.9 m -80.94 163.66 23.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.369 0.668 . . . . 0.0 109.423 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.06 56.51 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 111.793 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.06 -7.82 35.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.364 0.665 . . . . 0.0 111.51 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -125.01 7.31 7.97 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 123.719 0.808 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.2 tpt -60.4 -21.94 62.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -170.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -138.38 -3.4 1.73 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 C-N-CA 123.612 0.625 . . . . 0.0 111.832 -179.417 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 O4'-C1'-N19 113.405 5.205 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 O4'-C1'-N19 111.933 3.733 . 0.233 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.434 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 112.633 4.433 OUTLIER-DELTA 0.059 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 112.538 4.338 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 O4'-C1'-N19 110.997 2.797 . 0.116 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.483 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.421 -2.651 1 O4'-C1'-N19 112.766 4.566 . 0.095 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.286 1 O4'-C1'-N19 113.546 5.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.286 0.089 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -67.0 179.43 1.14 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.198 0.599 . . . . 0.0 111.048 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -110.79 20.32 17.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.249 0.62 . . . . 0.0 112.342 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -116.33 129.72 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 123.129 0.572 . . . . 0.0 110.825 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.1 p -148.66 19.41 1.03 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 119.14 -0.457 . . . . 0.0 112.064 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -120.86 31.36 6.44 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.64 5.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -134.58 48.41 3.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.94 142.13 67.5 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.783 2.322 . . . . 0.0 110.828 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -135.06 5.21 3.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.245 1.018 . . . . 0.0 111.015 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.03 153.79 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.25 0.62 . . . . 0.0 109.846 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -76.69 2.38 14.37 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.602 0.761 . . . . 0.0 112.47 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 48.6 43.75 20.58 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 123.245 0.618 . . . . 0.0 110.98 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.65 8.15 7.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.29 0.948 . . . . 0.0 114.327 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt 58.69 6.32 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 113.208 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.86 35.91 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.81 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.5 8.14 55.21 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.267 0.461 . . . . 0.0 112.655 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.44 -23.39 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 117.459 0.629 . . . . 0.0 111.526 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -75.28 155.67 36.43 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 122.152 -0.342 . . . . 0.0 110.896 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -110.41 166.29 11.1 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.213 1.005 . . . . 0.0 110.088 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -83.09 156.49 23.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.102 0.561 . . . . 0.0 110.093 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.15 -10.93 60.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.224 0.21 . . . . 0.0 111.299 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.84 -7.1 25.8 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 111.466 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.58 6.83 8.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.862 0.865 . . . . 0.0 110.761 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 tpp -75.23 -32.53 61.17 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.478 0.311 . . . . 0.0 110.714 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.41 -9.83 2.19 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.379 0.672 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 112.147 3.947 . 0.229 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 2 O4'-C1'-N19 112.442 4.242 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 O4'-C1'-N19 110.866 2.666 . 0.464 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 1 O4'-C1'-N19 112.421 4.221 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.019 1 O4'-C1'-N19 113.275 5.075 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -67.87 177.13 2.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.78 0.432 . . . . 0.0 111.05 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -108.23 19.74 19.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.869 0.868 . . . . 0.0 111.679 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 t -118.15 125.88 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.904 -0.498 . . . . 0.0 110.732 -170.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 p -147.92 8.66 0.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -102.55 20.45 17.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.08 1.309 . . . . 0.0 113.898 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.495 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 83' ' ' ASN . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.421 ' HA ' HG13 ' A' ' 67' ' ' VAL . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.8 12.65 3.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' C ' HD21 ' A' ' 83' ' ' ASN . 85.3 mt-10 -135.71 48.87 2.97 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.81 144.66 84.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.772 2.315 . . . . 0.0 110.373 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -129.32 0.32 5.1 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.419 0.687 . . . . 0.0 111.168 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.15 156.23 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.965 0.906 . . . . 0.0 110.231 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -73.4 -6.67 47.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.761 0.824 . . . . 0.0 112.043 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 44.9 35.96 1.72 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.32 1.448 . . . . 0.0 113.153 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 95' ' ' ALA . . . -77.63 42.45 2.0 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.255 1.407 . . . . 0.0 113.361 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 61.51 0.24 0.45 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 0.0 113.091 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 93' ' ' GLY . . . -161.84 156.32 22.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 0.0 109.0 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.97 0.03 74.07 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.4 t -83.03 -23.63 8.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 111.337 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -76.39 151.38 36.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.564 0.346 . . . . 0.0 111.152 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.98 173.99 12.75 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.05 0.94 . . . . 0.0 109.924 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -67.46 156.15 37.32 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.55 0.61 2.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -117.1 -4.03 11.49 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.128 0.971 . . . . 0.0 111.023 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.12 11.7 7.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.08 0.952 . . . . 0.0 111.335 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -20.05 64.43 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.928 0.491 . . . . 0.0 111.646 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.33 -11.27 1.43 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.905 1 O4'-C1'-N19 113.921 5.721 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 112.063 3.863 . 0.262 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 1 O4'-C1'-N19 112.961 4.761 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.409 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.745 1 O4'-C1'-N19 113.428 5.228 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.409 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 C5'-C4'-C3' 111.632 -2.578 . 0.026 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 1 O4'-C1'-N19 113.008 4.808 . 0.154 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 C5'-C4'-C3' 110.907 -3.062 . 0.243 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.465 0.174 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -66.1 177.56 1.36 Allowed 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.248 0.619 . . . . 0.0 111.674 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.48 25.14 12.13 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.328 0.651 . . . . 0.0 111.948 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.56 129.11 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.142 0.428 . . . . 0.0 110.745 -171.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 p -150.08 16.12 0.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.811 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -114.33 19.59 16.15 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -122.43 13.76 10.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 37.0 mt-10 -121.81 46.0 1.06 Allowed Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 57.3 Cg_endo -76.12 29.0 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.115 3.21 . . . . 0.0 111.727 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -69.85 -7.43 39.97 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.026 -0.421 . . . . 0.0 110.421 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -90.52 164.57 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.51 1.124 . . . . 0.0 109.596 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.86 4.76 1.05 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.027 0.931 . . . . 0.0 112.395 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 54.93 6.23 0.12 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.097 2.159 . . . . 0.0 115.201 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.82 -67.71 0.12 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.647 1.594 . . . . 0.0 113.219 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt 59.52 142.45 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.021 2.128 . . . . 0.0 113.333 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.23 163.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.455 1.502 . . . . 0.0 113.943 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.3 6.94 69.74 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.3 t -76.51 -24.69 15.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 123.543 0.737 . . . . 0.0 111.068 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -79.48 160.21 26.65 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.975 0.51 . . . . 0.0 110.846 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -119.04 165.71 13.79 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.834 0.853 . . . . 0.0 110.565 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -76.4 152.94 36.1 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.917 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.08 -6.56 23.46 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.254 -0.279 . . . . 0.0 111.375 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.64 -5.41 20.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.406 0.682 . . . . 0.0 111.472 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -122.88 7.77 9.34 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.359 0.663 . . . . 0.0 111.226 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.86 135.49 46.61 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.33 -0.231 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 52.49 10.61 0.14 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.71 1.604 . . . . 0.0 114.095 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.077 1 O4'-C1'-N19 113.795 5.595 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.02 1 O4'-C1'-N19 112.277 4.077 . 0.174 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 1 O4'-C1'-N19 112.979 4.779 . 0.056 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 O4'-C1'-N19 110.968 2.768 . 0.325 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.621 4.421 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C5'-C4'-C3' 112.956 -1.696 . 0.398 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -61.71 175.78 0.6 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.686 0.794 . . . . 0.0 111.493 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -106.84 21.76 17.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.72 131.81 67.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.756 -0.59 . . . . 0.0 110.499 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.6 p -146.02 6.04 1.01 Allowed 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 123.183 0.593 . . . . 0.0 111.653 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -96.84 -128.97 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.554 0.615 . . . . 0.0 109.762 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.447 HD21 HG23 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 HD21 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.614 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.95 14.58 6.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -133.52 46.41 2.03 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.37 145.21 82.69 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.791 2.327 . . . . 0.0 111.005 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -142.28 3.38 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.02 155.56 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.154 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.46 0.11 34.94 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.953 0.501 . . . . 0.0 112.104 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 49.03 41.54 19.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.807 0.843 . . . . 0.0 111.156 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.12 9.52 9.33 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.358 0.98 . . . . 0.0 113.845 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 60.66 178.09 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 112.454 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.7 161.37 29.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.732 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.51 -2.41 68.55 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.36 -25.61 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.342 0.657 . . . . 0.0 110.405 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -88.16 151.95 22.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.861 0.465 . . . . 0.0 110.328 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -110.76 160.76 16.44 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.572 0.749 . . . . 0.0 110.539 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 m -80.93 153.7 27.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.567 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.44 -7.85 28.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.9 -5.22 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.684 0.794 . . . . 0.0 111.446 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.01 15.77 11.62 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.711 0.805 . . . . 0.0 110.938 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mmt -71.14 174.13 6.73 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.562 0.696 . . . . 0.0 111.237 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.27 -13.62 62.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 112.617 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 1 O4'-C1'-N19 113.483 5.283 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.734 3.534 . 0.179 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 O4'-C1'-N19 112.16 3.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.401 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.888 1 O4'-C1'-N19 112.813 4.613 . 0.036 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.401 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.44 -2.707 . 0.162 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.0 3.8 . 0.137 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.726 4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -62.14 173.61 1.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.104 0.562 . . . . 0.0 111.736 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -106.97 25.44 11.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.251 0.62 . . . . 0.0 112.033 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.24 127.13 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 122.786 0.434 . . . . 0.0 110.408 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.2 p -149.59 18.92 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.163 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -120.81 31.15 6.54 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 28' ' ' VAL . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.42 13.54 5.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -134.23 45.36 1.49 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -62.35 137.09 63.28 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.838 2.359 . . . . 0.0 110.905 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -130.79 -12.25 3.78 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.571 0.748 . . . . 0.0 110.657 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -84.85 154.75 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.261 0.625 . . . . 0.0 109.652 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.46 -1.51 41.91 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.905 0.482 . . . . 0.0 111.948 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 46.92 50.2 13.91 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 123.874 0.87 . . . . 0.0 110.945 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.55 3.41 33.7 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.795 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 56.72 16.73 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 152.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.99 23.29 0.09 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.5 -25.62 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.125 0.97 . . . . 0.0 111.308 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -126.36 161.0 28.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.32 0.648 . . . . 0.0 110.464 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -78.54 168.32 19.96 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.997 0.519 . . . . 0.0 110.046 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.7 t -73.06 150.29 42.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.6 0.36 . . . . 0.0 110.202 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.86 -8.97 40.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.257 -0.277 . . . . 0.0 110.916 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.76 -7.48 21.62 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.801 0.84 . . . . 0.0 111.168 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -117.54 1.39 12.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.49 0.716 . . . . 0.0 111.417 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.63 -179.99 7.18 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.724 0.41 . . . . 0.0 110.54 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -64.56 -14.81 59.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.814 0.845 . . . . 0.0 112.834 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.552 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 113.53 5.33 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.813 3.613 . 0.228 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.82 4.62 . 0.033 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 0 O4'-C1'-N19 111.153 2.953 . 0.119 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 O4'-C1'-N19 112.437 4.237 . 0.09 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.555 0.216 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -72.75 174.56 7.48 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.944 0.402 . . . . 0.0 111.154 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.11 16.44 19.24 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.65 0.78 . . . . 0.0 111.452 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 5.1 p -123.89 135.5 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 56' ' ' GLN . 68.3 p -148.03 11.76 0.95 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.361 0.664 . . . . 0.0 112.028 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -104.02 19.33 20.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.402 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 83' ' ' ASN . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.39 9.75 5.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -138.55 58.82 15.09 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.0 103.51 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.31 2.674 . . . . 0.0 110.343 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.55 -11.0 59.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.81 0.444 . . . . 0.0 110.342 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.01 160.2 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.928 . . . . 0.0 110.447 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -91.18 4.87 51.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.222 0.609 . . . . 0.0 111.5 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 48.43 56.08 8.0 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.0 0.92 . . . . 0.0 111.341 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.56 3.23 43.13 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.781 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm 55.91 17.57 2.61 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.63 152.87 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.09 -0.381 . . . . 0.0 111.011 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.21 62.32 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.281 0.467 . . . . 0.0 112.67 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.92 -24.79 19.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 117.428 0.614 . . . . 0.0 110.269 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -81.62 161.25 23.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.419 0.628 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -73.04 167.61 20.75 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.164 0.985 . . . . 0.0 111.002 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.3 m -84.34 154.95 22.59 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.88 -16.0 36.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.94 -6.89 25.9 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.0 0.52 . . . . 0.0 111.797 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.01 14.77 7.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.748 0.819 . . . . 0.0 111.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.1 mmm -63.32 -26.97 69.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.798 0.272 . . . . 0.0 111.087 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.1 -10.15 0.88 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.144 0.577 . . . . 0.0 111.882 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.294 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 113.562 5.362 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 O4'-C1'-N19 112.375 4.175 . 0.141 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 2 C5'-C4'-C3' 108.292 -4.805 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 112.62 4.42 . 0.06 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C5'-C4'-C3' 111.412 -2.725 . 0.162 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.525 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.574 1 O4'-C1'-N19 112.35 4.15 . 0.197 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 111.817 3.617 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -59.73 168.77 1.59 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.548 0.739 . . . . 0.0 111.758 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -109.21 20.23 18.55 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.3 p -124.8 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 118.387 0.54 . . . . 0.0 110.125 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.5 p -148.27 19.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.017 0.527 . . . . 0.0 111.857 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -113.44 23.8 12.85 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.426 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.492 ' CD2' " H5'" ' B' ' 6' ' ' ' U' . 35.8 m80 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.74 13.26 5.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -132.92 46.58 2.19 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.78 150.93 79.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.814 2.343 . . . . 0.0 110.804 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.99 -2.39 1.02 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.173 0.589 . . . . 0.0 112.376 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.22 156.89 21.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.151 0.98 . . . . 0.0 110.545 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -75.09 -5.55 44.77 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.524 0.73 . . . . 0.0 112.391 -177.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 45.27 37.34 2.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.378 1.471 . . . . 0.0 112.39 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.6 37.18 0.85 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 126.107 1.813 . . . . 0.0 114.48 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt 61.56 -178.4 0.12 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.652 1.215 . . . . 0.0 112.312 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -19.82 66.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.142 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.02 7.69 82.02 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.07 -27.3 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 117.077 0.438 . . . . 0.0 110.681 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.07 153.19 22.87 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.818 0.447 . . . . 0.0 110.077 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -118.32 154.96 31.47 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.569 0.748 . . . . 0.0 110.689 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.2 t -80.71 152.2 28.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.85 -2.98 5.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.08 -3.99 14.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.619 0.768 . . . . 0.0 111.329 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.01 11.97 9.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.613 0.765 . . . . 0.0 111.431 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 36.5 mtp -74.55 172.81 11.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.317 0.579 . . . . 0.0 111.164 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -75.86 -10.99 59.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.836 0.854 . . . . 0.0 112.131 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.512 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.956 1 O4'-C1'-N19 113.938 5.738 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.42 0 O4'-C1'-N19 111.663 3.463 . 0.189 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 O4'-C1'-N19 112.899 4.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.404 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 113.027 4.827 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.404 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.032 0 O4'-C1'-N19 110.861 2.661 . 0.552 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.504 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.594 1 O4'-C1'-N19 112.433 4.233 . 0.106 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.026 1 O4'-C1'-N19 114.779 6.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.397 0.141 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -64.88 176.91 1.06 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.211 0.605 . . . . 0.0 111.228 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -112.29 30.73 6.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.407 0.683 . . . . 0.0 112.11 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.94 129.65 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 122.565 0.346 . . . . 0.0 110.372 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.8 p -149.39 22.31 0.93 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.924 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -122.98 32.66 5.63 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.1 11.42 4.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.49 48.67 3.23 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.72 127.53 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.827 2.351 . . . . 0.0 111.49 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -113.26 -1.1 14.38 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.853 0.861 . . . . 0.0 109.897 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 p -91.82 154.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 123.119 0.568 . . . . 0.0 110.343 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -86.35 1.01 52.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.217 0.607 . . . . 0.0 111.84 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 49.05 43.27 22.1 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.868 0.867 . . . . 0.0 111.319 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 8.59 7.45 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.203 0.906 . . . . 0.0 114.119 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 57.17 12.79 1.41 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.6 -25.97 0.19 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.76 0.424 . . . . 0.0 111.157 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.21 -1.21 85.94 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.136 0.398 . . . . 0.0 112.162 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.3 t -124.24 -24.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.411 0.684 . . . . 0.0 111.105 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.52 166.22 19.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.147 0.579 . . . . 0.0 110.673 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.79 171.77 14.7 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.527 0.731 . . . . 0.0 110.999 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.6 m -78.44 24.99 0.25 Allowed 'General case' 0 CA--C 1.524 -0.048 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 52.98 6.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.299 1.44 . . . . 0.0 114.63 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.69 -5.48 1.36 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.948 0.899 . . . . 0.0 110.417 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.59 20.43 8.64 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.501 1.12 . . . . 0.0 109.318 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.7 mtp -71.64 176.33 4.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -67.53 -13.3 61.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.49 0.716 . . . . 0.0 112.252 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.604 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.577 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.08 1 O4'-C1'-N19 113.401 5.201 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 O4'-C1'-N19 111.941 3.741 . 0.23 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 112.518 4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 1 O4'-C1'-N19 113.017 4.817 . 0.026 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 O4'-C1'-N19 110.933 2.733 . 0.145 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.502 4.302 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 O4'-C1'-N19 113.371 5.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -86.4 8.34 22.07 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.0 t30 53.97 32.99 16.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.506 0.594 . . . . 0.0 112.33 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 7.8 p -145.67 137.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 O-C-N 122.157 -0.339 . . . . 0.0 110.569 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -150.97 12.24 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.68 0.792 . . . . 0.0 112.063 -173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -112.4 15.05 20.39 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.543 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -126.39 13.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -135.99 48.1 2.45 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.31 142.08 71.34 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.742 2.294 . . . . 0.0 110.984 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -137.69 1.01 2.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.722 0.809 . . . . 0.0 111.052 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.0 153.61 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.318 0.647 . . . . 0.0 109.911 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.32 0.88 20.55 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.318 0.647 . . . . 0.0 112.549 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.3 46.93 16.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.049 0.939 . . . . 0.0 111.129 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.03 7.96 7.02 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.807 0.718 . . . . 0.0 113.945 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 59.18 4.7 0.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.085 1.354 . . . . 0.0 114.146 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.76 152.42 28.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.314 0.645 . . . . 0.0 109.672 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.45 -1.17 64.42 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.26 -23.0 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -78.24 152.84 32.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.742 0.417 . . . . 0.0 110.823 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.66 173.16 11.98 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.381 1.072 . . . . 0.0 110.51 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.5 t -72.24 151.82 42.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.76 -2.72 3.94 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.74 13.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.588 0.755 . . . . 0.0 111.396 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.48 7.33 10.62 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.467 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mtp -69.76 -24.82 63.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.077 -0.39 . . . . 0.0 112.052 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -140.16 -3.21 1.4 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.008 0.523 . . . . 0.0 111.904 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 O4'-C1'-N19 113.672 5.472 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 112.049 3.849 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 O4'-C1'-N19 112.195 3.995 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 O4'-C1'-N19 113.108 4.908 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 O4'-C1'-N19 110.664 2.464 . 0.507 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.469 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 112.234 4.034 . 0.12 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.101 1 O4'-C1'-N19 113.246 5.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.346 0.117 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -65.28 175.66 1.61 Allowed 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -106.65 21.5 17.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.9 0.48 . . . . 0.0 112.017 -176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.97 126.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 118.081 0.4 . . . . 0.0 111.035 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.4 p -150.13 16.2 0.84 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -115.13 18.26 16.34 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.407 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD21 HG11 ' A' ' 28' ' ' VAL . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 83' ' ' ASN . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.93 10.57 6.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.64 57.4 16.17 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 147.67 62.33 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.296 2.664 . . . . 0.0 109.714 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.32 2.85 3.05 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.18 0.592 . . . . 0.0 111.484 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.57 154.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.454 0.702 . . . . 0.0 109.469 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -73.93 4.63 5.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.763 0.825 . . . . 0.0 112.827 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 49.47 54.01 11.71 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.738 0.815 . . . . 0.0 111.028 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.83 13.45 3.14 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.103 0.859 . . . . 0.0 113.995 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 56.28 -97.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.976 1.311 . . . . 0.0 112.96 178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.52 -13.96 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.86 81.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.5 -30.97 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.62 162.76 14.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.726 0.81 . . . . 0.0 109.186 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.65 166.32 23.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.651 0.262 . . . . 0.0 110.419 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -69.34 159.24 33.51 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.99 -10.65 59.34 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.139 -0.351 . . . . 0.0 111.385 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -98.58 -6.38 30.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.408 0.683 . . . . 0.0 111.001 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.34 17.43 5.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.363 1.065 . . . . 0.0 109.741 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.1 tpt -64.83 -22.72 67.05 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.334 0.654 . . . . 0.0 111.621 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -139.81 -10.68 1.17 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.648 0.379 . . . . 0.0 111.968 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.972 1 O4'-C1'-N19 113.697 5.497 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 O4'-C1'-N19 111.798 3.598 . 0.213 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 C5'-C4'-C3' 108.557 -4.629 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.445 2 O4'-C1'-N19 112.978 4.778 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.827 0 C5'-C4'-C3' 111.897 -2.402 . 0.343 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 112.82 4.62 . 0.108 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 1 O4'-C1'-N19 112.471 4.271 . 0.577 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.302 0.096 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -74.03 174.45 8.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.844 0.458 . . . . 0.0 111.626 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -113.79 30.38 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.038 0.935 . . . . 0.0 111.526 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.73 140.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 56' ' ' GLN . 7.2 p -144.82 -8.55 0.63 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.85 0.86 . . . . 0.0 111.084 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -77.59 23.93 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -170.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.7 t-20 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.57 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.45 12.64 4.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -134.62 46.58 1.94 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.1 144.05 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.715 2.277 . . . . 0.0 110.895 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.66 4.94 3.65 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.83 0.852 . . . . 0.0 110.95 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.75 152.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -75.83 2.44 12.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.718 0.807 . . . . 0.0 112.217 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 48.78 52.06 14.73 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.874 0.869 . . . . 0.0 111.139 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 8.46 7.17 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.006 0.812 . . . . 0.0 113.316 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt 59.62 -5.0 0.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.995 1.718 . . . . 0.0 115.388 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.44 -24.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.864 0.756 . . . . 0.0 111.652 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.78 -0.89 75.81 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.3 t -102.64 -25.43 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.494 0.717 . . . . 0.0 110.707 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -76.46 159.66 30.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.156 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -76.7 164.86 25.48 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.706 0.803 . . . . 0.0 110.885 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -70.21 158.19 36.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.284 0.634 . . . . 0.0 109.653 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.45 -8.75 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.23 -6.84 27.38 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.165 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.39 7.92 6.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.016 0.926 . . . . 0.0 111.146 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -21.89 63.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.478 0.311 . . . . 0.0 111.435 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -140.5 -11.64 1.04 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.656 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 O4'-C1'-N19 113.552 5.352 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.405 4.205 . 0.165 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.455 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.645 1 O4'-C1'-N19 112.844 4.644 OUTLIER-DELTA 0.053 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.405 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.781 4.581 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.405 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 C5'-C4'-C3' 111.81 -2.46 . 0.108 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.881 3.681 . 0.193 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 O4'-C1'-N19 113.055 4.855 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -80.97 1.61 30.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.83 30.42 13.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.606 0.639 . . . . 0.0 112.383 176.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 12.0 p -142.43 136.38 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 17' ' ' ARG . 82.4 p -147.88 10.84 0.93 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -99.71 23.93 8.98 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.264 -0.897 . . . . 0.0 112.727 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.481 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HE2' " H5'" ' B' ' 1' ' ' ' A' . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.92 10.12 4.99 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.73 48.33 2.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.81 136.74 46.65 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.525 2.15 . . . . 0.0 110.811 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -129.89 -3.9 4.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.796 0.838 . . . . 0.0 110.201 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.31 156.05 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.582 0.753 . . . . 0.0 109.746 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.57 2.55 47.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.875 0.47 . . . . 0.0 111.926 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mtm105 48.39 40.84 15.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.885 0.874 . . . . 0.0 110.924 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 11.77 9.78 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.626 1.107 . . . . 0.0 113.888 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 59.5 4.81 0.55 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.02 1.328 . . . . 0.0 114.256 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.04 149.63 23.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.078 0.551 . . . . 0.0 109.753 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.29 -1.47 75.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.21 -20.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.014 0.926 . . . . 0.0 110.958 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -71.54 151.17 44.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.642 0.377 . . . . 0.0 111.606 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.84 165.01 13.85 Favored 'General case' 0 CA--C 1.524 -0.033 0 C-N-CA 123.879 0.872 . . . . 0.0 110.081 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 t -75.49 151.74 37.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.13 -5.02 15.67 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.935 -0.478 . . . . 0.0 111.802 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -6.48 22.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.621 0.768 . . . . 0.0 111.038 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.93 7.61 5.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.077 0.951 . . . . 0.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.5 ttm -89.7 160.54 16.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.567 0.747 . . . . 0.0 110.962 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.39 -14.44 62.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.667 1.587 . . . . 0.0 113.135 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.458 " H5'" ' HE2' ' A' ' 50' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.603 0 C3'-C2'-C1' 104.91 3.789 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 N19-C1'-C2' 107.046 -3.972 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 1 O4'-C1'-N19 112.845 4.645 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.402 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 O4'-C1'-N19 113.022 4.822 . 0.011 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.402 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.736 0 O4'-C1'-N19 110.708 2.508 . 0.125 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.494 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.429 4.229 . 0.157 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.412 H5'' " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 113.16 4.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.3 0.095 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -62.28 173.36 1.19 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.642 0.777 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -109.66 15.67 22.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -119.02 138.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 118.384 0.538 . . . . 0.0 110.181 -174.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 p -147.0 2.27 0.78 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -87.89 33.05 0.72 Allowed 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.642 -0.661 . . . . 0.0 112.334 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.477 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 83' ' ' ASN . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HA ' HG13 ' A' ' 67' ' ' VAL . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.18 13.91 5.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -131.24 50.09 5.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.25 71.11 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.829 3.019 . . . . 0.0 111.586 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.22 -9.18 59.09 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -86.77 155.49 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.095 0.958 . . . . 0.0 109.294 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.79 0.86 51.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.759 0.423 . . . . 0.0 111.62 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 56.48 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.284 1.433 . . . . 0.0 111.337 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.61 -2.55 15.59 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.866 0.746 . . . . 0.0 114.267 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 54.35 11.12 0.37 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.473 1.109 . . . . 0.0 113.893 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.8 -16.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.789 0.436 . . . . 0.0 111.907 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.75 9.24 86.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.49 -21.0 10.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.983 0.513 . . . . 0.0 110.911 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.01 149.75 49.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.95 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.22 154.74 18.46 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.689 0.796 . . . . 0.0 110.263 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 t -85.9 148.94 25.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.9 -6.27 11.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.677 0.391 . . . . 0.0 112.029 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.69 -8.81 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -117.49 8.15 12.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.299 0.64 . . . . 0.0 111.546 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 41.1 mtp -70.68 -26.09 63.27 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.6 -5.02 1.58 Allowed 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.075 0.55 . . . . 0.0 111.988 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 114.298 6.098 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.804 3.604 . 0.25 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.427 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.386 4.186 OUTLIER-DELTA 0.065 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.421 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 O4'-C1'-N19 112.39 4.19 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.421 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.142 3.942 . 0.089 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.521 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 112.433 4.233 . 0.187 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 O4'-C1'-N19 112.422 4.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -72.85 177.91 4.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.2 0.6 . . . . 0.0 111.553 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -118.04 34.99 4.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.339 1.056 . . . . 0.0 111.259 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.44 136.47 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 111.195 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -152.07 19.13 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.147 1.779 . . . . 0.0 109.37 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -112.97 15.25 19.72 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' CA ' ' HE2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.567 ' HA ' HG12 ' A' ' 28' ' ' VAL . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD21 ' C5 ' ' B' ' 2' ' ' ' U' . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.8 13.14 5.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -132.86 48.58 3.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.46 139.22 37.33 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.192 1.928 . . . . 0.0 109.325 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.9 3.21 8.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.134 0.574 . . . . 0.0 111.112 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.46 159.1 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 110.049 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.0 2.74 8.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.765 0.826 . . . . 0.0 111.412 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 63.17 -30.71 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.658 2.383 . . . . 0.0 113.949 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.31 -2.69 1.47 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.441 1.019 . . . . 0.0 114.838 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 53.66 5.09 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.57 -20.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.169 0.441 . . . . 0.0 111.2 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.57 -0.51 81.04 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.81 -23.43 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.714 0.806 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.75 151.74 41.98 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.046 -0.409 . . . . 0.0 110.636 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -84.91 161.27 19.91 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.8 m -82.97 152.81 25.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.81 -10.12 44.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.613 0.642 . . . . 0.0 111.789 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.32 -8.21 39.59 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.43 0.692 . . . . 0.0 111.373 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.73 3.03 6.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.706 0.803 . . . . 0.0 110.927 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.9 ttm -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.304 0.641 . . . . 0.0 111.033 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -133.48 -8.95 2.87 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.935 0.494 . . . . 0.0 111.559 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.389 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.483 " H3'" " H5'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C5'-C4'-C3' 110.179 -3.548 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.51 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.366 0 O4'-C1'-N19 112.12 3.92 . 0.144 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.425 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 111.367 3.167 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.413 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 O4'-C1'-N19 114.129 5.929 OUTLIER-DELTA 0.01 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.413 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 111.048 -2.968 . 0.021 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 111.056 2.856 . 0.213 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 1 O4'-C1'-N19 113.821 5.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.316 0.103 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -77.66 -174.15 3.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.842 0.457 . . . . 0.0 110.678 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -118.46 21.34 12.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 111.961 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG12 ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -117.72 129.51 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.533 0.606 . . . . 0.0 110.411 -174.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 56.3 p -148.82 16.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -111.73 17.05 20.23 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HE2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG12 ' A' ' 28' ' ' VAL . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD2' ' C5 ' ' B' ' 2' ' ' ' U' . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HD3' ' C2 ' ' B' ' 2' ' ' ' U' . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' N ' " H1'" ' B' ' 2' ' ' ' U' . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.27 14.11 5.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -132.78 46.91 2.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.05 144.08 74.56 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.995 2.464 . . . . 0.0 111.383 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -138.34 1.98 2.24 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.123 0.969 . . . . 0.0 111.032 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.61 154.46 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.386 0.675 . . . . 0.0 110.514 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -84.56 2.85 39.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.303 0.641 . . . . 0.0 111.881 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 48.51 51.6 15.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 111.4 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.78 1.92 35.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.399 0.523 . . . . 0.0 113.976 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 55.84 15.13 1.55 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.09 -18.79 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.53 3.14 82.45 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 67.9 t -89.14 -21.4 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.788 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -69.93 151.45 45.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.355 0.262 . . . . 0.0 110.632 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.38 156.55 19.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.792 0.837 . . . . 0.0 110.328 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.9 m -84.14 156.6 22.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -6.15 9.54 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.99 -5.8 15.34 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.385 0.674 . . . . 0.0 110.986 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -123.26 13.83 9.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 110.785 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.0 mmm -62.06 -22.47 65.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -139.72 -6.49 1.31 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.957 0.503 . . . . 0.0 111.822 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.535 " H3'" H5'' ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.285 2 O4'-C1'-N19 113.958 5.758 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.583 ' C5 ' ' CD2' ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.472 1 C5'-C4'-C3' 108.114 -4.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 O4'-C1'-N19 112.662 4.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 113.268 5.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 112.36 -2.093 . 0.333 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 1 O4'-C1'-N19 112.357 4.157 . 0.151 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 110.074 -3.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -72.37 176.98 4.85 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.911 0.485 . . . . 0.0 111.421 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -115.4 19.62 15.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.881 0.872 . . . . 0.0 111.383 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 6.5 p -123.24 133.53 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.1 p -149.32 18.6 0.95 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.401 0.68 . . . . 0.0 111.76 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.25 17.16 19.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' ' C2 ' ' B' ' 3' ' ' ' U' . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.01 13.03 7.27 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 79.3 mt-10 -130.87 45.53 1.81 Allowed Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 83.6 Cg_endo -70.22 81.25 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.178 2.585 . . . . 0.0 110.678 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.53 -7.04 59.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.784 0.434 . . . . 0.0 110.76 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.1 p -90.33 155.48 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.316 0.646 . . . . 0.0 109.345 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -75.88 -8.02 55.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 43.05 66.38 0.79 Allowed 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.123 0.969 . . . . 0.0 111.168 -175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.97 -3.1 20.99 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.919 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' C6 ' ' B' ' 3' ' ' ' U' . 44.1 mtmt 55.12 7.7 0.2 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.356 1.462 . . . . 0.0 113.991 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.34 -164.39 1.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.233 0.54 . . . . 0.0 110.976 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.07 -2.87 4.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.19 -24.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.74 0.816 . . . . 0.0 111.038 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -83.72 160.18 21.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.375 0.67 . . . . 0.0 111.024 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -98.45 164.48 12.26 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.835 0.854 . . . . 0.0 110.555 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t -77.12 153.68 34.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.248 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.22 -3.32 10.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.36 -4.54 12.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.987 0.915 . . . . 0.0 111.36 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.05 8.32 8.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.316 0.646 . . . . 0.0 111.13 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 106' ' ' GLY . 8.2 ptm -115.14 -176.08 2.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.57 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.68 -15.21 51.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.741 0.816 . . . . 0.0 113.148 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.503 ' H ' ' HG3' ' A' ' 104' ' ' MET . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 1 O4'-C1'-N19 114.022 5.822 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 112.063 3.863 . 0.243 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.422 ' C2 ' ' HA ' ' A' ' 22' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -2.962 4 O4'-C1'-N19 114.801 6.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.402 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.194 0 O5'-C5'-C4' 115.735 3.954 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.402 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.899 2.699 . 0.017 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.496 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.128 4.928 . 0.21 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 110.337 -3.442 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' HB3' HE21 ' A' ' 78' ' ' GLN . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.406 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 24' ' ' ASN . 4.3 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.637 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.448 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.608 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 28' ' ' VAL . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.499 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.495 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 83' ' ' ASN . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.421 ' HA ' HG13 ' A' ' 67' ' ' VAL . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 119.093 -0.479 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.447 HD21 HG23 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 HD21 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.614 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 28' ' ' VAL . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.402 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 83' ' ' ASN . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.605 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.426 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.594 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.543 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.407 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 HD21 HG11 ' A' ' 28' ' ' VAL . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.412 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 24.5 m-70 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 83' ' ' ASN . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.59 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.6 t30 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 2.0 pm0 -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.57 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.481 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.477 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 83' ' ' ASN . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HA ' HG13 ' A' ' 67' ' ' VAL . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.567 ' HA ' HG12 ' A' ' 28' ' ' VAL . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.588 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.45 ' HE3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG12 ' A' ' 28' ' ' VAL . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.595 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 13.2 m-70 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.461 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.59 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 120.402 0.144 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 m -65.27 177.26 1.12 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 123.551 0.74 . . . . 0.0 111.513 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -107.57 24.29 13.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.655 0.782 . . . . 0.0 112.488 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.55 128.62 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 118.214 0.461 . . . . 0.0 111.122 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.6 p -149.97 16.61 0.86 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.537 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -114.26 19.87 15.98 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.37 167.55 5.27 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.393 0.542 . . . . 0.0 109.936 175.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -132.82 22.63 4.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 122.053 -0.405 . . . . 0.0 112.048 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.59 153.9 94.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 122.644 0.377 . . . . 0.0 110.808 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.36 -5.76 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 124.112 3.208 . . . . 0.0 113.371 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? -124.39 -8.32 7.52 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.189 0.449 . . . . 0.0 111.513 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -95.17 -18.44 20.92 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 122.788 0.435 . . . . 0.0 110.563 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.48 -14.29 60.05 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.066 0.547 . . . . 0.0 110.992 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -123.62 2.49 8.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.6 p -101.57 13.57 34.56 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -112.82 155.97 23.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.562 1.145 . . . . 0.0 110.918 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.03 127.88 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.446 0.698 . . . . 0.0 109.602 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.35 136.28 34.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.49 92.44 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.09 172.55 29.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.2 0.429 . . . . 0.0 112.746 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.0 t30 52.82 25.42 3.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.89 1.276 . . . . 0.0 111.447 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.1 tp -75.74 149.46 38.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.401 0.68 . . . . 0.0 112.558 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' HB3' HE21 ' A' ' 78' ' ' GLN . 2.5 p-10 -75.52 57.26 0.93 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.972 1.709 . . . . 0.0 111.009 174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.459 ' HA ' HG12 ' A' ' 28' ' ' VAL . 76.2 p -66.93 -3.52 7.22 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -93.7 -0.13 56.16 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 122.723 0.409 . . . . 0.0 111.025 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.62 -25.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 122.756 0.422 . . . . 0.0 110.366 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.72 167.66 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.962 0.346 . . . . 0.0 110.175 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -146.66 173.4 12.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.577 0.751 . . . . 0.0 109.728 174.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -60.97 -33.64 73.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -77.21 -9.49 58.82 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.45 0.3 . . . . 0.0 110.853 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.9 m-20 -95.56 -41.16 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.0 -36.45 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.4 4.93 11.74 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.352 0.524 . . . . 0.0 111.794 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.95 -9.76 10.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.137 0.575 . . . . 0.0 111.416 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -102.97 -22.11 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.522 0.729 . . . . 0.0 110.412 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.52 -7.03 15.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.804 0.441 . . . . 0.0 111.811 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -76.21 -9.88 58.98 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.319 0.508 . . . . 0.0 111.311 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -81.58 -7.27 59.57 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.991 0.516 . . . . 0.0 111.739 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 10.1 m-85 -119.11 -2.23 10.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.241 0.616 . . . . 0.0 112.122 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.03 168.66 34.58 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.78 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -78.77 113.96 17.28 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.23 129.92 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.12 7.06 6.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.432 0.693 . . . . 0.0 110.551 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.58 145.66 8.67 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -155.52 144.91 21.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.819 0.809 . . . . 0.0 109.799 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.9 p -148.32 157.53 43.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.15 145.78 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -140.85 -169.7 2.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -83.66 129.55 34.96 Favored 'General case' 0 C--N 1.337 0.04 0 CA-C-N 118.568 0.622 . . . . 0.0 109.962 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.36 -12.12 3.58 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.232 0.92 . . . . 0.0 114.096 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.41 167.26 28.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.781 1.29 . . . . 0.0 111.136 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 170.38 18.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.825 0.85 . . . . 0.0 109.47 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.42 149.23 45.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.191 0.52 . . . . 0.0 111.687 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.3 t -134.84 138.89 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -118.09 111.79 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.584 0.754 . . . . 0.0 109.279 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -90.43 -179.67 5.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.154 0.582 . . . . 0.0 110.203 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.83 -26.95 7.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.692 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -151.35 175.15 12.52 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.799 0.44 . . . . 0.0 111.701 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.01 -34.82 71.7 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.239 0.616 . . . . 0.0 111.756 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -57.61 -39.76 77.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.965 0.506 . . . . 0.0 110.018 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.94 -34.58 76.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.44 78.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.838 -0.539 . . . . 0.0 111.189 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.87 -25.76 68.03 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.304 0.502 . . . . 0.0 110.416 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.6 -40.7 76.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.06 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.94 -28.91 16.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.92 -22.19 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 O-C-N 122.229 -0.294 . . . . 0.0 110.228 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.45 -10.13 14.57 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.0 -22.12 16.36 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.008 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -123.35 -15.47 7.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.235 1.018 . . . . 0.0 111.933 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.79 130.91 49.19 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.73 0.696 . . . . 0.0 110.811 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.08 13.96 73.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.529 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -92.11 160.16 15.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.433 1.117 . . . . 0.0 111.497 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ttm -97.71 138.26 35.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.1 mt -143.84 137.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.32 13.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.4 -2.93 39.9 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.388 -0.673 . . . . 0.0 113.726 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 24' ' ' ASN . 4.3 mp0 -127.0 163.19 24.26 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.233 1.016 . . . . 0.0 109.743 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.86 147.08 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.637 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.31 144.49 44.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.503 0.721 . . . . 0.0 110.227 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.05 106.95 18.76 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.7 mt -104.21 139.55 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.14 164.73 38.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.823 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -64.14 145.64 55.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.82 -3.55 42.05 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -128.53 14.51 6.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.571 0.348 . . . . 0.0 111.306 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -133.5 47.69 2.8 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.83 138.46 63.5 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.586 2.19 . . . . 0.0 111.069 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -130.99 -23.21 2.5 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.932 0.893 . . . . 0.0 110.693 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.54 154.48 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.201 0.601 . . . . 0.0 110.229 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.41 3.26 28.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.26 0.624 . . . . 0.0 111.611 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 49.05 45.9 22.72 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.312 1.045 . . . . 0.0 111.006 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.78 8.68 10.32 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.135 0.874 . . . . 0.0 113.869 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 57.46 9.3 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.634 1.174 . . . . 0.0 113.927 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.96 -15.63 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.715 0.406 . . . . 0.0 111.706 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.61 5.99 89.15 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.8 t -86.57 -23.59 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 117.392 0.596 . . . . 0.0 111.057 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -72.92 148.93 43.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.33 0.252 . . . . 0.0 110.65 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -121.96 159.61 26.57 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.341 1.056 . . . . 0.0 110.0 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 t -82.78 153.68 25.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.9 -7.66 30.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.491 0.316 . . . . 0.0 111.636 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.91 -7.11 17.19 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -119.33 14.7 12.96 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.85 0.86 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.3 mmt -65.73 169.55 6.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.699 0.761 . . . . 0.0 111.499 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.77 -13.72 62.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.199 1.4 . . . . 0.0 112.408 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 1 O4'-C1'-N19 113.513 5.313 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.426 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.424 -2.412 1 O4'-C1'-N19 113.155 4.955 . 0.193 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 2 O4'-C1'-N19 112.705 4.505 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.779 1 O4'-C1'-N19 112.623 4.423 . 0.025 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 0 O4'-C1'-N19 110.626 2.426 . 0.161 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.554 1 O4'-C1'-N19 112.238 4.038 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.154 1 O4'-C1'-N19 113.928 5.728 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.371 0.129 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 t -63.28 172.05 2.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.933 0.493 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -108.18 13.55 25.76 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.196 0.598 . . . . 0.0 112.571 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 7.4 p -120.35 135.43 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 110.231 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.0 p -148.69 10.76 0.84 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.941 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -99.96 18.36 18.62 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.554 1.07 . . . . 0.0 113.821 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -64.45 158.51 23.67 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.776 0.43 . . . . 0.0 109.872 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -130.06 26.25 5.2 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.21 158.67 87.15 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 122.761 0.424 . . . . 0.0 110.91 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.27 -9.32 19.41 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.026 3.151 . . . . 0.0 113.615 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -127.64 -10.93 5.6 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.4 p -88.61 -23.2 23.15 Favored 'General case' 0 CA--C 1.526 0.037 0 CA-C-N 118.079 0.4 . . . . 0.0 110.464 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -14.72 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.681 0.393 . . . . 0.0 111.376 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.8 p30 -121.5 5.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.756 0.422 . . . . 0.0 111.849 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.6 p -107.0 14.94 25.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -119.75 153.13 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.748 0.819 . . . . 0.0 110.536 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.74 133.87 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.886 0.874 . . . . 0.0 109.923 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -98.18 136.61 38.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -129.44 95.75 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.48 171.58 25.43 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 122.799 0.238 . . . . 0.0 112.902 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.5 19.01 3.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.001 1.321 . . . . 0.0 112.785 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -71.35 152.31 43.31 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.795 -0.566 . . . . 0.0 109.773 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.79 -42.39 95.1 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.639 0.376 . . . . 0.0 111.584 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.448 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.5 p 52.95 9.77 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.073 1.749 . . . . 0.0 115.565 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.28 -17.81 15.74 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.72 0.691 . . . . 0.0 111.255 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.2 t -128.84 -15.74 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 122.765 0.426 . . . . 0.0 110.668 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.14 158.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.02 11.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -57.9 -37.64 74.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 p -75.99 -6.47 51.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.783 0.833 . . . . 0.0 111.005 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -96.43 -42.0 8.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.36 -36.93 78.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 O-C-N 121.819 -0.551 . . . . 0.0 109.94 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.84 7.16 13.5 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.979 -0.451 . . . . 0.0 111.45 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.18 -10.3 9.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.419 0.687 . . . . 0.0 111.354 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.7 -22.28 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.041 0 C-N-CA 123.687 0.795 . . . . 0.0 110.101 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.89 -6.03 15.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.74 0.416 . . . . 0.0 111.791 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t -79.66 -3.71 48.49 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.541 -0.725 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 65.0 pttt -87.36 -6.88 58.3 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.203 0.601 . . . . 0.0 111.353 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 8.9 m-85 -119.77 -2.02 10.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.207 0.603 . . . . 0.0 111.869 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.11 168.74 35.41 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.662 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -79.82 113.48 18.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -86.24 128.36 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 m -115.99 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 123.025 0.53 . . . . 0.0 110.571 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.38 144.77 8.63 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.1 t -153.44 147.58 25.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 117.599 0.7 . . . . 0.0 110.787 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.7 p -148.22 155.82 41.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.72 143.28 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -138.46 -171.09 2.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.636 0.774 . . . . 0.0 109.178 -170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -83.67 129.66 34.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.49 -14.95 4.93 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.165 0.888 . . . . 0.0 114.123 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -154.81 169.62 23.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.127 1.464 . . . . 0.0 112.157 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.97 169.25 21.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.025 0.93 . . . . 0.0 110.117 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -138.03 145.78 42.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.189 0.596 . . . . 0.0 111.461 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.68 121.37 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -102.2 110.97 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.568 0.747 . . . . 0.0 109.026 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.36 -177.45 5.37 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.086 0.554 . . . . 0.0 110.507 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -83.92 -29.34 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 122.828 0.451 . . . . 0.0 110.985 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -150.3 174.79 12.45 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 120.912 0.387 . . . . 0.0 111.949 -176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -70.1 -34.95 73.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.275 0.63 . . . . 0.0 111.473 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.88 -40.22 79.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.796 0.438 . . . . 0.0 109.863 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.36 -34.86 78.18 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.523 0.329 . . . . 0.0 110.276 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.06 -41.35 77.71 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.031 -0.418 . . . . 0.0 111.063 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -65.86 -25.14 67.06 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.276 0.489 . . . . 0.0 110.415 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.83 75.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 117.565 0.166 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.73 -28.84 17.16 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 t -68.79 -22.41 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 O-C-N 122.03 -0.419 . . . . 0.0 110.332 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.97 -9.58 14.42 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.39 -25.28 11.15 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.291 -0.727 . . . . 0.0 113.88 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -121.36 -15.15 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.265 1.033 . . . . 0.0 111.753 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.36 130.61 47.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.913 0.779 . . . . 0.0 110.73 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.14 12.41 73.77 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.451 -0.638 . . . . 0.0 112.494 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.67 160.81 15.67 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.258 1.029 . . . . 0.0 111.067 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 ttm -98.29 138.42 35.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.628 0.251 . . . . 0.0 111.113 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -142.87 136.44 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.84 14.84 0.47 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.05 1.26 48.41 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.313 -0.715 . . . . 0.0 113.326 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.62 156.51 44.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.488 1.144 . . . . 0.0 110.063 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.8 t -95.07 147.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.608 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.47 142.77 47.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.655 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -99.03 106.98 19.29 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.55 139.24 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -155.84 164.0 39.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.699 -175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.15 146.06 54.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.23 -2.5 34.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.43 12.59 5.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.003 0.521 . . . . 0.0 111.675 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -134.07 48.3 3.1 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.75 141.46 65.94 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.573 2.182 . . . . 0.0 110.874 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -135.66 -5.11 2.24 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.404 0.682 . . . . 0.0 111.074 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -99.18 154.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.356 0.662 . . . . 0.0 109.72 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.11 0.58 18.35 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.38 0.672 . . . . 0.0 112.53 -174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 47.69 47.32 17.98 Favored 'General case' 0 CA--C 1.522 -0.1 0 C-N-CA 123.699 0.8 . . . . 0.0 110.849 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 14.13 6.1 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.899 0.761 . . . . 0.0 114.21 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp 59.2 5.61 0.6 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.53 -18.08 0.17 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.53 0.604 . . . . 0.0 112.292 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.43 10.37 84.53 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.84 -21.82 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 CA-C-N 117.315 0.557 . . . . 0.0 111.145 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -69.96 150.93 46.18 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 122.352 0.261 . . . . 0.0 110.578 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -114.65 159.59 20.31 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.717 0.807 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.5 t -82.29 157.96 23.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.233 0.613 . . . . 0.0 110.311 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.73 -8.97 57.44 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.21 0.204 . . . . 0.0 111.202 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -7.9 21.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 111.219 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -119.12 6.17 11.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.468 0.707 . . . . 0.0 110.745 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.3 tpp -76.22 163.63 26.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.859 0.463 . . . . 0.0 110.225 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 105' ' ' TYR . 3.6 m-85 -85.44 -9.83 56.98 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.59 1.156 . . . . 0.0 112.848 -170.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 123.513 0.578 . . . . 0.0 111.719 -179.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.953 1 O4'-C1'-N19 113.464 5.264 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 111.786 3.586 . 0.231 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 2 O4'-C1'-N19 112.88 4.68 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.931 1 O4'-C1'-N19 112.666 4.466 . 0.031 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 111.643 -2.572 . 0.15 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.483 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.423 -2.502 1 O4'-C1'-N19 112.736 4.536 . 0.195 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C4'-C3'-C2' 100.099 -2.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.464 0.174 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -63.73 176.23 0.95 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.303 0.641 . . . . 0.0 111.757 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -101.22 9.48 41.81 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.329 0.652 . . . . 0.0 111.731 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.38 125.02 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 118.238 0.472 . . . . 0.0 111.475 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 66.7 p -148.18 17.86 1.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.214 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -118.37 19.73 13.3 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.19 165.59 5.65 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.591 0.632 . . . . 0.0 110.005 176.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -130.73 26.02 5.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -72.23 154.29 92.14 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.598 0.359 . . . . 0.0 110.08 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.24 0.74 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.325 3.35 . . . . 0.0 112.847 -176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -131.43 -12.47 3.49 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.938 0.495 . . . . 0.0 111.876 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -89.67 -22.2 22.38 Favored 'General case' 0 C--N 1.336 0.013 0 CA-C-N 117.94 0.336 . . . . 0.0 110.174 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 47.5 mmm -75.46 -11.32 60.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 111.993 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -124.23 -1.61 8.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.102 0.561 . . . . 0.0 111.572 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.2 p -99.76 12.81 35.69 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 123.024 0.53 . . . . 0.0 109.936 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -112.73 156.56 22.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.339 1.056 . . . . 0.0 110.655 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.41 127.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.689 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -96.93 131.4 43.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.47 89.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.56 33.48 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.716 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.4 t30 56.42 17.85 3.16 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.106 1.362 . . . . 0.0 112.584 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -70.92 151.45 44.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.13 0.572 . . . . 0.0 109.935 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -65.37 -40.31 93.37 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 122.29 -0.256 . . . . 0.0 111.248 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' HG12 ' A' ' 28' ' ' VAL . 30.8 p 52.73 8.82 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.142 1.777 . . . . 0.0 115.376 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -103.26 -21.27 13.87 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 119.18 0.9 . . . . 0.0 111.019 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.68 -19.11 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.543 0.737 . . . . 0.0 109.983 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.11 157.02 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.39 173.54 11.4 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.663 0.785 . . . . 0.0 108.901 176.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.05 -39.49 78.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 76.8 p -72.53 -7.6 50.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.563 0.745 . . . . 0.0 111.088 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -96.74 -40.92 8.74 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 175.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -67.68 -35.17 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.318 0.508 . . . . 0.0 109.776 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.79 7.65 14.5 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.069 -0.394 . . . . 0.0 111.351 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.15 -11.35 9.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.122 0.569 . . . . 0.0 111.192 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.09 -20.25 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.508 0.723 . . . . 0.0 109.838 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.24 -13.82 13.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.351 0.261 . . . . 0.0 111.667 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -72.93 -8.7 56.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.483 -0.761 . . . . 0.0 110.618 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -87.32 0.13 55.9 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.593 0.757 . . . . 0.0 111.566 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -121.06 -6.42 9.49 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.456 0.702 . . . . 0.0 111.675 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.67 169.76 36.35 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.469 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -78.89 114.17 17.61 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.46 129.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.56 3.85 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.046 0 C-N-CA 123.604 0.761 . . . . 0.0 110.785 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.79 140.21 6.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 50.6 t -151.79 144.01 23.98 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.53 0.665 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.4 t -152.35 152.03 31.58 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.44 144.44 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -138.09 -170.95 2.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.306 1.043 . . . . 0.0 108.825 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -81.35 137.17 35.75 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.83 -17.35 1.27 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.512 1.053 . . . . 0.0 114.485 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -154.8 168.27 27.43 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.683 1.241 . . . . 0.0 111.714 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.27 169.02 21.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.899 0.879 . . . . 0.0 110.075 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -139.0 148.35 43.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.248 0.547 . . . . 0.0 111.616 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.8 t -135.91 138.98 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -118.87 111.16 18.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -90.44 -179.29 5.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.371 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.41 -26.38 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 122.588 0.355 . . . . 0.0 110.655 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.87 174.88 13.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.199 0.523 . . . . 0.0 111.909 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -69.57 -36.31 76.17 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.595 0.758 . . . . 0.0 111.523 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -57.7 -40.11 78.75 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.147 0.579 . . . . 0.0 110.16 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.15 -35.17 77.65 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.92 76.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.008 -0.433 . . . . 0.0 111.147 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.22 -25.15 67.94 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 117.955 0.343 . . . . 0.0 110.221 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.66 71.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.174 0.19 . . . . 0.0 110.924 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.03 -27.25 19.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.931 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.69 -21.89 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.515 0.326 . . . . 0.0 110.711 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.78 -10.8 15.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.41 -41.05 4.61 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 117.979 0.354 . . . . 0.0 113.622 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -106.25 -13.79 15.3 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-N 117.667 0.734 . . . . 0.0 112.199 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -59.01 129.95 44.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.29 -0.881 . . . . 0.0 110.809 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.28 12.65 72.83 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.626 -0.541 . . . . 0.0 112.693 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.01 160.46 15.6 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.303 1.051 . . . . 0.0 111.493 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.04 138.16 35.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 111.197 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.2 mt -143.5 135.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.49 15.04 0.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.9 1.52 52.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 118.899 0.772 . . . . 0.0 113.179 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 155.89 45.33 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 118.113 0.956 . . . . 0.0 109.958 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.03 148.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.88 141.39 48.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.658 0.783 . . . . 0.0 109.619 -178.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -98.36 104.63 16.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.75 138.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -155.43 166.1 34.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.1 160.68 23.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.23 -3.99 57.97 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.02 13.19 4.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.029 0.377 . . . . 0.0 111.8 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -132.18 46.5 2.2 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.1 141.55 64.08 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.681 2.254 . . . . 0.0 110.978 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -133.67 -11.41 2.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.725 0.81 . . . . 0.0 110.798 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.21 156.07 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.319 0.647 . . . . 0.0 110.212 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -81.89 1.92 32.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.068 0.547 . . . . 0.0 111.82 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 48.51 43.08 19.73 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.91 0.884 . . . . 0.0 110.688 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.2 12.97 4.94 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.06 0.838 . . . . 0.0 113.849 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt 58.75 6.13 0.58 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.069 1.348 . . . . 0.0 113.948 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.96 144.76 24.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.115 0.566 . . . . 0.0 109.574 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.16 3.47 65.96 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.224 -0.351 . . . . 0.0 112.224 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.98 -24.37 14.06 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 123.45 0.7 . . . . 0.0 111.018 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 99' ' ' ARG . 75.3 mmtt -75.12 156.61 35.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.8 0.44 . . . . 0.0 111.084 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 98' ' ' LYS . 3.3 mpt_? -119.92 167.51 12.06 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 124.21 1.004 . . . . 0.0 109.869 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -72.43 155.4 40.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.484 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.11 -6.62 29.57 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.237 -0.289 . . . . 0.0 111.25 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.61 -5.9 18.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.76 0.824 . . . . 0.0 111.186 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.11 2.35 9.25 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 123.206 0.603 . . . . 0.0 111.085 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 55.3 tpp -79.24 -32.6 43.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.038 0.535 . . . . 0.0 110.714 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.4 -10.15 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.709 0.804 . . . . 0.0 111.362 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.944 1 O4'-C1'-N19 113.541 5.341 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 111.888 3.688 . 0.259 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 O4'-C1'-N19 112.581 4.381 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.808 1 O4'-C1'-N19 113.189 4.989 . 0.035 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 0 O4'-C1'-N19 110.778 2.578 . 0.169 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 1 O4'-C1'-N19 112.389 4.189 . 0.097 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.919 1 O4'-C1'-N19 112.49 4.29 . 0.615 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -61.36 173.04 0.97 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 123.327 0.651 . . . . 0.0 111.487 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -111.13 12.1 21.92 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.201 0.6 . . . . 0.0 112.4 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -113.1 129.82 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 118.306 0.503 . . . . 0.0 109.936 -175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 78.4 p -148.54 20.16 1.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.844 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -119.27 26.68 9.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.335 0.971 . . . . 0.0 113.338 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.28 166.93 19.1 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 174.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -129.98 24.26 5.3 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.5 154.29 91.32 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 122.602 0.361 . . . . 0.0 110.717 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.11 -6.57 13.28 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.328 3.352 . . . . 0.0 113.179 -175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 0.6 OUTLIER -120.0 -25.43 5.8 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.371 0.532 . . . . 0.0 111.267 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 m -79.28 -19.59 50.16 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.176 0.191 . . . . 0.0 110.935 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -13.2 60.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.731 0.412 . . . . 0.0 111.23 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.5 p30 -126.31 1.65 7.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.6 p -101.84 13.09 35.82 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -111.44 155.36 23.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.71 1.204 . . . . 0.0 110.859 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -123.36 129.87 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.118 0.567 . . . . 0.0 110.057 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -95.56 136.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 88.58 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.93 170.19 31.7 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.787 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.3 t30 55.97 21.42 4.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.717 1.207 . . . . 0.0 111.77 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 28' ' ' VAL . 61.0 tp -73.88 146.84 43.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.637 0.775 . . . . 0.0 111.029 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.4 96.06 6.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.499 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.8 p -94.14 9.7 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.91 -14.73 36.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 117.9 0.318 . . . . 0.0 111.492 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.0 t -132.28 -21.85 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 C-N-CA 122.444 0.298 . . . . 0.0 110.813 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -82.57 157.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.66 173.58 11.54 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.166 0.587 . . . . 0.0 109.841 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 87.1 tttt -58.51 -33.14 69.5 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.714 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 -8.29 57.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.336 0.655 . . . . 0.0 111.292 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -98.12 -38.67 9.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 122.893 0.477 . . . . 0.0 109.822 174.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.3 -33.04 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 121.878 -0.514 . . . . 0.0 110.015 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.65 4.18 19.55 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 121.899 -0.501 . . . . 0.0 111.186 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.94 -7.95 10.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.405 0.682 . . . . 0.0 111.354 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.4 mt -106.7 -21.28 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.695 0.798 . . . . 0.0 110.628 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.23 -8.99 13.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.678 0.391 . . . . 0.0 111.799 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -76.78 -7.74 55.99 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.804 -0.56 . . . . 0.0 111.081 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.4 pttt -84.02 -6.23 59.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.844 0.458 . . . . 0.0 111.669 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.2 m-85 -120.03 -2.27 10.27 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.31 0.644 . . . . 0.0 112.005 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.39 167.16 33.48 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.517 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -79.56 113.66 17.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.49 125.95 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.78 1.2 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 C-N-CA 123.416 0.686 . . . . 0.0 110.37 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.71 147.07 9.52 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 18.6 p -157.99 155.93 30.27 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.529 0.665 . . . . 0.0 110.477 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.0 t -154.39 159.14 40.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -137.18 147.03 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -140.49 -169.8 2.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.486 0.715 . . . . 0.0 109.589 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -80.9 127.69 32.83 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.31 -12.85 2.26 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.034 0.826 . . . . 0.0 114.262 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.4 p90 -148.46 169.49 20.11 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.883 1.342 . . . . 0.0 111.582 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.02 166.78 26.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.709 0.804 . . . . 0.0 109.359 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -135.64 146.09 47.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.511 0.672 . . . . 0.0 111.352 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.0 t -135.26 139.3 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.112 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -119.69 111.12 17.64 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.866 0.866 . . . . 0.0 109.277 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -90.46 -178.9 5.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.8 t -82.89 -26.23 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.769 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.48 175.45 13.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 112.064 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.6 -32.57 69.98 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 124.104 0.962 . . . . 0.0 112.073 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -61.84 -39.89 93.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.447 0.699 . . . . 0.0 110.364 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.44 -34.95 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.525 0.33 . . . . 0.0 110.473 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.14 -43.19 82.98 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 121.938 -0.477 . . . . 0.0 111.31 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -72.69 -19.33 61.43 Favored 'General case' 0 CA--C 1.524 -0.055 0 CA-C-N 118.07 0.396 . . . . 0.0 110.617 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.83 82.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.486 -0.19 . . . . 0.0 110.486 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.25 -28.55 17.73 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.48 -19.71 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 122.317 0.247 . . . . 0.0 110.344 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.26 -10.18 13.36 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.181 -0.325 . . . . 0.0 111.681 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.67 12.75 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.571 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -121.29 -15.42 8.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.121 0.96 . . . . 0.0 111.916 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -58.78 131.26 50.4 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.966 0.803 . . . . 0.0 110.86 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.69 12.91 73.91 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.444 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.25 161.43 15.06 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.257 1.029 . . . . 0.0 111.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -98.39 138.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.421 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.4 mt -143.45 134.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.64 18.29 0.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.55 -1.85 36.77 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.922 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.63 160.07 37.72 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 118.526 1.163 . . . . 0.0 110.514 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.46 147.46 5.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.586 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.25 143.47 45.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.648 0.779 . . . . 0.0 109.688 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -99.03 103.31 15.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.1 138.96 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -156.3 162.94 40.06 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.742 0.306 . . . . 0.0 110.806 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.6 145.1 55.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.95 -3.93 41.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.36 13.67 5.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.673 0.389 . . . . 0.0 111.408 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -134.42 45.51 1.54 Allowed Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.01 143.01 77.38 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.799 2.332 . . . . 0.0 111.306 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.18 6.08 3.86 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.152 0.981 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 p -106.35 154.36 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 123.529 0.732 . . . . 0.0 110.348 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -82.07 0.62 39.67 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.844 0.458 . . . . 0.0 111.903 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.95 49.44 17.01 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.097 0.959 . . . . 0.0 110.96 -175.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 3.87 23.08 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.418 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt 59.07 -2.24 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.306 1.442 . . . . 0.0 114.58 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.88 -29.34 0.06 Allowed 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.025 0.53 . . . . 0.0 110.689 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.44 88.91 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.8 -24.97 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 123.374 0.669 . . . . 0.0 111.452 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.61 161.5 29.49 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.061 0.458 . . . . 0.0 111.48 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -89.6 166.83 13.39 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.333 1.053 . . . . 0.0 111.62 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.9 m -80.94 163.66 23.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.369 0.668 . . . . 0.0 109.423 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.06 56.51 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 111.793 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -96.06 -7.82 35.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.364 0.665 . . . . 0.0 111.51 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -125.01 7.31 7.97 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 123.719 0.808 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.2 tpt -60.4 -21.94 62.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -170.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -138.38 -3.4 1.73 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 C-N-CA 123.612 0.625 . . . . 0.0 111.832 -179.417 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 O4'-C1'-N19 113.405 5.205 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 O4'-C1'-N19 111.933 3.733 . 0.233 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.434 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 112.633 4.433 OUTLIER-DELTA 0.059 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 112.538 4.338 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.967 0 O4'-C1'-N19 110.997 2.797 . 0.116 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.483 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.421 -2.651 1 O4'-C1'-N19 112.766 4.566 . 0.095 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.286 1 O4'-C1'-N19 113.546 5.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 120.286 0.089 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -67.0 179.43 1.14 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.198 0.599 . . . . 0.0 111.048 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -110.79 20.32 17.7 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.249 0.62 . . . . 0.0 112.342 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -116.33 129.72 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 123.129 0.572 . . . . 0.0 110.825 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.1 p -148.66 19.41 1.03 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 119.14 -0.457 . . . . 0.0 112.064 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -120.86 31.36 6.44 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -74.16 171.94 12.66 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.644 -0.66 . . . . 0.0 109.508 173.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.0 p -134.64 24.24 3.7 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.934 -0.479 . . . . 0.0 112.094 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.57 153.24 95.89 Favored Pre-proline 0 C--O 1.233 0.228 0 C-N-CA 122.537 0.335 . . . . 0.0 110.632 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.78 -5.86 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.246 3.297 . . . . 0.0 113.129 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.09 0.14 7.85 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.792 0.437 . . . . 0.0 111.63 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 t -102.05 -22.1 14.32 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.481 0.712 . . . . 0.0 110.278 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -12.34 60.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.591 0.756 . . . . 0.0 111.476 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -123.68 -1.81 8.42 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.379 0.671 . . . . 0.0 111.52 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.66 12.37 37.55 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.139 0.576 . . . . 0.0 109.882 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -112.24 154.34 25.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.697 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -121.84 124.49 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -92.7 133.27 36.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -127.47 91.77 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.04 171.52 32.79 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 116.586 -0.279 . . . . 0.0 113.002 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 t30 56.18 16.52 2.33 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.48 1.512 . . . . 0.0 112.681 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.13 150.48 48.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.552 -0.718 . . . . 0.0 110.056 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.81 -39.26 93.81 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.8 p 49.42 13.66 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.08 1.752 . . . . 0.0 115.499 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.54 -23.41 13.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.873 0.761 . . . . 0.0 111.025 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.5 -20.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.313 0.645 . . . . 0.0 110.58 -175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.0 167.91 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -152.55 175.4 12.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.551 0.74 . . . . 0.0 109.322 175.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -61.1 -34.09 74.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.678 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.0 m -77.22 -10.97 59.75 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.249 0.343 . . . . 0.0 110.617 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 56.1 m-20 -93.87 -41.69 9.49 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.67 -37.73 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 O-C-N 122.015 -0.428 . . . . 0.0 110.138 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -76.67 4.09 10.22 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.776 -0.577 . . . . 0.0 111.494 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.57 -9.14 10.86 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.571 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.92 -17.34 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.477 0.711 . . . . 0.0 109.95 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -112.74 -6.18 13.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.76 0.424 . . . . 0.0 111.307 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -74.95 -10.16 59.23 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.593 -0.692 . . . . 0.0 110.387 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.72 -8.29 56.46 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.929 0.892 . . . . 0.0 111.755 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -127.69 -1.25 6.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.31 0.644 . . . . 0.0 112.481 -174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.4 170.03 36.48 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.33 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -79.48 111.27 15.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -85.34 129.18 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.25 4.54 7.06 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 123.188 0.595 . . . . 0.0 110.604 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.57 144.94 8.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.0 t -154.9 145.66 22.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.56 0.68 . . . . 0.0 110.037 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -148.7 157.34 43.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.0 146.48 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.92 -171.95 3.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -85.01 129.66 34.76 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.02 -11.62 7.55 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.169 -0.795 . . . . 0.0 113.882 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.61 168.96 25.8 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.899 1.349 . . . . 0.0 111.509 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.54 172.16 14.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.88 0.872 . . . . 0.0 109.811 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -140.65 150.19 43.21 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.0 111.611 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.74 141.77 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -120.59 114.69 22.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.253 0.621 . . . . 0.0 109.353 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -93.23 -178.45 4.77 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.844 0.458 . . . . 0.0 110.392 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.3 t -84.66 -26.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -150.45 173.99 13.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.132 0.492 . . . . 0.0 112.005 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.94 -36.83 78.41 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.356 0.662 . . . . 0.0 111.609 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.12 -40.2 76.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 109.989 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.05 -35.53 78.39 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.34 -41.97 75.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.03 -0.419 . . . . 0.0 110.827 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -63.54 -27.45 69.27 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.93 77.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.525 0.33 . . . . 0.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.91 -27.55 18.68 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.42 -22.75 24.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 122.175 -0.328 . . . . 0.0 110.497 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.33 -9.97 14.95 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.28 -24.35 10.38 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.366 -0.686 . . . . 0.0 114.22 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -120.27 -14.14 8.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.329 1.064 . . . . 0.0 111.649 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -59.93 130.42 46.68 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.695 0.679 . . . . 0.0 110.716 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.99 13.6 74.28 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.757 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.27 160.79 15.34 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.414 1.107 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.6 ttm -97.11 137.51 36.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.111 0.481 . . . . 0.0 111.016 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.0 mt -143.39 135.24 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.11 13.22 0.76 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.32 45.88 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 121.665 -0.647 . . . . 0.0 113.329 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -128.39 158.37 38.46 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 117.893 0.847 . . . . 0.0 109.454 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.46 149.34 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.71 142.62 48.34 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.442 0.697 . . . . 0.0 109.973 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -100.28 104.5 15.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -102.43 142.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 122.733 0.413 . . . . 0.0 109.94 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -156.51 165.06 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 157.63 30.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 -3.27 56.34 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.64 5.39 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.096 0.407 . . . . 0.0 111.675 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -134.58 48.41 3.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.94 142.13 67.5 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.783 2.322 . . . . 0.0 110.828 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -135.06 5.21 3.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.245 1.018 . . . . 0.0 111.015 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.03 153.79 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 123.25 0.62 . . . . 0.0 109.846 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -76.69 2.38 14.37 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.602 0.761 . . . . 0.0 112.47 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 48.6 43.75 20.58 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 123.245 0.618 . . . . 0.0 110.98 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.65 8.15 7.88 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.29 0.948 . . . . 0.0 114.327 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt 58.69 6.32 0.59 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 113.208 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.86 35.91 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.81 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.5 8.14 55.21 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.267 0.461 . . . . 0.0 112.655 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.44 -23.39 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 117.459 0.629 . . . . 0.0 111.526 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -75.28 155.67 36.43 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 122.152 -0.342 . . . . 0.0 110.896 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -110.41 166.29 11.1 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 124.213 1.005 . . . . 0.0 110.088 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -83.09 156.49 23.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.102 0.561 . . . . 0.0 110.093 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.15 -10.93 60.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.224 0.21 . . . . 0.0 111.299 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.84 -7.1 25.8 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 111.466 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -123.58 6.83 8.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.862 0.865 . . . . 0.0 110.761 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 tpp -75.23 -32.53 61.17 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.478 0.311 . . . . 0.0 110.714 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -135.41 -9.83 2.19 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.379 0.672 . . . . 0.0 111.305 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.527 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 O4'-C1'-N19 112.147 3.947 . 0.229 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 2 O4'-C1'-N19 112.442 4.242 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 O4'-C1'-N19 110.866 2.666 . 0.464 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 1 O4'-C1'-N19 112.421 4.221 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.019 1 O4'-C1'-N19 113.275 5.075 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 t -67.87 177.13 2.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.78 0.432 . . . . 0.0 111.05 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -108.23 19.74 19.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.869 0.868 . . . . 0.0 111.679 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.2 t -118.15 125.88 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.904 -0.498 . . . . 0.0 110.732 -170.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.6 p -147.92 8.66 0.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -102.55 20.45 17.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.08 1.309 . . . . 0.0 113.898 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.08 153.85 36.25 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -124.88 21.27 8.29 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 122.788 0.435 . . . . 0.0 111.783 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -68.83 153.29 96.15 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 122.591 0.356 . . . . 0.0 110.385 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.22 -0.92 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 124.202 3.268 . . . . 0.0 113.165 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -129.4 -13.03 4.42 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.536 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.8 m -89.15 -23.15 22.52 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 122.536 0.334 . . . . 0.0 110.647 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 33.7 mmm -74.36 -15.66 60.93 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.552 0.741 . . . . 0.0 111.563 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -119.77 -3.23 10.28 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.15 0.58 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -98.07 13.85 29.55 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 122.897 0.479 . . . . 0.0 110.035 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -121.24 152.77 38.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.472 0.709 . . . . 0.0 110.946 -176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.96 135.86 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.864 0.865 . . . . 0.0 109.612 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -104.72 133.08 50.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.37 106.54 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.95 173.67 16.22 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 120.883 0.157 . . . . 0.0 112.846 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.8 t30 53.73 24.84 4.6 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.357 1.063 . . . . 0.0 111.529 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.5 tp -74.14 150.24 40.57 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.903 0.881 . . . . 0.0 112.32 -172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -76.82 57.51 1.31 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.957 1.703 . . . . 0.0 110.824 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.495 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.0 p -68.77 -0.75 5.76 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -96.38 0.83 51.15 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.725 0.41 . . . . 0.0 111.077 175.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.77 -22.27 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.317 0.647 . . . . 0.0 110.307 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.66 158.69 3.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -136.5 170.62 15.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.882 0.873 . . . . 0.0 108.707 176.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -61.28 -32.38 72.21 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.164 -0.335 . . . . 0.0 110.682 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 p -78.22 -7.01 56.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.508 0.723 . . . . 0.0 111.142 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.3 m-20 -94.9 -41.35 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.11 -37.07 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 O-C-N 121.772 -0.58 . . . . 0.0 109.734 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -79.76 4.51 16.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.354 -0.216 . . . . 0.0 111.388 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.65 -9.31 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.275 0.63 . . . . 0.0 111.381 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -104.17 -22.18 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.627 0.771 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -109.83 -12.28 14.61 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.5 t -72.4 -9.19 58.21 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.258 -0.901 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.9 pttt -82.29 -7.85 59.63 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.728 0.411 . . . . 0.0 111.673 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.9 m-85 -118.94 -2.65 10.8 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.105 0.562 . . . . 0.0 112.132 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.47 35.66 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.73 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.24 113.26 18.29 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.11 127.83 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.05 4.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 C-N-CA 123.337 0.655 . . . . 0.0 110.525 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 139.57 5.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.9 p -156.18 151.81 27.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.083 0.942 . . . . 0.0 110.801 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.3 p -154.82 157.2 37.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.99 140.55 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.96 -170.03 2.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -79.79 129.85 34.83 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.753 -0.592 . . . . 0.0 109.713 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.01 -17.39 2.91 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.394 0.997 . . . . 0.0 114.43 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -150.65 168.61 23.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.855 1.328 . . . . 0.0 111.852 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 168.08 25.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.767 0.827 . . . . 0.0 109.967 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -136.33 147.68 47.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.387 0.613 . . . . 0.0 111.197 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -138.78 118.46 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -100.89 111.8 24.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.835 0.854 . . . . 0.0 108.705 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -89.31 -176.98 5.26 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.564 0.346 . . . . 0.0 110.137 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.46 -28.33 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.83 174.24 13.3 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.149 0.499 . . . . 0.0 111.738 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.64 -36.68 78.91 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.304 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -57.02 -40.25 76.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.055 0.542 . . . . 0.0 110.158 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.21 -35.21 77.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.46 0.304 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.73 -42.27 77.86 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.008 -0.432 . . . . 0.0 110.983 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -65.01 -25.82 68.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.99 0.359 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.04 -41.21 74.52 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.366 -0.209 . . . . 0.0 111.206 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.26 -27.82 18.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 83' ' ' ASN . 24.4 t -70.01 -21.73 24.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.7 -9.37 14.51 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.77 -26.64 10.37 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.72 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -120.06 -15.06 8.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.283 1.042 . . . . 0.0 112.085 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.9 130.99 49.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.854 0.752 . . . . 0.0 110.899 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.89 75.35 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.314 -0.715 . . . . 0.0 112.673 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.25 160.96 15.26 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.359 1.079 . . . . 0.0 111.431 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.61 139.48 34.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.982 0.42 . . . . 0.0 110.825 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 mt -143.46 136.75 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.41 10.89 0.15 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.31 0.72 38.0 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 118.993 0.815 . . . . 0.0 113.518 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.3 158.53 37.95 Favored 'General case' 0 C--O 1.228 -0.058 0 CA-C-N 118.68 1.24 . . . . 0.0 109.995 175.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.75 146.37 7.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.97 141.61 48.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.91 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.59 113.03 24.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -110.06 139.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.421 ' HA ' HG13 ' A' ' 67' ' ' VAL . 7.4 t30 -156.18 167.07 31.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 160.98 18.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.8 12.65 3.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' C ' HD21 ' A' ' 83' ' ' ASN . 85.3 mt-10 -135.71 48.87 2.97 Favored Pre-proline 0 C--O 1.232 0.164 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.81 144.66 84.18 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.772 2.315 . . . . 0.0 110.373 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -129.32 0.32 5.1 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.419 0.687 . . . . 0.0 111.168 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -129.15 156.23 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.965 0.906 . . . . 0.0 110.231 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -73.4 -6.67 47.74 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.761 0.824 . . . . 0.0 112.043 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 44.9 35.96 1.72 Allowed 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.32 1.448 . . . . 0.0 113.153 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 95' ' ' ALA . . . -77.63 42.45 2.0 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.255 1.407 . . . . 0.0 113.361 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 61.51 0.24 0.45 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 0.0 113.091 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 93' ' ' GLY . . . -161.84 156.32 22.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 0.0 109.0 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.97 0.03 74.07 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.4 t -83.03 -23.63 8.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 111.337 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -76.39 151.38 36.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.564 0.346 . . . . 0.0 111.152 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.98 173.99 12.75 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.05 0.94 . . . . 0.0 109.924 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -67.46 156.15 37.32 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.55 0.61 2.95 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -117.1 -4.03 11.49 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.128 0.971 . . . . 0.0 111.023 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.12 11.7 7.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.08 0.952 . . . . 0.0 111.335 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -20.05 64.43 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.928 0.491 . . . . 0.0 111.646 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.33 -11.27 1.43 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.596 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.905 1 O4'-C1'-N19 113.921 5.721 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 112.063 3.863 . 0.262 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.681 1 O4'-C1'-N19 112.961 4.761 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.409 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.745 1 O4'-C1'-N19 113.428 5.228 OUTLIER-DELTA 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.409 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 C5'-C4'-C3' 111.632 -2.578 . 0.026 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 1 O4'-C1'-N19 113.008 4.808 . 0.154 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 C5'-C4'-C3' 110.907 -3.062 . 0.243 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.465 0.174 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.4 m -66.1 177.56 1.36 Allowed 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.248 0.619 . . . . 0.0 111.674 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.48 25.14 12.13 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.328 0.651 . . . . 0.0 111.948 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.56 129.11 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.142 0.428 . . . . 0.0 110.745 -171.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 p -150.08 16.12 0.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.4 -0.809 . . . . 0.0 112.811 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -114.33 19.59 16.15 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.11 168.26 4.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.362 0.528 . . . . 0.0 109.815 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.3 p -132.31 23.95 4.46 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.992 -0.442 . . . . 0.0 111.559 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -68.01 153.27 95.59 Favored Pre-proline 0 CA--C 1.53 0.206 0 O-C-N 122.154 -0.341 . . . . 0.0 110.615 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.06 -6.31 14.22 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.153 3.235 . . . . 0.0 113.322 -175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -124.34 -8.99 7.53 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 118.314 0.506 . . . . 0.0 111.842 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -94.05 -20.19 20.16 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -18.5 60.74 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.162 0.585 . . . . 0.0 110.866 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -118.32 4.39 11.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.861 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 t -104.12 13.05 33.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.602 0.761 . . . . 0.0 109.326 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -114.18 151.92 31.98 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.556 0.742 . . . . 0.0 110.865 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 t -118.51 126.84 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.307 0.643 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.09 132.15 40.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -125.89 92.23 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.05 168.21 31.12 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.21 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 t30 55.09 19.3 2.72 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.319 1.448 . . . . 0.0 112.858 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.96 149.32 48.96 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.917 -0.49 . . . . 0.0 111.038 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -78.35 95.17 4.99 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 28' ' ' VAL . 62.8 p -95.09 8.29 43.43 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -172.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.49 -12.61 34.09 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.912 0.324 . . . . 0.0 111.427 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.6 t -133.4 -19.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 122.431 0.292 . . . . 0.0 110.882 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.24 157.85 4.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.0 173.53 11.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -58.19 -36.62 73.35 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.3 p -76.0 -8.66 57.48 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.289 0.636 . . . . 0.0 110.786 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 7.1 m-20 -93.52 -41.49 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.84 -38.32 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -78.84 5.87 10.41 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.959 -0.463 . . . . 0.0 111.94 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.26 -8.56 10.58 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.181 0.592 . . . . 0.0 111.441 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.7 mt -104.31 -23.35 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.459 0.704 . . . . 0.0 110.251 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.14 -8.33 16.51 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.323 0.249 . . . . 0.0 111.547 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 t -73.03 -9.65 58.95 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.436 -0.79 . . . . 0.0 111.641 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -87.19 -4.19 59.09 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.818 -0.551 . . . . 0.0 111.933 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -117.45 -3.04 11.42 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.279 0.632 . . . . 0.0 111.377 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.2 167.79 33.52 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.402 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -78.55 113.03 16.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.58 129.92 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.76 7.06 6.51 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.063 0 C-N-CA 123.783 0.833 . . . . 0.0 110.484 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.31 143.48 7.44 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 44.1 t -150.52 148.48 28.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.847 0.823 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.0 t -153.43 156.03 37.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.56 145.15 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.982 0.42 . . . . 0.0 109.928 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -138.63 -165.75 1.88 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 0.0 109.003 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -85.87 130.41 34.56 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 117.975 0.352 . . . . 0.0 110.079 173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.53 -14.87 3.95 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.173 0.892 . . . . 0.0 114.014 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.88 168.29 26.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.754 1.277 . . . . 0.0 111.426 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 172.15 15.27 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.6 0.76 . . . . 0.0 110.384 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -141.12 148.95 40.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.353 0.597 . . . . 0.0 111.821 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -137.75 140.82 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -119.81 114.58 22.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -91.93 -174.15 3.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.113 0.565 . . . . 0.0 110.431 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -88.82 -26.38 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.061 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -150.23 174.08 13.22 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 111.719 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -71.28 -31.82 67.93 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 123.65 0.78 . . . . 0.0 111.98 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -61.76 -39.2 90.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.038 0.535 . . . . 0.0 109.843 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.3 -34.99 77.15 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.746 0.418 . . . . 0.0 110.644 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.85 -43.87 82.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.933 -0.479 . . . . 0.0 111.412 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -73.48 -18.94 61.06 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.833 0.288 . . . . 0.0 110.548 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.18 -42.4 84.28 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.76 18.46 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 t -68.79 -20.27 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 O-C-N 122.165 -0.334 . . . . 0.0 110.306 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.9 -10.51 13.54 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.371 0.268 . . . . 0.0 111.515 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.86 -29.88 9.45 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.676 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.83 -12.88 10.14 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.029 0.915 . . . . 0.0 111.995 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.89 129.72 43.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.817 0.735 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.46 13.34 70.79 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.634 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.46 161.86 14.8 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.608 1.204 . . . . 0.0 111.19 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.4 138.74 36.06 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.33 135.17 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.74 17.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.84 -1.07 38.81 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.906 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.89 160.56 36.63 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.582 1.191 . . . . 0.0 110.282 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.1 t -96.0 146.51 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.599 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 142.02 47.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.846 0.858 . . . . 0.0 109.714 -179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -102.47 105.9 16.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.0 mt -102.42 142.04 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.001 0.52 . . . . 0.0 110.146 -173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -155.86 165.21 37.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.568 0.347 . . . . 0.0 110.506 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.34 147.6 53.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.43 -3.42 43.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -122.43 13.76 10.26 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.837 0.455 . . . . 0.0 111.557 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 37.0 mt-10 -121.81 46.0 1.06 Allowed Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 57.3 Cg_endo -76.12 29.0 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.115 3.21 . . . . 0.0 111.727 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -69.85 -7.43 39.97 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.026 -0.421 . . . . 0.0 110.421 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.7 p -90.52 164.57 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.51 1.124 . . . . 0.0 109.596 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 2.4 m-80 -67.86 4.76 1.05 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.027 0.931 . . . . 0.0 112.395 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 54.93 6.23 0.12 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.097 2.159 . . . . 0.0 115.201 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.82 -67.71 0.12 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.647 1.594 . . . . 0.0 113.219 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt 59.52 142.45 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.021 2.128 . . . . 0.0 113.333 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 57.23 163.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.455 1.502 . . . . 0.0 113.943 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.3 6.94 69.74 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.3 t -76.51 -24.69 15.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 123.543 0.737 . . . . 0.0 111.068 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -79.48 160.21 26.65 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.975 0.51 . . . . 0.0 110.846 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -119.04 165.71 13.79 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.834 0.853 . . . . 0.0 110.565 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -76.4 152.94 36.1 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.917 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.08 -6.56 23.46 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.254 -0.279 . . . . 0.0 111.375 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.64 -5.41 20.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.406 0.682 . . . . 0.0 111.472 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -122.88 7.77 9.34 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.359 0.663 . . . . 0.0 111.226 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 mmt -71.86 135.49 46.61 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 122.33 -0.231 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 52.49 10.61 0.14 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.71 1.604 . . . . 0.0 114.095 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.543 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.077 1 O4'-C1'-N19 113.795 5.595 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.02 1 O4'-C1'-N19 112.277 4.077 . 0.174 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.672 2 O4'-C1'-N19 113.021 4.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.83 1 O4'-C1'-N19 112.979 4.779 . 0.056 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 O4'-C1'-N19 110.968 2.768 . 0.325 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.621 4.421 . 0.11 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.499 0 C5'-C4'-C3' 112.956 -1.696 . 0.398 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -61.71 175.78 0.6 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.686 0.794 . . . . 0.0 111.493 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -106.84 21.76 17.0 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.72 131.81 67.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 O-C-N 121.756 -0.59 . . . . 0.0 110.499 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.6 p -146.02 6.04 1.01 Allowed 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 123.183 0.593 . . . . 0.0 111.653 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -96.84 -128.97 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.554 0.615 . . . . 0.0 109.762 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER 61.55 172.85 0.12 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.774 1.229 . . . . 0.0 110.096 -168.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.3 p -138.2 29.96 2.46 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.779 -0.575 . . . . 0.0 112.355 -173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -65.82 151.24 95.33 Favored Pre-proline 0 CA--C 1.532 0.285 0 O-C-N 122.238 -0.289 . . . . 0.0 110.485 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.95 -9.06 21.79 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.074 3.183 . . . . 0.0 113.47 -173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -123.34 -7.36 8.17 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.226 0.466 . . . . 0.0 111.527 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -88.98 -28.75 20.02 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -12.12 59.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.665 0.786 . . . . 0.0 110.906 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.431 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -127.85 10.8 6.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.3 p -113.38 2.27 15.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.524 0.33 . . . . 0.0 111.21 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -108.13 168.65 9.14 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.861 0.464 . . . . 0.0 109.792 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.36 132.35 71.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.248 0.619 . . . . 0.0 109.897 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -93.43 135.4 34.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.78 82.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.41 173.19 43.89 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.515 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.43 20.26 4.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.917 1.287 . . . . 0.0 112.138 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.12 152.34 41.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.934 0.494 . . . . 0.0 110.971 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.447 HD21 HG23 ' A' ' 27' ' ' VAL . 13.4 t30 -61.82 -47.49 84.88 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.809 0.843 . . . . 0.0 111.313 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p 53.34 7.02 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.72 -15.1 18.62 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.971 0.805 . . . . 0.0 111.058 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 HD21 ' A' ' 24' ' ' ASN . 13.7 t -133.39 -14.55 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.181 0.592 . . . . 0.0 110.718 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.04 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.9 174.22 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.095 0.558 . . . . 0.0 110.494 178.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -58.95 -23.5 61.58 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.65 0.78 . . . . 0.0 110.894 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -93.36 -4.48 51.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.844 0.293 . . . . 0.0 111.754 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 2.3 m-20 -98.88 -41.71 7.49 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.555 0.342 . . . . 0.0 110.402 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -66.94 -36.42 77.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.334 0.515 . . . . 0.0 109.657 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -77.88 2.6 16.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.302 -0.249 . . . . 0.0 111.64 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.37 -8.77 11.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.079 0.552 . . . . 0.0 111.415 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.1 mt -103.45 -22.87 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.63 -9.79 15.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.759 0.423 . . . . 0.0 111.508 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -72.05 -9.52 58.51 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.585 -0.697 . . . . 0.0 111.411 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -83.83 -5.42 59.2 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -120.55 -2.99 9.88 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.96 0.504 . . . . 0.0 112.075 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.33 167.03 33.9 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.394 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -77.27 113.02 14.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -85.97 128.91 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.53 7.05 6.58 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.657 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.25 146.99 9.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -155.22 151.7 28.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.833 0.817 . . . . 0.0 109.261 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -153.26 154.04 33.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.75 143.69 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.265 0.555 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -136.91 -164.82 1.64 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.829 0.852 . . . . 0.0 108.769 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.3 mmtm -92.62 131.58 37.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.72 -14.83 6.67 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.292 0.949 . . . . 0.0 113.622 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.17 169.86 23.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.854 1.327 . . . . 0.0 111.281 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.89 14.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.165 0.986 . . . . 0.0 109.773 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -142.15 152.01 42.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.256 0.623 . . . . 0.0 110.814 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -137.34 147.68 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -125.3 114.11 18.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -93.94 -178.71 4.74 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.938 0.495 . . . . 0.0 109.844 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.45 -23.9 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.499 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.06 177.74 10.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.038 0.535 . . . . 0.0 111.753 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -72.5 -34.96 68.02 Favored 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.515 0.726 . . . . 0.0 111.754 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -57.62 -40.35 79.0 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.214 0.606 . . . . 0.0 109.993 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.59 -33.98 75.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.575 0.35 . . . . 0.0 110.077 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.93 -40.72 83.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.898 -0.501 . . . . 0.0 111.013 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -66.09 -25.64 67.1 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.225 0.466 . . . . 0.0 110.156 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.86 80.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.681 0.219 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 -28.22 16.81 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.39 -21.71 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 CA-C-N 118.034 0.379 . . . . 0.0 110.076 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.13 -11.37 14.61 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.21 -26.9 11.48 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.477 -0.624 . . . . 0.0 114.157 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -119.38 -14.55 9.18 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.283 1.041 . . . . 0.0 111.928 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.7 130.31 46.18 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.797 0.726 . . . . 0.0 110.713 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.67 70.86 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.202 -0.777 . . . . 0.0 112.431 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.92 160.98 15.01 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.487 1.144 . . . . 0.0 111.242 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.5 ttm -98.46 138.91 34.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.6 mt -143.4 134.44 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.85 19.1 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.38 -0.19 43.53 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.033 173.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.37 157.71 44.85 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 118.374 1.087 . . . . 0.0 110.154 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.9 147.3 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.614 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.76 143.37 46.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.458 0.703 . . . . 0.0 109.935 -178.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -99.42 103.37 15.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.2 140.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -158.75 163.68 36.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.734 0.302 . . . . 0.0 110.442 -175.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.49 146.23 55.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.84 37.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -172.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.95 14.58 6.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.921 0.488 . . . . 0.0 111.14 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -133.52 46.41 2.03 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.37 145.21 82.69 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.791 2.327 . . . . 0.0 111.005 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -142.28 3.38 1.54 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.02 155.56 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.154 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -80.46 0.11 34.94 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.953 0.501 . . . . 0.0 112.104 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 49.03 41.54 19.37 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.807 0.843 . . . . 0.0 111.156 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.12 9.52 9.33 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.358 0.98 . . . . 0.0 113.845 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 60.66 178.09 0.1 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 112.454 -176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.7 161.37 29.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.732 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.51 -2.41 68.55 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.36 -25.61 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.342 0.657 . . . . 0.0 110.405 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -88.16 151.95 22.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.861 0.465 . . . . 0.0 110.328 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -110.76 160.76 16.44 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.572 0.749 . . . . 0.0 110.539 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 m -80.93 153.7 27.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.567 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.44 -7.85 28.58 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -105.9 -5.22 19.86 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.684 0.794 . . . . 0.0 111.446 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.01 15.77 11.62 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.711 0.805 . . . . 0.0 110.938 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mmt -71.14 174.13 6.73 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.562 0.696 . . . . 0.0 111.237 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.27 -13.62 62.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.482 1.113 . . . . 0.0 112.617 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 179.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 1 O4'-C1'-N19 113.483 5.283 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.734 3.534 . 0.179 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.674 0 O4'-C1'-N19 112.16 3.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.401 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.888 1 O4'-C1'-N19 112.813 4.613 . 0.036 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.401 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.652 0 C5'-C4'-C3' 111.44 -2.707 . 0.162 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.0 3.8 . 0.137 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 1 O4'-C1'-N19 112.726 4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -62.14 173.61 1.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.104 0.562 . . . . 0.0 111.736 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -106.97 25.44 11.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.251 0.62 . . . . 0.0 112.033 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.24 127.13 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 122.786 0.434 . . . . 0.0 110.408 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.2 p -149.59 18.92 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.163 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -120.81 31.15 6.54 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -73.04 167.2 21.6 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.57 -0.706 . . . . 0.0 109.346 173.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -131.44 23.05 4.75 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 122.079 -0.388 . . . . 0.0 111.555 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -70.46 152.94 95.35 Favored Pre-proline 0 N--CA 1.453 -0.306 0 C-N-CA 122.641 0.376 . . . . 0.0 110.346 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.07 -6.07 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.443 3.429 . . . . 0.0 113.303 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.24 -9.0 8.14 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.241 0.473 . . . . 0.0 112.02 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -91.48 -23.87 19.85 Favored 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 122.486 0.314 . . . . 0.0 110.545 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -15.01 61.79 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.246 0.618 . . . . 0.0 110.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.4 p30 -123.11 2.69 9.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.3 p -102.39 12.41 36.6 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.085 0.469 . . . . 0.0 109.829 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -112.32 157.07 21.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 110.983 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 t -124.36 128.82 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.387 0.675 . . . . 0.0 109.774 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -95.16 135.99 36.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -129.66 90.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.42 171.29 32.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.413 -0.358 . . . . 0.0 112.92 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 t30 56.03 17.47 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.23 1.412 . . . . 0.0 112.835 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.55 151.8 46.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.777 -0.577 . . . . 0.0 109.686 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -64.81 -42.23 95.15 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.154 0.182 . . . . 0.0 111.256 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 28' ' ' VAL . 18.5 p 51.97 9.96 0.1 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.9 1.68 . . . . 0.0 115.194 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -101.43 -16.45 16.85 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.02 0.827 . . . . 0.0 111.148 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.8 t -130.56 -15.71 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.957 0.503 . . . . 0.0 110.699 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -85.24 159.01 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -142.62 172.88 12.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.888 0.475 . . . . 0.0 110.402 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 46' ' ' CYS . 19.2 tptm -57.41 -29.46 64.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.944 0.497 . . . . 0.0 110.518 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -86.74 -5.47 59.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.815 0.446 . . . . 0.0 112.039 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.3 m-20 -97.44 -40.49 8.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.697 0.226 . . . . 0.0 110.607 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.44 -34.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -81.71 4.5 21.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.276 -0.265 . . . . 0.0 111.492 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.87 -8.67 10.77 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.191 0.597 . . . . 0.0 111.165 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.0 mt -104.4 -23.25 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.444 0.698 . . . . 0.0 110.277 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -109.05 -11.41 14.95 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 111.667 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -72.29 -9.46 58.52 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.493 -0.754 . . . . 0.0 111.439 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -82.27 -7.57 59.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.004 0.522 . . . . 0.0 111.524 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -119.14 -1.69 10.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.269 0.627 . . . . 0.0 112.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.51 168.02 34.04 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.881 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -79.2 114.36 18.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -87.36 129.01 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.33 7.37 6.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 123.7 0.8 . . . . 0.0 110.588 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.23 6.59 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 30' ' ' LYS . 40.6 t -157.92 147.03 19.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.177 0.989 . . . . 0.0 109.824 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.2 p -149.01 157.46 43.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.773 0.429 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 p -142.04 143.43 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -139.47 -170.3 2.88 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.574 0.75 . . . . 0.0 109.661 -171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -79.75 127.46 32.23 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.8 -13.57 4.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.104 0.859 . . . . 0.0 114.538 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -152.45 168.46 25.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.145 1.472 . . . . 0.0 111.416 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 169.34 20.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.929 0.892 . . . . 0.0 109.732 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.2 149.67 44.66 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.467 0.651 . . . . 0.0 111.319 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.87 139.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tp60 -119.93 112.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.643 0.777 . . . . 0.0 109.084 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -91.49 -178.81 5.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.257 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.16 -26.05 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -151.47 174.64 13.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.079 0.466 . . . . 0.0 112.077 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -70.3 -32.29 70.01 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.436 1.094 . . . . 0.0 112.035 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -62.77 -39.73 95.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.329 0.652 . . . . 0.0 110.079 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.22 -34.89 77.08 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.338 0.255 . . . . 0.0 110.471 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.05 84.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.925 -0.485 . . . . 0.0 111.495 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -73.52 -19.46 60.91 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 117.972 0.351 . . . . 0.0 110.664 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.7 85.0 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.403 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.42 -28.72 17.48 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.6 t -67.83 -20.79 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.061 0 CA-C-N 118.017 0.371 . . . . 0.0 110.347 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 -9.95 13.95 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.28 -26.38 12.37 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.594 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -120.99 -15.12 8.33 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.102 0.951 . . . . 0.0 112.206 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.83 130.4 46.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.906 0.776 . . . . 0.0 110.935 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.99 74.21 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.615 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.78 161.22 15.39 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.372 1.086 . . . . 0.0 111.167 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 ttm -98.3 138.39 35.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 110.72 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.88 135.9 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.58 15.73 0.55 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.92 0.79 48.7 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.704 0.684 . . . . 0.0 113.661 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 157.7 42.03 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.255 1.027 . . . . 0.0 110.113 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.0 t -96.43 147.16 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.03 140.8 49.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.591 0.756 . . . . 0.0 109.726 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -96.4 110.9 23.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.3 mt -106.88 138.34 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -155.26 162.77 40.81 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.868 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -62.85 144.63 56.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 173.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.49 -3.91 39.83 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.42 13.54 5.52 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.879 0.472 . . . . 0.0 111.465 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -134.23 45.36 1.49 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -62.35 137.09 63.28 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.838 2.359 . . . . 0.0 110.905 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -130.79 -12.25 3.78 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.571 0.748 . . . . 0.0 110.657 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -84.85 154.75 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.261 0.625 . . . . 0.0 109.652 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -80.46 -1.51 41.91 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.905 0.482 . . . . 0.0 111.948 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 46.92 50.2 13.91 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 123.874 0.87 . . . . 0.0 110.945 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.55 3.41 33.7 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.795 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 56.72 16.73 2.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 152.32 35.45 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.99 23.29 0.09 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.5 -25.62 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.125 0.97 . . . . 0.0 111.308 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -126.36 161.0 28.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.32 0.648 . . . . 0.0 110.464 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -78.54 168.32 19.96 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.997 0.519 . . . . 0.0 110.046 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.7 t -73.06 150.29 42.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.6 0.36 . . . . 0.0 110.202 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.86 -8.97 40.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.257 -0.277 . . . . 0.0 110.916 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.76 -7.48 21.62 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.801 0.84 . . . . 0.0 111.168 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -117.54 1.39 12.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.49 0.716 . . . . 0.0 111.417 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.1 mtt -79.63 -179.99 7.18 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 122.724 0.41 . . . . 0.0 110.54 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -64.56 -14.81 59.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.814 0.845 . . . . 0.0 112.834 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.552 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 113.53 5.33 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.813 3.613 . 0.228 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 1 O4'-C1'-N19 112.372 4.172 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.82 4.62 . 0.033 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 0 O4'-C1'-N19 111.153 2.953 . 0.119 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 O4'-C1'-N19 112.437 4.237 . 0.09 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 112.517 4.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.555 0.216 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -72.75 174.56 7.48 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.944 0.402 . . . . 0.0 111.154 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.11 16.44 19.24 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.65 0.78 . . . . 0.0 111.452 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 5.1 p -123.89 135.5 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 56' ' ' GLN . 68.3 p -148.03 11.76 0.95 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.361 0.664 . . . . 0.0 112.028 -176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -104.02 19.33 20.25 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -64.93 172.32 2.95 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.302 0.641 . . . . 0.0 110.163 177.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 p -136.02 24.5 3.31 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 122.626 0.37 . . . . 0.0 111.724 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.27 152.57 95.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 122.127 -0.358 . . . . 0.0 110.722 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.86 -8.5 19.91 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 124.105 3.203 . . . . 0.0 113.09 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -122.63 -7.72 8.55 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 118.139 0.427 . . . . 0.0 111.608 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 t -93.37 -22.75 18.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.897 0.479 . . . . 0.0 110.032 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -11.64 61.05 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.74 0.416 . . . . 0.0 111.546 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.01 -7.3 6.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.838 0.455 . . . . 0.0 112.1 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 p -95.12 9.0 41.22 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 121.376 0.607 . . . . 0.0 110.147 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -110.25 154.33 23.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.203 1.401 . . . . 0.0 110.483 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.13 131.12 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 123.437 0.695 . . . . 0.0 109.37 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -99.32 135.5 40.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 59.6 mt -127.8 106.88 15.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.65 169.93 15.02 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 122.94 0.305 . . . . 0.0 113.012 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 t30 53.84 24.33 4.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.874 1.27 . . . . 0.0 111.892 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.93 148.78 48.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.924 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.45 53.86 0.42 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.549 1.539 . . . . 0.0 111.719 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.402 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.1 p -64.63 2.59 0.63 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mt -86.89 -13.54 44.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 118.482 0.583 . . . . 0.0 110.844 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.2 -21.25 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 122.821 0.449 . . . . 0.0 110.546 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -80.99 159.35 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.82 172.47 12.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.576 0.75 . . . . 0.0 109.185 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -60.36 -33.47 72.49 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.419 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.3 m -76.23 -8.59 57.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.446 0.698 . . . . 0.0 111.081 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.72 -40.92 9.13 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.553 0.341 . . . . 0.0 110.24 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.9 t -65.77 -35.34 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 118.275 0.488 . . . . 0.0 109.774 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.25 1.96 26.42 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.17 -0.331 . . . . 0.0 111.538 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.32 -8.11 11.69 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.256 0.622 . . . . 0.0 111.306 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -105.7 -22.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.395 0.678 . . . . 0.0 110.56 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -110.98 -6.98 14.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 122.776 0.431 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -77.12 -8.09 56.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.312 -0.868 . . . . 0.0 111.051 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -84.71 -5.14 59.31 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.879 -0.513 . . . . 0.0 111.93 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.37 -1.42 10.2 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.29 0.636 . . . . 0.0 112.016 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.08 166.17 31.13 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.333 -0.461 . . . . 0.0 112.285 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -77.5 113.22 15.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.7 mt -83.8 127.42 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.32 -0.96 9.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 124.161 0.984 . . . . 0.0 110.732 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.63 145.67 10.54 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.35 145.51 20.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.624 0.712 . . . . 0.0 111.166 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.0 p -152.81 159.39 43.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.209 0.604 . . . . 0.0 109.57 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.93 146.98 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -137.88 -164.48 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.579 0.752 . . . . 0.0 109.953 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -88.97 127.54 35.67 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.94 -12.47 3.84 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.279 -0.734 . . . . 0.0 113.881 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.02 170.72 19.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.8 1.3 . . . . 0.0 111.422 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.8 23.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.094 0.958 . . . . 0.0 109.582 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -137.32 144.0 42.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.37 0.605 . . . . 0.0 110.797 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -133.46 143.43 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -123.52 118.06 26.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.134 0.574 . . . . 0.0 109.487 -176.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.15 178.53 4.75 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.346 0.658 . . . . 0.0 111.102 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -78.67 -28.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.788 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.36 175.62 12.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.362 0.601 . . . . 0.0 112.044 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -33.3 74.01 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.147 0.979 . . . . 0.0 111.878 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -63.04 -40.37 97.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.714 0.806 . . . . 0.0 110.162 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -67.76 -34.15 76.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.57 74.29 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.718 -0.614 . . . . 0.0 111.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -64.56 -23.42 67.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.039 0.836 . . . . 0.0 110.601 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.03 82.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.162 0.437 . . . . 0.0 110.93 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.53 -27.52 19.12 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 83' ' ' ASN . 6.6 t -68.03 -22.7 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.099 -0.376 . . . . 0.0 110.512 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.16 14.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.269 -0.269 . . . . 0.0 111.658 174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.87 -23.0 14.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.223 -0.765 . . . . 0.0 113.938 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -124.42 -13.95 7.01 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.322 1.061 . . . . 0.0 112.096 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.92 129.66 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.692 0.678 . . . . 0.0 110.7 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.51 13.28 73.57 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.229 -0.762 . . . . 0.0 112.783 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -90.45 161.29 15.61 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.483 1.141 . . . . 0.0 111.156 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.1 ttm -98.15 138.79 34.91 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.258 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 52.8 mt -143.7 136.45 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.02 14.03 0.3 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.37 -3.56 37.39 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.166 -0.796 . . . . 0.0 113.597 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.59 162.72 25.81 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-N 118.501 1.151 . . . . 0.0 109.908 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.1 t -101.7 148.33 7.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.605 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -121.41 144.6 48.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.733 0.813 . . . . 0.0 109.646 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -102.83 121.67 42.95 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.25 138.35 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HA ' HG13 ' A' ' 67' ' ' VAL . 3.6 p-10 -156.63 165.47 36.17 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.01 147.86 52.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.84 -3.68 13.41 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.39 9.75 5.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.98 0.512 . . . . 0.0 111.224 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -138.55 58.82 15.09 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.0 103.51 1.49 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.31 2.674 . . . . 0.0 110.343 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.55 -11.0 59.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.81 0.444 . . . . 0.0 110.342 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.01 160.2 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.019 0.928 . . . . 0.0 110.447 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -91.18 4.87 51.12 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.222 0.609 . . . . 0.0 111.5 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 48.43 56.08 8.0 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.0 0.92 . . . . 0.0 111.341 -174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.56 3.23 43.13 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.781 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm 55.91 17.57 2.61 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.63 152.87 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 122.09 -0.381 . . . . 0.0 111.011 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.21 62.32 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.281 0.467 . . . . 0.0 112.67 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.92 -24.79 19.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 117.428 0.614 . . . . 0.0 110.269 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -81.62 161.25 23.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.419 0.628 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -73.04 167.61 20.75 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.164 0.985 . . . . 0.0 111.002 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.3 m -84.34 154.95 22.59 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.88 -16.0 36.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.94 -6.89 25.9 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.0 0.52 . . . . 0.0 111.797 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.01 14.77 7.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.748 0.819 . . . . 0.0 111.326 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.1 mmm -63.32 -26.97 69.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 117.798 0.272 . . . . 0.0 111.087 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -142.1 -10.15 0.88 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.144 0.577 . . . . 0.0 111.882 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.294 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 113.562 5.362 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 O4'-C1'-N19 112.375 4.175 . 0.141 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 2 C5'-C4'-C3' 108.292 -4.805 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.791 1 O4'-C1'-N19 112.62 4.42 . 0.06 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C5'-C4'-C3' 111.412 -2.725 . 0.162 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.525 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.574 1 O4'-C1'-N19 112.35 4.15 . 0.197 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 0 O4'-C1'-N19 111.817 3.617 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.499 0.19 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -59.73 168.77 1.59 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.548 0.739 . . . . 0.0 111.758 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -109.21 20.23 18.55 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.3 p -124.8 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 118.387 0.54 . . . . 0.0 110.125 -175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.5 p -148.27 19.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.017 0.527 . . . . 0.0 111.857 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -113.44 23.8 12.85 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -70.48 166.91 19.46 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.586 -0.697 . . . . 0.0 109.315 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -132.47 24.59 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.28 153.21 95.17 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 122.544 0.338 . . . . 0.0 110.644 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.21 -7.02 14.39 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.514 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.06 -16.03 7.62 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.463 0.574 . . . . 0.0 111.364 175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -86.92 -18.0 31.86 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 122.619 0.368 . . . . 0.0 110.629 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -13.77 60.09 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.03 0.532 . . . . 0.0 111.045 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.6 p30 -124.6 1.82 8.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.2 p -101.8 11.79 38.13 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.753 0.421 . . . . 0.0 109.884 171.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -110.45 156.55 20.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.646 1.178 . . . . 0.0 110.881 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.1 128.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.389 0.676 . . . . 0.0 109.604 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -94.61 136.92 34.36 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 172.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.18 86.86 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.13 170.86 34.84 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.693 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 t30 57.23 19.44 4.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.547 1.139 . . . . 0.0 112.349 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -73.37 148.57 43.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.452 0.701 . . . . 0.0 110.814 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -81.75 101.33 10.04 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.3 p -100.08 13.93 32.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -171.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.45 -12.7 23.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.81 0.277 . . . . 0.0 111.334 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.12 -21.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 C-N-CA 122.224 0.21 . . . . 0.0 110.508 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.19 158.86 3.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -144.51 173.15 12.05 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.946 0.499 . . . . 0.0 109.724 177.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.5 tttt -58.63 -33.11 69.68 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.635 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -77.96 -7.17 56.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.526 0.73 . . . . 0.0 111.136 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -99.41 -39.57 8.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -68.2 -34.44 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -80.46 5.32 15.44 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.159 -0.338 . . . . 0.0 111.356 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.94 -8.53 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.1 0.56 . . . . 0.0 111.253 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.6 mt -105.42 -22.77 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.487 0.715 . . . . 0.0 110.186 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -110.74 -6.54 14.77 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.139 -0.35 . . . . 0.0 111.712 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.6 t -77.67 -9.06 58.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.761 -0.587 . . . . 0.0 111.396 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.74 -2.8 58.57 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.954 -0.466 . . . . 0.0 111.977 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.43 -2.41 10.02 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.143 0.577 . . . . 0.0 111.612 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.1 168.88 34.18 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.643 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.97 114.18 19.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt -86.31 127.59 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.37 4.78 7.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.497 0.719 . . . . 0.0 110.515 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.93 146.57 9.13 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.426 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 19.7 p -158.83 152.13 22.69 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.426 0.613 . . . . 0.0 110.661 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.1 m -147.87 158.79 44.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.387 0.675 . . . . 0.0 109.54 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 73.6 t -135.56 151.51 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.29 -168.25 2.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.062 0.545 . . . . 0.0 109.703 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -87.14 120.05 28.01 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.94 -9.53 30.98 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.139 -0.812 . . . . 0.0 113.906 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -152.27 170.29 20.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.881 1.34 . . . . 0.0 110.802 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.24 170.72 17.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 0.0 109.981 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -138.67 147.49 42.87 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.331 0.586 . . . . 0.0 111.415 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.76 141.87 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.79 111.48 16.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.683 0.793 . . . . 0.0 109.131 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.82 -178.83 5.35 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.194 0.598 . . . . 0.0 110.566 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.5 t -82.7 -26.59 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.984 0.514 . . . . 0.0 110.997 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -153.29 175.48 13.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.579 0.704 . . . . 0.0 112.064 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.48 -33.02 70.77 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.189 0.996 . . . . 0.0 111.915 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -62.32 -39.82 94.28 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.358 0.663 . . . . 0.0 109.902 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.58 -35.08 76.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.338 0.255 . . . . 0.0 110.666 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.19 -43.92 85.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.073 -0.392 . . . . 0.0 111.403 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.04 -20.22 61.72 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 117.593 0.179 . . . . 0.0 110.642 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.85 85.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.673 -0.203 . . . . 0.0 110.497 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.17 -28.82 17.61 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.0 t -68.23 -20.21 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.3 -0.25 . . . . 0.0 110.488 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.19 -10.04 13.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 173.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.83 -28.13 11.59 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.437 -0.646 . . . . 0.0 113.611 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.69 -13.9 8.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.137 0.968 . . . . 0.0 112.253 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.04 130.7 48.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.425 -0.797 . . . . 0.0 110.633 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.73 72.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.284 -0.731 . . . . 0.0 112.775 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -91.57 161.7 14.83 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.332 1.066 . . . . 0.0 111.37 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 ttm -99.09 138.64 35.9 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.2 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.6 mt -143.41 134.23 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.96 18.14 0.76 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.72 -0.73 39.24 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.149 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.45 158.76 42.25 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.429 1.115 . . . . 0.0 110.137 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.4 148.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.577 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.39 142.33 47.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.58 0.752 . . . . 0.0 109.839 -178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.03 104.83 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.9 mt -103.08 138.55 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -155.81 162.54 40.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.591 0.234 . . . . 0.0 110.774 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.16 144.76 56.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.41 38.21 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.74 13.26 5.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.748 0.419 . . . . 0.0 111.372 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -132.92 46.58 2.19 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.78 150.93 79.13 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.814 2.343 . . . . 0.0 110.804 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.99 -2.39 1.02 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.173 0.589 . . . . 0.0 112.376 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.22 156.89 21.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.151 0.98 . . . . 0.0 110.545 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -75.09 -5.55 44.77 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 123.524 0.73 . . . . 0.0 112.391 -177.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 45.27 37.34 2.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.378 1.471 . . . . 0.0 112.39 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.6 37.18 0.85 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 126.107 1.813 . . . . 0.0 114.48 -173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt 61.56 -178.4 0.12 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.652 1.215 . . . . 0.0 112.312 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -19.82 66.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.325 -1.761 . . . . 0.0 112.142 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.02 7.69 82.02 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.3 t -78.07 -27.3 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 117.077 0.438 . . . . 0.0 110.681 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -85.07 153.19 22.87 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.818 0.447 . . . . 0.0 110.077 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -118.32 154.96 31.47 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.569 0.748 . . . . 0.0 110.689 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.2 t -80.71 152.2 28.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.85 -2.98 5.81 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.08 -3.99 14.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.619 0.768 . . . . 0.0 111.329 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -123.01 11.97 9.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.613 0.765 . . . . 0.0 111.431 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 36.5 mtp -74.55 172.81 11.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.317 0.579 . . . . 0.0 111.164 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -75.86 -10.99 59.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.836 0.854 . . . . 0.0 112.131 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.512 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.956 1 O4'-C1'-N19 113.938 5.738 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.42 0 O4'-C1'-N19 111.663 3.463 . 0.189 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 1 O4'-C1'-N19 112.899 4.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.404 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 113.027 4.827 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.404 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.032 0 O4'-C1'-N19 110.861 2.661 . 0.552 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.504 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.594 1 O4'-C1'-N19 112.433 4.233 . 0.106 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.026 1 O4'-C1'-N19 114.779 6.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.397 0.141 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -64.88 176.91 1.06 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.211 0.605 . . . . 0.0 111.228 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -112.29 30.73 6.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.407 0.683 . . . . 0.0 112.11 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.94 129.65 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 122.565 0.346 . . . . 0.0 110.372 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.8 p -149.39 22.31 0.93 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.924 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -122.98 32.66 5.63 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -74.51 167.03 22.53 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.636 -0.665 . . . . 0.0 109.225 174.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.6 p -132.18 21.43 4.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.83 -0.544 . . . . 0.0 112.119 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.58 153.61 95.55 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 122.808 0.443 . . . . 0.0 111.015 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.51 -5.59 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 124.402 3.402 . . . . 0.0 113.264 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -125.59 -1.28 7.43 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.241 0.473 . . . . 0.0 111.518 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 m -104.02 -17.13 15.08 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 122.865 0.466 . . . . 0.0 110.78 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -13.65 59.67 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.09 -0.382 . . . . 0.0 111.231 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -119.04 3.36 11.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.667 0.787 . . . . 0.0 111.284 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.2 p -104.3 8.88 36.09 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.045 0.538 . . . . 0.0 110.587 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -108.55 166.94 10.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.315 0.578 . . . . 0.0 111.952 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.4 126.51 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.321 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -94.13 130.26 40.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.82 85.86 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.26 171.66 38.82 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.87 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 t30 56.45 18.05 3.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.976 1.31 . . . . 0.0 112.337 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.9 tp -71.11 151.09 44.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.153 0.581 . . . . 0.0 110.148 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -64.4 -40.74 96.39 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.478 -0.139 . . . . 0.0 111.154 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.6 p 52.4 9.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.074 1.75 . . . . 0.0 115.475 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -102.86 -21.72 13.97 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.76 0.709 . . . . 0.0 111.08 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.62 -22.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 123.318 0.647 . . . . 0.0 110.311 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.86 169.73 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 3.5 ptpt -160.2 175.88 12.4 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.078 0.551 . . . . 0.0 110.767 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 46' ' ' CYS . 26.7 tptp -60.38 -27.84 67.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.93 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 m -87.58 -7.59 57.34 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 117.751 0.251 . . . . 0.0 111.654 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 54.8 m-20 -97.33 -43.2 7.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.397 0.279 . . . . 0.0 110.285 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.28 -34.23 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.111 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -79.22 3.29 18.3 Favored 'General case' 0 C--N 1.34 0.153 0 O-C-N 122.063 -0.398 . . . . 0.0 111.473 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.11 -9.52 10.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.25 0.62 . . . . 0.0 111.465 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.76 -23.0 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.537 0.735 . . . . 0.0 110.647 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -109.27 -9.67 14.98 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.518 0.327 . . . . 0.0 111.576 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -74.09 -3.3 28.66 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.73 -0.606 . . . . 0.0 111.663 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -88.95 -6.02 57.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 111.37 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -119.68 -1.51 10.57 Favored 'General case' 0 N--CA 1.458 -0.06 0 C-N-CA 123.398 0.679 . . . . 0.0 111.837 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.92 169.25 35.93 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.174 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -81.05 113.66 19.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.3 mt -86.62 129.56 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 4.02 7.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 C-N-CA 123.42 0.688 . . . . 0.0 110.444 177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.2 145.01 9.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 53.4 t -155.71 145.32 21.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.003 0.902 . . . . 0.0 109.752 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.9 m -146.12 156.21 43.28 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.65 148.91 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -142.35 -171.34 3.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.467 0.707 . . . . 0.0 109.218 -175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -86.75 129.52 34.84 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 174.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.64 -11.51 7.07 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.093 0.854 . . . . 0.0 113.948 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -155.54 168.82 25.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.717 1.258 . . . . 0.0 110.865 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.17 170.12 18.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.563 0.745 . . . . 0.0 109.815 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -139.11 152.22 47.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.138 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 81.6 t -137.47 147.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.877 0.871 . . . . 0.0 108.834 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -124.79 110.5 14.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.907 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.15 -177.89 5.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.015 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.96 -24.77 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.56 175.1 13.13 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.331 0.586 . . . . 0.0 112.192 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -70.28 -33.31 71.42 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.407 1.083 . . . . 0.0 112.001 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.608 0.763 . . . . 0.0 110.33 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.74 -33.89 75.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.569 0.348 . . . . 0.0 110.163 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.44 74.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.848 -0.533 . . . . 0.0 111.276 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -65.05 -23.85 67.3 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.635 0.652 . . . . 0.0 110.59 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.92 85.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.95 0.341 . . . . 0.0 110.74 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 -26.87 18.17 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.93 -21.59 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.23 -10.21 14.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.3 -23.75 16.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.126 -177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -122.55 -13.76 7.92 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 118.39 1.095 . . . . 0.0 111.861 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -58.88 129.9 44.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.536 -0.727 . . . . 0.0 110.907 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 13.09 72.15 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.681 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -91.42 160.5 15.43 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.365 1.082 . . . . 0.0 111.407 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttm -97.86 138.49 35.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.838 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.2 mt -143.51 135.13 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.98 14.55 0.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.93 1.57 48.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.458 -0.635 . . . . 0.0 113.455 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -130.44 155.79 45.83 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.111 0.956 . . . . 0.0 110.161 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.07 147.37 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.594 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.27 141.64 48.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.456 0.702 . . . . 0.0 109.918 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -99.13 107.38 19.74 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.12 139.87 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.67 0.388 . . . . 0.0 110.042 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -155.23 163.96 39.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.858 0.463 . . . . 0.0 109.954 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 157.37 30.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.33 -2.43 52.8 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.1 11.42 4.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -134.49 48.67 3.23 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.72 127.53 16.44 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.827 2.351 . . . . 0.0 111.49 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -113.26 -1.1 14.38 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.853 0.861 . . . . 0.0 109.897 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 p -91.82 154.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 123.119 0.568 . . . . 0.0 110.343 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.35 1.01 52.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.217 0.607 . . . . 0.0 111.84 -176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 49.05 43.27 22.1 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.868 0.867 . . . . 0.0 111.319 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 8.59 7.45 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.203 0.906 . . . . 0.0 114.119 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt 57.17 12.79 1.41 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.6 -25.97 0.19 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.76 0.424 . . . . 0.0 111.157 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.21 -1.21 85.94 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.136 0.398 . . . . 0.0 112.162 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.3 t -124.24 -24.94 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.411 0.684 . . . . 0.0 111.105 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.52 166.22 19.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.147 0.579 . . . . 0.0 110.673 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -78.79 171.77 14.7 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 123.527 0.731 . . . . 0.0 110.999 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.6 m -78.44 24.99 0.25 Allowed 'General case' 0 CA--C 1.524 -0.048 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -171.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 52.98 6.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.299 1.44 . . . . 0.0 114.63 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.69 -5.48 1.36 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.948 0.899 . . . . 0.0 110.417 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.59 20.43 8.64 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.501 1.12 . . . . 0.0 109.318 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.7 mtp -71.64 176.33 4.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.203 0.525 . . . . 0.0 111.386 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -67.53 -13.3 61.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.49 0.716 . . . . 0.0 112.252 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.604 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.577 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.08 1 O4'-C1'-N19 113.401 5.201 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 O4'-C1'-N19 111.941 3.741 . 0.23 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 112.518 4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.669 1 O4'-C1'-N19 113.017 4.817 . 0.026 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 O4'-C1'-N19 110.933 2.733 . 0.145 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.502 4.302 . 0.057 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 O4'-C1'-N19 113.371 5.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -86.4 8.34 22.07 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 -169.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.0 t30 53.97 32.99 16.43 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.506 0.594 . . . . 0.0 112.33 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 7.8 p -145.67 137.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 O-C-N 122.157 -0.339 . . . . 0.0 110.569 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -150.97 12.24 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.68 0.792 . . . . 0.0 112.063 -173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -112.4 15.05 20.39 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -62.05 171.78 1.63 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.656 0.662 . . . . 0.0 109.643 175.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -133.37 29.31 3.97 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.847 -0.533 . . . . 0.0 111.862 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.55 154.18 95.06 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.69 -8.28 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.237 3.291 . . . . 0.0 112.757 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 -27.84 5.82 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.041 0.382 . . . . 0.0 111.367 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 m -76.14 -22.78 55.05 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.187 0.448 . . . . 0.0 110.702 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -15.75 63.33 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.246 0.619 . . . . 0.0 110.837 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.2 p30 -124.74 9.66 8.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.825 0.45 . . . . 0.0 111.733 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.4 m -110.83 8.99 22.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.978 0.511 . . . . 0.0 110.865 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -118.62 172.94 7.14 Favored 'General case' 0 C--N 1.337 0.056 0 C-N-CA 122.651 0.38 . . . . 0.0 110.832 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 t -126.57 131.04 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.94 0.896 . . . . 0.0 110.046 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -93.22 137.14 32.84 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -131.67 89.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 168.92 30.7 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 122.835 0.255 . . . . 0.0 113.021 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.8 t30 57.25 18.25 4.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.946 1.298 . . . . 0.0 112.388 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.53 147.75 47.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.941 0.496 . . . . 0.0 110.758 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.07 108.57 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.543 ' HA ' HG12 ' A' ' 28' ' ' VAL . 81.5 p -104.88 12.8 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.93 -12.4 26.87 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.14 -21.44 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.623 0.369 . . . . 0.0 110.373 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.43 156.35 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.84 173.55 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.4 -34.25 70.54 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.2 m -74.45 -10.94 60.06 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.441 0.696 . . . . 0.0 111.032 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -95.03 -40.07 9.83 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.1 -38.55 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.93 3.02 13.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -116.56 -13.07 10.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.777 0.431 . . . . 0.0 111.689 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.3 -21.66 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.433 0.693 . . . . 0.0 110.35 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -109.85 -8.91 14.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -75.18 -8.69 57.28 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.628 -0.67 . . . . 0.0 111.497 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -88.4 -3.27 58.86 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 121.877 -0.515 . . . . 0.0 112.149 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -118.22 -3.11 11.06 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.35 0.66 . . . . 0.0 111.358 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.45 167.31 33.04 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -79.02 115.35 18.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.0 mt -85.45 128.27 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.73 8.05 6.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 C-N-CA 123.451 0.7 . . . . 0.0 110.685 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.09 147.36 10.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.9 t -157.26 148.38 21.75 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.186 0.993 . . . . 0.0 110.588 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.6 p -151.22 158.03 43.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.116 0.484 . . . . 0.0 109.825 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.5 146.25 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -140.82 -171.51 3.26 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.053 0.541 . . . . 0.0 109.909 -170.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -81.37 127.61 32.95 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.34 -9.71 5.47 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.72 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -157.07 170.44 22.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.391 1.595 . . . . 0.0 111.605 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.83 171.42 16.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.582 0.753 . . . . 0.0 110.395 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -141.47 149.98 41.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.361 0.665 . . . . 0.0 111.219 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.89 139.11 37.91 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -116.46 118.85 33.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -96.2 -179.77 4.77 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.183 0.593 . . . . 0.0 110.177 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.6 t -80.76 -25.62 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.795 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -153.4 177.54 10.77 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.93 0.492 . . . . 0.0 111.382 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -72.18 -34.38 68.39 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.514 0.726 . . . . 0.0 111.438 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.62 -40.38 79.04 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 122.954 0.502 . . . . 0.0 110.205 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.06 -33.9 75.43 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.99 78.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.003 -0.436 . . . . 0.0 110.913 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -65.51 -24.49 67.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.05 0.386 . . . . 0.0 110.203 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.61 -41.86 75.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.286 0.235 . . . . 0.0 111.155 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.75 -27.94 17.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.7 t -69.86 -21.23 23.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.891 0.314 . . . . 0.0 110.297 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.59 -10.22 14.13 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 173.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.58 -32.99 7.34 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.493 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -117.03 -12.71 10.62 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.057 0.928 . . . . 0.0 112.152 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.2 130.63 47.88 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.172 0.897 . . . . 0.0 110.641 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 13.72 73.54 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.264 -0.742 . . . . 0.0 112.555 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.85 160.96 15.04 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.271 1.035 . . . . 0.0 111.025 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.4 ttm -97.63 138.35 35.16 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.01 0.433 . . . . 0.0 111.096 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -142.97 134.62 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.53 1.132 . . . . 0.0 108.133 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.34 18.7 0.66 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.49 -1.41 39.76 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.091 -0.838 . . . . 0.0 113.823 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -132.91 160.12 37.96 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.585 1.193 . . . . 0.0 110.195 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.98 148.29 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.28 142.99 46.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.843 0.857 . . . . 0.0 109.875 -178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -98.94 102.04 13.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.6 mt -100.26 138.82 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -157.44 163.21 38.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.23 145.83 55.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.61 -1.4 42.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -126.39 13.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.671 0.389 . . . . 0.0 111.169 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -135.99 48.1 2.45 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.31 142.08 71.34 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.742 2.294 . . . . 0.0 110.984 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -137.69 1.01 2.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.722 0.809 . . . . 0.0 111.052 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.0 153.61 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.318 0.647 . . . . 0.0 109.911 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.32 0.88 20.55 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.318 0.647 . . . . 0.0 112.549 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 47.3 46.93 16.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.049 0.939 . . . . 0.0 111.129 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.03 7.96 7.02 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 123.807 0.718 . . . . 0.0 113.945 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 59.18 4.7 0.48 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.085 1.354 . . . . 0.0 114.146 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.76 152.42 28.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.314 0.645 . . . . 0.0 109.672 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.45 -1.17 64.42 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.26 -23.0 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.346 0.659 . . . . 0.0 110.841 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -78.24 152.84 32.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.742 0.417 . . . . 0.0 110.823 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.66 173.16 11.98 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.381 1.072 . . . . 0.0 110.51 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.5 t -72.24 151.82 42.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.76 -2.72 3.94 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.74 13.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.588 0.755 . . . . 0.0 111.396 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.48 7.33 10.62 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.467 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.6 mtp -69.76 -24.82 63.58 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.077 -0.39 . . . . 0.0 112.052 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -140.16 -3.21 1.4 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.008 0.523 . . . . 0.0 111.904 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 O4'-C1'-N19 113.672 5.472 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 112.049 3.849 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 O4'-C1'-N19 112.195 3.995 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.903 1 O4'-C1'-N19 113.108 4.908 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.8 0 O4'-C1'-N19 110.664 2.464 . 0.507 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.469 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 112.234 4.034 . 0.12 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.101 1 O4'-C1'-N19 113.246 5.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.346 0.117 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 m -65.28 175.66 1.61 Allowed 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -106.65 21.5 17.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.9 0.48 . . . . 0.0 112.017 -176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.97 126.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 118.081 0.4 . . . . 0.0 111.035 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.4 p -150.13 16.2 0.84 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -115.13 18.26 16.34 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -61.94 163.87 7.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.434 0.561 . . . . 0.0 109.675 176.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -128.29 22.83 6.04 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.51 0.324 . . . . 0.0 111.467 -177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -67.54 154.23 93.55 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.79 -7.84 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.006 3.137 . . . . 0.0 112.611 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.407 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 6.6 ppt_? -117.65 -24.2 7.34 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.325 0.511 . . . . 0.0 111.4 175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.6 m -79.58 -19.55 49.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.232 0.469 . . . . 0.0 110.893 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -13.32 61.09 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.372 0.669 . . . . 0.0 111.085 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -125.3 -6.66 7.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.693 0.397 . . . . 0.0 111.843 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -90.16 13.23 15.63 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 122.764 0.426 . . . . 0.0 109.893 171.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -117.76 152.02 36.12 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.25 1.02 . . . . 0.0 111.283 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.96 131.45 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.623 0.769 . . . . 0.0 108.99 176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -100.95 139.59 36.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.97 101.66 3.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.18 166.77 18.98 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.5 0.572 . . . . 0.0 112.597 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.4 t30 55.69 24.48 7.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.865 1.266 . . . . 0.0 112.452 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD21 HG11 ' A' ' 28' ' ' VAL . 40.8 tp -69.64 149.64 47.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.626 0.77 . . . . 0.0 112.069 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -76.0 58.04 1.14 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.584 1.554 . . . . 0.0 110.989 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -65.48 3.7 0.66 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.04 -15.82 37.49 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.195 0.907 . . . . 0.0 111.318 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.0 -21.32 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 122.504 0.322 . . . . 0.0 110.594 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -85.47 156.33 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.76 172.51 12.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.502 ' HE3' ' SG ' ' A' ' 46' ' ' CYS . 85.8 tttt -60.07 -30.19 69.06 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.31 -0.244 . . . . 0.0 110.702 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 p -79.48 -8.64 59.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.386 0.675 . . . . 0.0 111.036 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -98.04 -40.04 8.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.19 -33.08 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 O-C-N 121.962 -0.461 . . . . 0.0 110.057 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.03 4.18 17.87 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.738 -0.601 . . . . 0.0 111.205 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.19 -9.17 11.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.405 0.682 . . . . 0.0 111.398 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -104.19 -22.42 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.576 0.75 . . . . 0.0 110.566 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -112.22 -8.0 14.0 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.725 0.41 . . . . 0.0 111.769 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.1 t -76.32 -9.07 58.36 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.637 -0.664 . . . . 0.0 111.001 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.7 pttt -82.61 -6.4 59.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.072 0.549 . . . . 0.0 111.746 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 9.9 m-85 -120.29 -2.68 10.06 Favored 'General case' 0 C--N 1.334 -0.067 0 C-N-CA 123.246 0.618 . . . . 0.0 112.127 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.99 168.32 35.45 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.634 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -80.3 112.92 18.08 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.3 mt -84.56 127.94 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.79 6.44 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 123.537 0.735 . . . . 0.0 110.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.74 141.38 6.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.502 ' SG ' ' HE3' ' A' ' 30' ' ' LYS . 17.6 p -157.59 151.08 23.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.983 0.891 . . . . 0.0 110.581 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 t -154.65 158.28 39.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.804 0.335 . . . . 0.0 110.119 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.6 t -138.84 146.59 25.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.412 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 24.5 m-70 -141.41 -171.46 3.31 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.769 . . . . 0.0 109.088 -175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -80.01 127.28 32.1 Favored 'General case' 0 C--O 1.227 -0.107 0 O-C-N 121.979 -0.451 . . . . 0.0 109.92 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 -12.1 2.67 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.033 -0.87 . . . . 0.0 114.286 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 36.6 p90 -149.48 163.12 38.68 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.013 1.406 . . . . 0.0 111.712 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.88 23.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.134 0.574 . . . . 0.0 110.623 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -140.66 149.44 42.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.407 0.622 . . . . 0.0 112.101 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.08 138.75 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.192 0.997 . . . . 0.0 108.772 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -120.51 116.38 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.665 0.786 . . . . 0.0 109.183 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.41 -178.3 4.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.987 0.515 . . . . 0.0 110.477 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -82.95 -26.08 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -151.94 174.73 13.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.415 0.626 . . . . 0.0 112.125 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.35 -32.02 69.55 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.865 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -62.98 -40.79 98.82 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.242 0.617 . . . . 0.0 110.053 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.51 -34.73 77.7 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.23 -43.97 76.74 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.883 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -65.51 -24.0 67.02 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.866 0.757 . . . . 0.0 110.634 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.79 80.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.028 0.377 . . . . 0.0 110.645 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.79 -28.21 19.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 83' ' ' ASN . 4.1 t -68.21 -23.38 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 122.683 0.393 . . . . 0.0 110.557 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.98 -9.88 14.74 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 174.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.91 -27.0 10.7 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-O 119.538 -0.59 . . . . 0.0 113.677 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -121.97 -14.88 7.94 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 118.194 0.997 . . . . 0.0 112.587 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -59.27 131.17 50.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.876 0.762 . . . . 0.0 110.689 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.23 13.83 75.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.676 -0.514 . . . . 0.0 112.811 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -91.61 160.81 15.2 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.05 0.925 . . . . 0.0 111.327 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -98.21 138.94 34.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.643 0.258 . . . . 0.0 110.963 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 53.7 mt -142.73 136.38 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.57 12.17 0.15 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.67 34.97 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.112 -0.827 . . . . 0.0 114.024 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.91 159.07 37.75 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.73 1.265 . . . . 0.0 110.117 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.33 145.52 9.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.59 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -116.93 146.45 42.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.706 0.803 . . . . 0.0 110.051 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -100.37 111.12 23.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -113.82 137.21 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.184 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' A' ' 67' ' ' VAL . 1.9 p-10 -159.93 169.08 24.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 148.25 49.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.09 -4.64 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.93 10.57 6.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.128 0.571 . . . . 0.0 111.199 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.64 57.4 16.17 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 147.67 62.33 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.296 2.664 . . . . 0.0 109.714 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -135.32 2.85 3.05 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.18 0.592 . . . . 0.0 111.484 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.6 t -115.57 154.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.454 0.702 . . . . 0.0 109.469 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.93 4.63 5.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.763 0.825 . . . . 0.0 112.827 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 mtm105 49.47 54.01 11.71 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.738 0.815 . . . . 0.0 111.028 -174.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.83 13.45 3.14 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.103 0.859 . . . . 0.0 113.995 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 56.28 -97.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.976 1.311 . . . . 0.0 112.96 178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -160.52 -13.96 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.86 81.39 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.5 -30.97 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.62 162.76 14.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.726 0.81 . . . . 0.0 109.186 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.65 166.32 23.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.651 0.262 . . . . 0.0 110.419 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.5 t -69.34 159.24 33.51 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.99 -10.65 59.34 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.139 -0.351 . . . . 0.0 111.385 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -98.58 -6.38 30.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.408 0.683 . . . . 0.0 111.001 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -129.34 17.43 5.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.363 1.065 . . . . 0.0 109.741 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.1 tpt -64.83 -22.72 67.05 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.334 0.654 . . . . 0.0 111.621 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -139.81 -10.68 1.17 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.648 0.379 . . . . 0.0 111.968 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.972 1 O4'-C1'-N19 113.697 5.497 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.668 0 O4'-C1'-N19 111.798 3.598 . 0.213 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.535 1 C5'-C4'-C3' 108.557 -4.629 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.445 2 O4'-C1'-N19 112.978 4.778 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.827 0 C5'-C4'-C3' 111.897 -2.402 . 0.343 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 O4'-C1'-N19 112.82 4.62 . 0.108 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.786 1 O4'-C1'-N19 112.471 4.271 . 0.577 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.302 0.096 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -74.03 174.45 8.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.844 0.458 . . . . 0.0 111.626 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -113.79 30.38 7.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.038 0.935 . . . . 0.0 111.526 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.73 140.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 56' ' ' GLN . 7.2 p -144.82 -8.55 0.63 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.85 0.86 . . . . 0.0 111.084 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -77.59 23.93 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -170.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -67.51 157.24 34.76 Favored 'General case' 0 CA--C 1.526 0.038 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.9 p -128.39 23.27 5.95 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 122.62 0.368 . . . . 0.0 111.925 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.71 153.95 95.27 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 122.778 0.431 . . . . 0.0 110.56 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.36 -1.68 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 0.0 113.136 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -129.21 -13.58 4.43 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.831 0.452 . . . . 0.0 111.616 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -88.13 -22.27 24.19 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.4 mmm -75.12 -14.95 60.61 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.532 0.733 . . . . 0.0 111.685 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -120.73 -1.68 9.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.15 0.58 . . . . 0.0 111.616 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.9 p -100.58 13.35 34.98 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 122.805 0.442 . . . . 0.0 109.939 172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -122.31 153.59 38.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.344 0.658 . . . . 0.0 110.68 -175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.86 134.17 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.416 0.686 . . . . 0.0 110.448 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -100.87 135.58 42.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.9 mt -129.02 108.33 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.01 167.35 12.29 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 123.039 0.212 . . . . 0.0 112.577 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t30 59.81 4.81 0.62 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.849 1.26 . . . . 0.0 112.084 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.7 tp -65.48 141.99 58.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' CD ' ' A' ' 78' ' ' GLN . 6.6 t30 -75.39 129.76 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 28' ' ' VAL . 73.2 p -121.29 15.2 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.766 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -94.25 -10.35 33.2 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t -132.14 -21.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.671 0.388 . . . . 0.0 110.785 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -83.78 155.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.47 173.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.668 0.387 . . . . 0.0 110.497 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -56.79 -30.06 63.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.988 0.515 . . . . 0.0 110.822 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 m -84.08 -7.0 59.5 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.88 0.472 . . . . 0.0 111.441 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 4.2 m-20 -95.82 -41.18 8.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.747 0.248 . . . . 0.0 110.567 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.41 -33.66 64.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 118.526 0.603 . . . . 0.0 109.561 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -80.84 1.15 31.89 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.115 -0.366 . . . . 0.0 111.267 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.58 -9.73 11.97 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.188 0.595 . . . . 0.0 111.486 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.45 -22.98 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.75 0.82 . . . . 0.0 110.9 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -111.67 -6.93 14.29 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.7 t -77.44 -6.63 54.16 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.741 -0.599 . . . . 0.0 111.004 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 40' ' ' TYR . 64.1 pttt -86.09 -7.78 58.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.894 0.477 . . . . 0.0 111.86 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 7.4 m-85 -118.39 -2.23 11.13 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.021 0.528 . . . . 0.0 111.923 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.18 166.66 33.26 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.414 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -78.39 111.41 14.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -83.49 126.68 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 m -115.15 0.24 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 123.168 0.587 . . . . 0.0 110.669 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.41 140.97 6.76 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.8 t -152.26 150.55 29.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.786 0.793 . . . . 0.0 111.166 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.4 p -154.64 160.4 41.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.284 0.633 . . . . 0.0 110.152 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.2 143.67 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -138.48 -168.81 2.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.582 0.753 . . . . 0.0 109.89 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -78.9 123.73 27.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.04 -10.44 4.44 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.999 0.809 . . . . 0.0 114.37 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 54.8 p90 -149.84 170.59 18.43 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.054 1.427 . . . . 0.0 111.967 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.32 165.49 32.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.582 0.753 . . . . 0.0 109.757 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -136.33 139.71 42.77 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.156 0.503 . . . . 0.0 110.461 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.21 124.29 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 32.5 tp60 -104.84 114.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.676 0.791 . . . . 0.0 109.275 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -92.32 -178.16 4.85 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.751 0.42 . . . . 0.0 110.089 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.5 t -82.41 -27.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 122.442 0.297 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -152.65 174.8 13.52 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.987 0.422 . . . . 0.0 111.758 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -68.54 -37.04 79.63 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 123.261 0.625 . . . . 0.0 111.066 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -57.57 -39.78 77.49 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.604 0.761 . . . . 0.0 110.02 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.08 -35.25 76.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.88 -41.66 78.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.771 -0.581 . . . . 0.0 110.823 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -65.14 -26.37 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 122.474 0.31 . . . . 0.0 111.186 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.8 -28.79 17.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.31 -21.93 23.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.074 0 C-N-CA 122.299 0.24 . . . . 0.0 110.378 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.15 -9.0 14.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.58 -23.91 11.66 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.426 -0.652 . . . . 0.0 113.706 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -121.46 -16.35 7.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.078 0.939 . . . . 0.0 112.043 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.75 130.0 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.546 -0.722 . . . . 0.0 110.701 -177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.49 12.65 72.23 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.375 -0.681 . . . . 0.0 112.832 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -91.39 162.4 14.6 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.403 1.101 . . . . 0.0 111.214 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.7 ttm -99.16 136.88 38.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.777 0.323 . . . . 0.0 111.043 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 76.7 mt -142.34 136.5 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.42 1.088 . . . . 0.0 108.144 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.44 8.69 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.94 1.88 26.93 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 119.011 0.823 . . . . 0.0 114.673 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' CD ' ' HB2' ' A' ' 24' ' ' ASN . 2.0 pm0 -140.98 163.01 34.13 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 118.152 0.976 . . . . 0.0 109.691 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.1 t -94.94 152.55 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.159 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.57 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -122.03 142.74 50.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.951 0.9 . . . . 0.0 110.101 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.3 107.56 20.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.96 140.09 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -156.06 165.4 36.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 159.15 24.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.07 -2.81 53.09 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.45 12.64 4.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -134.62 46.58 1.94 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.1 144.05 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.715 2.277 . . . . 0.0 110.895 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.66 4.94 3.65 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.83 0.852 . . . . 0.0 110.95 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.75 152.57 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.83 2.44 12.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.718 0.807 . . . . 0.0 112.217 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 48.78 52.06 14.73 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.874 0.869 . . . . 0.0 111.139 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.51 8.46 7.17 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.006 0.812 . . . . 0.0 113.316 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt 59.62 -5.0 0.08 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.995 1.718 . . . . 0.0 115.388 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.44 -24.73 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.864 0.756 . . . . 0.0 111.652 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.78 -0.89 75.81 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 77.3 t -102.64 -25.43 3.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.494 0.717 . . . . 0.0 110.707 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -76.46 159.66 30.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.156 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -76.7 164.86 25.48 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.706 0.803 . . . . 0.0 110.885 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 t -70.21 158.19 36.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.284 0.634 . . . . 0.0 109.653 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.45 -8.75 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.23 -6.84 27.38 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.27 0.628 . . . . 0.0 111.165 176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.39 7.92 6.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.016 0.926 . . . . 0.0 111.146 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -21.89 63.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 122.478 0.311 . . . . 0.0 111.435 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -140.5 -11.64 1.04 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.656 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 1 O4'-C1'-N19 113.552 5.352 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 1 O4'-C1'-N19 112.405 4.205 . 0.165 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.455 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.645 1 O4'-C1'-N19 112.844 4.644 OUTLIER-DELTA 0.053 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.405 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.781 4.581 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.405 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 C5'-C4'-C3' 111.81 -2.46 . 0.108 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.881 3.681 . 0.193 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 O4'-C1'-N19 113.055 4.855 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -80.97 1.61 30.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.3 t30 54.83 30.42 13.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.606 0.639 . . . . 0.0 112.383 176.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 12.0 p -142.43 136.38 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 17' ' ' ARG . 82.4 p -147.88 10.84 0.93 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -99.71 23.93 8.98 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.264 -0.897 . . . . 0.0 112.727 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' HE2' ' N ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -73.52 159.42 33.19 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 121.694 -0.629 . . . . 0.0 109.4 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.3 p -131.37 27.99 4.71 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.71 154.09 94.52 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 122.709 0.403 . . . . 0.0 110.099 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.8 -4.56 10.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.217 3.278 . . . . 0.0 112.981 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -128.53 -4.41 5.36 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -96.46 -28.66 14.32 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.062 0.392 . . . . 0.0 110.551 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -22.71 64.51 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.955 0.502 . . . . 0.0 111.679 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -109.4 3.49 21.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.388 0.675 . . . . 0.0 110.776 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -106.37 4.95 29.08 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.739 0.816 . . . . 0.0 109.374 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 32.3 ttp180 -110.18 149.66 29.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.957 -0.464 . . . . 0.0 111.013 -175.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.6 t -113.79 132.04 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.746 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -100.62 131.43 46.53 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.12 93.93 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.68 173.77 28.63 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.436 -0.347 . . . . 0.0 112.655 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.6 t30 55.23 16.05 1.52 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.299 1.44 . . . . 0.0 112.498 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.4 152.06 45.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.749 -0.594 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -64.46 -41.79 96.32 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 122.215 0.206 . . . . 0.0 111.105 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.474 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.8 p 53.19 -3.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.244 2.218 . . . . 0.0 116.828 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -95.39 -11.22 28.04 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.58 1.082 . . . . 0.0 111.261 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 t -130.92 -15.85 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.474 0.31 . . . . 0.0 110.541 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.92 159.4 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 171.9 13.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HE2' ' SG ' ' A' ' 46' ' ' CYS . 60.8 tttm -60.0 -32.19 70.63 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.642 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.1 p -76.52 -8.39 57.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.138 0.575 . . . . 0.0 110.977 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -40.76 8.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.92 0.488 . . . . 0.0 109.952 175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.6 -34.23 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 O-C-N 122.009 -0.432 . . . . 0.0 110.359 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.14 1.56 15.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.059 0.39 . . . . 0.0 111.589 174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.97 -9.82 11.71 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.166 0.586 . . . . 0.0 111.414 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.35 -22.68 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.313 0.645 . . . . 0.0 110.428 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.18 -8.69 14.74 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.497 0.319 . . . . 0.0 111.73 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.6 t -77.46 -3.56 41.01 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.781 -0.574 . . . . 0.0 111.719 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -91.94 -3.76 55.52 Favored 'General case' 0 C--N 1.338 0.093 0 C-N-CA 122.547 0.339 . . . . 0.0 111.766 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -117.8 -4.01 11.18 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.363 0.665 . . . . 0.0 111.329 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.29 170.28 36.68 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -82.25 115.0 21.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.4 126.58 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 m -115.12 2.26 8.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 122.947 0.499 . . . . 0.0 110.661 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.22 143.02 7.56 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.481 ' SG ' ' HE2' ' A' ' 30' ' ' LYS . 9.6 p -158.83 153.62 24.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.216 1.008 . . . . 0.0 110.167 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 t -157.11 160.28 38.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.956 0.502 . . . . 0.0 109.662 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.07 147.04 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -140.13 -176.65 4.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.428 0.691 . . . . 0.0 109.194 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HE2' " H5'" ' B' ' 1' ' ' ' A' . 69.9 mttt -81.42 129.77 34.77 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.61 -17.65 6.5 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.156 0.884 . . . . 0.0 113.967 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.4 170.2 21.92 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.109 1.455 . . . . 0.0 111.659 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.22 169.36 20.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.485 0.714 . . . . 0.0 110.252 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -138.51 146.18 41.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 112.068 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.9 t -140.98 124.14 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 C-N-CA 123.588 0.755 . . . . 0.0 109.211 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -105.8 120.08 40.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.873 0.869 . . . . 0.0 108.736 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -94.69 -173.36 2.99 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.776 0.43 . . . . 0.0 110.67 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.5 t -87.14 -28.4 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.106 0.562 . . . . 0.0 111.316 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -149.72 173.68 13.44 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.978 0.511 . . . . 0.0 111.46 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.72 -36.76 78.85 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 123.077 0.551 . . . . 0.0 111.215 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 tpp85 -57.54 -39.43 76.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.393 0.677 . . . . 0.0 110.309 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -68.19 -33.82 75.14 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.55 0.34 . . . . 0.0 110.34 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.15 -42.07 69.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.959 -0.463 . . . . 0.0 110.601 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.62 -25.03 67.78 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.86 -42.63 73.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.364 0.265 . . . . 0.0 111.036 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.76 -27.09 19.14 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 120.564 -0.454 . . . . 0.0 112.122 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -70.0 -22.19 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 117.734 0.243 . . . . 0.0 110.378 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.47 14.77 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.044 0.386 . . . . 0.0 112.044 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.11 -33.89 6.72 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.722 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -114.35 -12.58 12.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.942 0.871 . . . . 0.0 112.117 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.81 129.89 44.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.758 0.708 . . . . 0.0 110.598 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.77 72.85 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.442 -0.643 . . . . 0.0 112.651 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -90.67 161.71 15.26 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.519 1.159 . . . . 0.0 111.187 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.4 ttm -99.11 138.7 35.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 110.932 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.3 mt -143.92 136.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.51 14.91 0.63 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.47 1.21 50.26 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 118.618 0.645 . . . . 0.0 113.427 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.67 156.57 44.69 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.196 0.998 . . . . 0.0 110.109 176.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.7 t -95.5 147.87 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.6 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.19 140.62 49.88 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.551 0.74 . . . . 0.0 109.582 -178.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -98.04 107.58 20.1 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.9 mt -104.34 139.58 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -154.81 164.61 38.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.89 153.3 40.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.3 -2.44 41.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -130.92 10.12 4.99 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.949 0.499 . . . . 0.0 111.797 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -134.73 48.33 2.95 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.81 136.74 46.65 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.525 2.15 . . . . 0.0 110.811 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -129.89 -3.9 4.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.796 0.838 . . . . 0.0 110.201 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 p -88.31 156.05 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.582 0.753 . . . . 0.0 109.746 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.57 2.55 47.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.875 0.47 . . . . 0.0 111.926 -175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mtm105 48.39 40.84 15.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.885 0.874 . . . . 0.0 110.924 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.74 11.77 9.78 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.626 1.107 . . . . 0.0 113.888 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt 59.5 4.81 0.55 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.02 1.328 . . . . 0.0 114.256 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.04 149.63 23.35 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.078 0.551 . . . . 0.0 109.753 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.29 -1.47 75.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.21 -20.02 11.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.014 0.926 . . . . 0.0 110.958 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -71.54 151.17 44.09 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.642 0.377 . . . . 0.0 111.606 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.84 165.01 13.85 Favored 'General case' 0 CA--C 1.524 -0.033 0 C-N-CA 123.879 0.872 . . . . 0.0 110.081 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.6 t -75.49 151.74 37.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.13 -5.02 15.67 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.935 -0.478 . . . . 0.0 111.802 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -102.91 -6.48 22.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.621 0.768 . . . . 0.0 111.038 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.93 7.61 5.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.077 0.951 . . . . 0.0 110.87 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.5 ttm -89.7 160.54 16.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.567 0.747 . . . . 0.0 110.962 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.39 -14.44 62.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.667 1.587 . . . . 0.0 113.135 -172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 180.0 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.458 " H5'" ' HE2' ' A' ' 50' ' ' LYS . . . . . . . . 0 O4'--C4' 1.41 -3.603 0 C3'-C2'-C1' 104.91 3.789 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 N19-C1'-C2' 107.046 -3.972 . 0.235 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.864 1 O4'-C1'-N19 112.845 4.645 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.402 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.576 1 O4'-C1'-N19 113.022 4.822 . 0.011 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.402 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.736 0 O4'-C1'-N19 110.708 2.508 . 0.125 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.494 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 O4'-C1'-N19 112.429 4.229 . 0.157 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.412 H5'' " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.483 1 O4'-C1'-N19 113.16 4.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 120.3 0.095 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -62.28 173.36 1.19 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.642 0.777 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -109.66 15.67 22.67 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.521 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 9.4 p -119.02 138.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 118.384 0.538 . . . . 0.0 110.181 -174.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 p -147.0 2.27 0.78 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -87.89 33.05 0.72 Allowed 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.642 -0.661 . . . . 0.0 112.334 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -80.16 149.43 30.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.0 p -131.22 18.52 4.92 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.93 0.492 . . . . 0.0 112.198 -172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -65.74 158.26 75.54 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 122.3 -0.25 . . . . 0.0 110.703 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.08 -11.13 20.39 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.943 3.095 . . . . 0.0 113.634 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -121.95 -7.35 8.94 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.866 0.467 . . . . 0.0 111.26 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -93.83 -20.54 19.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.004 0.521 . . . . 0.0 110.343 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -12.49 61.35 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.997 0.519 . . . . 0.0 110.766 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.58 1.23 6.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.5 p -102.33 7.52 40.53 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -104.65 167.37 9.77 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 123.958 0.903 . . . . 0.0 110.794 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.2 t -131.73 127.55 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.477 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.41 89.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.03 171.55 34.3 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.846 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 56.52 18.69 3.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.264 1.426 . . . . 0.0 112.539 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.3 tp -70.84 152.47 43.68 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 109.918 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -65.64 -41.71 92.32 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 122.776 0.43 . . . . 0.0 111.354 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.477 ' HA ' HG12 ' A' ' 28' ' ' VAL . 31.3 p 52.17 0.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.14 -13.11 27.1 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.516 1.053 . . . . 0.0 110.87 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 t -131.12 -14.26 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 C-N-CA 123.046 0.538 . . . . 0.0 110.761 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -86.58 156.3 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -138.89 172.83 12.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 123.488 0.715 . . . . 0.0 109.188 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -59.02 -35.48 73.36 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.289 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -77.11 -6.34 52.46 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.009 0.524 . . . . 0.0 110.857 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 3.1 m-20 -95.52 -41.25 9.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -67.86 -38.86 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.852 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.06 7.72 6.91 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.01 -0.431 . . . . 0.0 111.724 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.24 -10.29 9.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.28 0.632 . . . . 0.0 111.686 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.72 -21.09 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.233 0.613 . . . . 0.0 109.976 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -108.77 -11.54 15.03 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.676 0.39 . . . . 0.0 111.486 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -73.2 -8.7 56.92 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.658 -0.651 . . . . 0.0 110.964 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -89.08 0.82 56.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.668 0.787 . . . . 0.0 111.589 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.97 -5.79 9.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.733 0.813 . . . . 0.0 111.461 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.97 169.22 35.25 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -79.23 113.5 17.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.3 mt -86.57 130.58 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.43 6.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.297 0.639 . . . . 0.0 110.511 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.5 145.56 8.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 t -154.97 148.1 24.82 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 117.575 0.687 . . . . 0.0 110.395 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.4 p -149.31 158.22 43.99 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.75 145.25 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 109.812 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -138.54 -170.42 2.83 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -86.83 134.22 33.57 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 118.536 0.607 . . . . 0.0 110.022 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.56 -15.88 3.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.109 0.861 . . . . 0.0 113.703 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 45.8 p90 -153.99 170.19 21.68 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.934 1.367 . . . . 0.0 112.059 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.79 168.3 22.51 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.008 0.923 . . . . 0.0 109.85 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.79 147.67 44.84 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.066 0.546 . . . . 0.0 110.982 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -135.84 147.25 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -124.36 109.32 13.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.988 0.915 . . . . 0.0 109.039 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -89.7 -178.16 5.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.5 t -83.67 -25.79 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.941 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -153.05 176.45 11.88 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.958 0.503 . . . . 0.0 111.711 -176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.29 -36.03 71.52 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.621 0.768 . . . . 0.0 111.251 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -57.79 -39.73 78.19 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.933 0.493 . . . . 0.0 110.096 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.33 -34.97 77.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.171 -0.33 . . . . 0.0 110.269 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.04 -42.48 76.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.181 -0.324 . . . . 0.0 110.752 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -64.16 -26.2 68.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.02 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.95 75.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.192 0.197 . . . . 0.0 111.054 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.07 -27.13 19.88 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 83' ' ' ASN . 28.3 t -71.71 -22.58 21.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 O-C-N 122.323 -0.235 . . . . 0.0 110.739 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.4 -9.99 14.93 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.96 -39.25 4.38 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.589 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -105.94 -13.84 15.37 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.646 0.723 . . . . 0.0 112.234 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.8 129.6 42.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.746 0.703 . . . . 0.0 110.507 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.68 12.95 71.02 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.485 -0.62 . . . . 0.0 112.694 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -90.76 160.72 15.65 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.392 1.096 . . . . 0.0 111.157 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttm -98.25 138.7 35.12 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.035 0.445 . . . . 0.0 110.861 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.4 mt -143.2 135.2 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.14 16.39 0.77 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.65 1.03 49.67 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.736 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.01 156.95 44.26 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 118.086 0.943 . . . . 0.0 110.311 175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.5 147.69 5.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.05 141.72 48.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.229 0.612 . . . . 0.0 109.582 -177.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -98.71 106.34 18.59 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.3 mt -103.15 139.77 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.414 ' HA ' HG13 ' A' ' 67' ' ' VAL . 6.5 t30 -155.77 165.27 37.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.36 27.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.7 -2.34 56.01 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.18 13.91 5.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.734 0.414 . . . . 0.0 111.572 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -131.24 50.09 5.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.25 71.11 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.829 3.019 . . . . 0.0 111.586 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.22 -9.18 59.09 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.6 p -86.77 155.49 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.095 0.958 . . . . 0.0 109.294 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -85.79 0.86 51.78 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.759 0.423 . . . . 0.0 111.62 -174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 56.48 -78.3 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.284 1.433 . . . . 0.0 111.337 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.61 -2.55 15.59 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.866 0.746 . . . . 0.0 114.267 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 54.35 11.12 0.37 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.473 1.109 . . . . 0.0 113.893 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.8 -16.68 0.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.789 0.436 . . . . 0.0 111.907 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.75 9.24 86.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -81.49 -21.0 10.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 122.983 0.513 . . . . 0.0 110.911 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -66.01 149.75 49.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.755 0.312 . . . . 0.0 110.95 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -92.22 154.74 18.46 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 123.689 0.796 . . . . 0.0 110.263 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.8 t -85.9 148.94 25.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.9 -6.27 11.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.677 0.391 . . . . 0.0 112.029 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -106.69 -8.81 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -117.49 8.15 12.89 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.299 0.64 . . . . 0.0 111.546 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 41.1 mtp -70.68 -26.09 63.27 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -138.6 -5.02 1.58 Allowed 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.075 0.55 . . . . 0.0 111.988 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.178 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 1 O4'-C1'-N19 114.298 6.098 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.804 3.604 . 0.25 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.427 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.386 4.186 OUTLIER-DELTA 0.065 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.421 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.702 1 O4'-C1'-N19 112.39 4.19 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.421 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 112.142 3.942 . 0.089 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.521 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 112.433 4.233 . 0.187 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.821 1 O4'-C1'-N19 112.422 4.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -72.85 177.91 4.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.2 0.6 . . . . 0.0 111.553 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -118.04 34.99 4.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.339 1.056 . . . . 0.0 111.259 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.44 136.47 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 111.195 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -152.07 19.13 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.147 1.779 . . . . 0.0 109.37 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -112.97 15.25 19.72 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -65.62 169.59 6.07 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -131.42 29.2 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.895 -0.503 . . . . 0.0 111.62 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -71.37 153.39 94.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 122.651 0.381 . . . . 0.0 110.659 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.06 -6.96 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.397 3.398 . . . . 0.0 113.719 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -123.83 -13.18 7.46 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.281 0.491 . . . . 0.0 111.569 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.8 m -87.14 -23.61 24.79 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.71 0.232 . . . . 0.0 110.941 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -13.57 61.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.31 0.644 . . . . 0.0 111.079 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 2.1 p30 -124.31 9.94 8.59 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.626 0.371 . . . . 0.0 111.91 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -110.83 8.32 22.27 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.677 0.391 . . . . 0.0 111.045 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -120.46 171.56 8.45 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 122.187 -0.32 . . . . 0.0 110.905 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.83 134.87 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.669 0.788 . . . . 0.0 110.537 -173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -96.5 138.77 33.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 171.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.27 95.52 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.62 168.59 23.99 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 122.877 0.275 . . . . 0.0 112.838 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t30 56.87 21.36 6.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 0.0 112.649 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.39 148.34 45.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.962 0.505 . . . . 0.0 110.884 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.81 95.3 6.64 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.567 ' HA ' HG12 ' A' ' 28' ' ' VAL . 82.7 p -90.67 12.29 19.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.395 0.678 . . . . 0.0 112.19 -174.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD21 ' C5 ' ' B' ' 2' ' ' ' U' . 2.2 mm? -90.09 -30.01 17.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 111.028 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.19 -18.59 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 122.624 0.37 . . . . 0.0 110.932 -175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -81.75 158.35 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -140.59 172.71 12.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.248 0.619 . . . . 0.0 109.411 177.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -58.59 -36.38 73.9 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.149 -0.344 . . . . 0.0 110.174 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.2 m -74.56 -8.11 55.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.363 0.665 . . . . 0.0 110.927 -176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -96.89 -39.08 9.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 122.522 0.329 . . . . 0.0 110.116 177.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.0 -38.92 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.607 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.5 4.93 8.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.963 -0.461 . . . . 0.0 111.951 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.41 -12.7 9.33 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.745 0.418 . . . . 0.0 111.761 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.2 mt -100.99 -19.87 5.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.068 0 C-N-CA 123.318 0.647 . . . . 0.0 110.088 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.56 -8.53 14.23 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.258 -0.276 . . . . 0.0 111.65 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 t -76.53 -7.73 55.76 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.695 -0.628 . . . . 0.0 110.768 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -89.81 2.46 54.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.726 0.811 . . . . 0.0 111.773 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -124.98 -3.15 7.66 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.533 0.733 . . . . 0.0 111.935 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.82 169.27 35.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -80.25 111.98 17.14 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.24 128.67 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 m -117.41 1.31 7.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 C-N-CA 123.178 0.591 . . . . 0.0 110.365 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.33 145.49 10.23 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 22.1 p -157.74 155.13 29.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.077 0.938 . . . . 0.0 111.594 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.9 p -158.1 163.63 37.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.68 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.56 145.11 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -137.47 -165.79 1.83 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.605 0.762 . . . . 0.0 109.604 -172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -83.46 125.76 32.06 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.77 -10.97 2.66 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.119 0.866 . . . . 0.0 114.322 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.425 ' HB3' " H4'" ' B' ' 3' ' ' ' U' . 55.3 p90 -149.87 170.56 18.5 Favored 'General case' 0 C--O 1.23 0.059 0 CA-C-N 119.105 1.453 . . . . 0.0 111.381 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.18 166.8 27.76 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.032 0.933 . . . . 0.0 109.563 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -139.03 143.87 38.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.839 0.456 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -135.92 138.35 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.6 tp60 -117.26 115.08 24.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.722 0.809 . . . . 0.0 109.609 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.21 -178.57 4.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.096 0.558 . . . . 0.0 110.099 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -81.7 -26.5 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.889 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -153.77 177.83 10.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.813 0.445 . . . . 0.0 111.471 -176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.32 -35.66 71.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.228 0.611 . . . . 0.0 111.711 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -56.7 -41.09 76.78 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.294 0.638 . . . . 0.0 109.954 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.52 -34.0 75.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.05 81.35 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.766 -0.584 . . . . 0.0 110.748 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -65.29 -25.7 67.75 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.153 0.433 . . . . 0.0 110.302 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.13 -41.58 77.16 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 119.786 -0.15 . . . . 0.0 111.066 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.41 -28.87 18.36 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.24 -22.26 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.418 0.287 . . . . 0.0 110.497 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 -10.66 14.77 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -41.1 4.62 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.796 -0.447 . . . . 0.0 113.385 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -107.21 -13.7 15.08 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 117.633 0.716 . . . . 0.0 112.549 -175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -59.45 129.93 44.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 119.135 0.879 . . . . 0.0 110.789 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.08 13.18 72.17 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.733 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -91.22 161.08 15.21 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 118.436 1.118 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttm -98.56 138.62 35.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.692 0.282 . . . . 0.0 110.997 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.3 mt -142.7 134.59 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.84 17.49 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.93 -1.27 38.54 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.167 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.89 158.65 42.05 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 118.523 1.161 . . . . 0.0 110.388 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -95.01 148.12 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.588 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -118.22 143.84 46.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.69 0.796 . . . . 0.0 109.866 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -99.73 105.69 17.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.0 139.24 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -156.59 163.61 39.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.889 0.376 . . . . 0.0 110.509 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -63.92 144.34 57.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.39 -1.66 34.54 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.8 13.14 5.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.667 0.387 . . . . 0.0 111.24 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -132.86 48.58 3.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.46 139.22 37.33 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.192 1.928 . . . . 0.0 109.325 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -124.9 3.21 8.09 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.134 0.574 . . . . 0.0 111.112 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.46 159.1 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 110.049 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -74.0 2.74 8.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.765 0.826 . . . . 0.0 111.412 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 63.17 -30.71 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 127.658 2.383 . . . . 0.0 113.949 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.31 -2.69 1.47 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.441 1.019 . . . . 0.0 114.838 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm 53.66 5.09 0.05 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.57 -20.66 0.07 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.169 0.441 . . . . 0.0 111.2 177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.57 -0.51 81.04 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.81 -23.43 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.714 0.806 . . . . 0.0 111.309 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.75 151.74 41.98 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.046 -0.409 . . . . 0.0 110.636 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -84.91 161.27 19.91 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.8 m -82.97 152.81 25.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.81 -10.12 44.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.613 0.642 . . . . 0.0 111.789 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.32 -8.21 39.59 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.43 0.692 . . . . 0.0 111.373 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.73 3.03 6.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.706 0.803 . . . . 0.0 110.927 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.9 ttm -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.304 0.641 . . . . 0.0 111.033 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -133.48 -8.95 2.87 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.935 0.494 . . . . 0.0 111.559 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.389 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.483 " H3'" " H5'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C5'-C4'-C3' 110.179 -3.548 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.51 ' C5 ' HD21 ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.425 -2.366 0 O4'-C1'-N19 112.12 3.92 . 0.144 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.425 " H4'" ' HB3' ' A' ' 52' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 111.367 3.167 . 0.13 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.413 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 O4'-C1'-N19 114.129 5.929 OUTLIER-DELTA 0.01 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.413 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.843 0 C5'-C4'-C3' 111.048 -2.968 . 0.021 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 111.056 2.856 . 0.213 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 1 O4'-C1'-N19 113.821 5.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.316 0.103 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -77.66 -174.15 3.31 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.842 0.457 . . . . 0.0 110.678 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -118.46 21.34 12.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 111.961 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG12 ' HE2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -117.72 129.51 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 118.533 0.606 . . . . 0.0 110.411 -174.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 56.3 p -148.82 16.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.16 0.584 . . . . 0.0 112.335 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -111.73 17.05 20.23 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HE2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -68.27 166.88 15.51 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.514 0.597 . . . . 0.0 110.222 178.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.5 p -130.96 22.49 4.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.05 154.08 93.26 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 122.605 0.362 . . . . 0.0 110.593 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.79 -6.4 14.0 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.151 3.234 . . . . 0.0 113.163 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -120.65 -15.41 8.44 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.301 0.501 . . . . 0.0 111.367 175.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -89.43 -18.19 27.27 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.448 0.299 . . . . 0.0 110.37 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -11.09 59.8 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.29 0.636 . . . . 0.0 111.242 176.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -126.95 -1.04 6.58 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.045 0.538 . . . . 0.0 111.878 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.9 p -100.02 11.84 38.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.978 0.511 . . . . 0.0 109.949 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -113.61 156.02 24.42 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.13 0.972 . . . . 0.0 111.081 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -122.49 127.78 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -96.05 136.1 36.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.1 mt -130.41 95.98 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.075 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.02 168.36 25.92 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.943 0.306 . . . . 0.0 112.655 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 t30 52.87 26.04 4.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.682 1.193 . . . . 0.0 112.423 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.72 151.9 46.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.937 0.495 . . . . 0.0 111.522 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -73.69 46.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.405 1.482 . . . . 0.0 111.651 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.434 ' HA ' HG12 ' A' ' 28' ' ' VAL . 35.9 p -57.82 -9.64 1.36 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -169.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD2' ' C5 ' ' B' ' 2' ' ' ' U' . 5.5 mt -81.69 -5.71 58.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.432 1.015 . . . . 0.0 110.207 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 t -132.97 -18.5 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 123.568 0.747 . . . . 0.0 110.525 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -81.9 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.097 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -141.98 171.06 14.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.07 -25.59 63.89 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.367 0.267 . . . . 0.0 110.911 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.5 m -86.29 -6.37 58.98 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.586 0.355 . . . . 0.0 111.649 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 29' ' ' LYS . 5.5 m-20 -94.61 -40.16 9.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 117.992 0.36 . . . . 0.0 110.682 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -68.35 -32.99 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 118.517 0.599 . . . . 0.0 109.838 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.79 1.06 32.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.193 -0.317 . . . . 0.0 111.368 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.59 -10.71 11.83 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.952 0.501 . . . . 0.0 111.39 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.2 mt -103.35 -25.17 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 123.358 0.663 . . . . 0.0 110.727 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -108.55 -5.7 16.41 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -80.2 -1.37 40.18 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 111.411 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -94.85 -2.19 51.24 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.739 0.415 . . . . 0.0 112.008 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -119.24 -2.8 10.61 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.279 0.632 . . . . 0.0 111.628 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.14 171.71 38.05 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.379 -0.438 . . . . 0.0 112.552 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -81.99 109.82 16.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.399 0.68 . . . . 0.0 109.259 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 mt -83.4 129.51 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.92 1.79 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 C-N-CA 123.29 0.636 . . . . 0.0 110.445 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.78 143.62 8.57 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.7 t -154.29 148.71 26.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.608 0.704 . . . . 0.0 110.408 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.5 p -154.14 161.72 41.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.889 0.475 . . . . 0.0 110.527 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.58 148.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -143.13 176.48 9.08 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HD3' ' C2 ' ' B' ' 2' ' ' ' U' . 19.7 mmtp -69.13 89.95 0.46 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.654 0.382 . . . . 0.0 110.189 176.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' N ' " H1'" ' B' ' 2' ' ' ' U' . . . 113.78 -14.09 22.18 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 124.759 1.171 . . . . 0.0 113.317 169.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.26 174.1 14.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.45 165.04 30.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.2 147.24 52.01 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 111.417 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.25 136.07 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -117.07 110.66 18.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.617 0.767 . . . . 0.0 109.244 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -89.25 -178.95 5.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -83.84 -24.39 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.911 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -153.84 174.92 13.94 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.977 0.418 . . . . 0.0 112.047 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.35 -37.0 77.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.701 0.8 . . . . 0.0 111.31 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -57.09 -39.98 76.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.207 0.603 . . . . 0.0 110.255 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.16 -35.11 75.97 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.72 74.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.753 -0.592 . . . . 0.0 110.934 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -63.42 -25.8 68.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 117.918 0.326 . . . . 0.0 110.162 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.63 72.05 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 119.692 -0.194 . . . . 0.0 111.3 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.16 -28.16 19.11 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.9 -23.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 122.47 0.308 . . . . 0.0 110.567 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.44 -11.18 15.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.11 -32.77 6.9 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.563 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -114.78 -14.76 11.95 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.951 0.876 . . . . 0.0 112.542 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -58.7 131.69 51.62 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.893 0.77 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.35 76.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.366 -0.685 . . . . 0.0 112.383 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -93.2 159.87 15.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.461 1.13 . . . . 0.0 111.448 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 ttm -95.68 138.67 33.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.851 0.358 . . . . 0.0 110.833 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.8 mt -143.56 134.79 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 51.98 15.44 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.11 -3.78 38.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.75 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -127.5 161.63 28.3 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.399 1.099 . . . . 0.0 109.615 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.07 147.79 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -117.58 145.88 43.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.581 0.752 . . . . 0.0 110.259 -179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -100.52 101.68 12.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.8 mt -101.79 139.16 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -156.03 164.09 38.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.09 156.78 30.44 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.79 -3.7 51.98 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -131.27 14.11 5.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.937 0.335 . . . . 0.0 111.708 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -132.78 46.91 2.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.05 144.08 74.56 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.995 2.464 . . . . 0.0 111.383 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -138.34 1.98 2.24 Favored 'General case' 0 CA--C 1.527 0.07 0 C-N-CA 124.123 0.969 . . . . 0.0 111.032 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.61 154.46 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.386 0.675 . . . . 0.0 110.514 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -84.56 2.85 39.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.303 0.641 . . . . 0.0 111.881 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 48.51 51.6 15.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 111.4 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.78 1.92 35.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.399 0.523 . . . . 0.0 113.976 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 55.84 15.13 1.55 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.09 -18.79 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.53 3.14 82.45 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 67.9 t -89.14 -21.4 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.788 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -69.93 151.45 45.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.355 0.262 . . . . 0.0 110.632 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.38 156.55 19.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.792 0.837 . . . . 0.0 110.328 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.9 m -84.14 156.6 22.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -6.15 9.54 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.99 -5.8 15.34 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.385 0.674 . . . . 0.0 110.986 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -123.26 13.83 9.63 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.234 1.014 . . . . 0.0 110.785 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.0 mmm -62.06 -22.47 65.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -139.72 -6.49 1.31 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.957 0.503 . . . . 0.0 111.822 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.535 " H3'" H5'' ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.285 2 O4'-C1'-N19 113.958 5.758 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.583 ' C5 ' ' CD2' ' A' ' 26' ' ' LEU . . . . . . . . 0 O4'--C4' 1.423 -2.472 1 C5'-C4'-C3' 108.114 -4.924 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 O4'-C1'-N19 112.662 4.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 113.268 5.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 C5'-C4'-C3' 112.36 -2.093 . 0.333 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 1 O4'-C1'-N19 112.357 4.157 . 0.151 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 110.074 -3.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -72.37 176.98 4.85 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.911 0.485 . . . . 0.0 111.421 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -115.4 19.62 15.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.881 0.872 . . . . 0.0 111.383 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 ' H3 ' ' B' ' 6' ' ' ' U' . 6.5 p -123.24 133.53 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.1 p -149.32 18.6 0.95 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 123.401 0.68 . . . . 0.0 111.76 -176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -112.25 17.16 19.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HE2' ' CA ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -63.36 165.26 7.87 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.145 0.429 . . . . 0.0 109.886 177.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.6 p -129.6 21.96 5.52 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.73 152.98 95.85 Favored Pre-proline 0 C--O 1.234 0.27 0 O-C-N 122.055 -0.403 . . . . 0.0 110.591 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.03 -6.93 15.56 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 124.262 3.308 . . . . 0.0 113.199 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -122.29 -8.83 8.65 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 118.182 0.446 . . . . 0.0 111.714 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 m -95.27 -19.39 20.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.893 0.477 . . . . 0.0 110.733 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -11.68 60.07 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.397 0.679 . . . . 0.0 111.231 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.38 -2.94 6.83 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.787 0.435 . . . . 0.0 111.925 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -97.45 12.02 34.7 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.25 0.548 . . . . 0.0 109.856 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -112.65 153.07 28.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.145 0.978 . . . . 0.0 110.703 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -119.98 130.4 74.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.01 0.524 . . . . 0.0 109.591 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -95.49 140.7 29.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 171.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.38 81.68 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.9 172.44 47.95 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' HA ' ' C2 ' ' B' ' 3' ' ' ' U' . 54.8 t30 52.47 25.72 3.75 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.546 1.138 . . . . 0.0 112.413 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.4 tp -70.38 153.87 42.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.568 -0.708 . . . . 0.0 112.217 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -76.05 49.9 0.58 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.598 1.559 . . . . 0.0 110.727 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.413 ' HA ' HG12 ' A' ' 28' ' ' VAL . 67.7 p -64.26 -0.01 1.12 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.45 -12.29 56.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.939 0.336 . . . . 0.0 110.439 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.81 -21.32 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.097 0.559 . . . . 0.0 111.046 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -77.2 159.94 4.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.15 172.07 13.27 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -60.77 -31.38 70.73 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 122.031 -0.418 . . . . 0.0 110.439 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.1 m -76.41 -9.69 58.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.471 0.708 . . . . 0.0 111.245 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.83 -39.29 10.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.99 -36.67 77.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 O-C-N 121.729 -0.607 . . . . 0.0 109.718 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -78.55 1.14 23.51 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.2 -0.312 . . . . 0.0 111.439 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.19 -8.99 12.32 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.879 0.471 . . . . 0.0 111.277 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.72 -16.83 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.343 0.657 . . . . 0.0 110.509 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -114.45 -10.09 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -73.07 -7.35 50.89 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.486 -0.759 . . . . 0.0 110.642 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -79.08 -8.3 58.85 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.079 0.952 . . . . 0.0 111.943 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -127.89 -1.91 5.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.44 167.79 35.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.964 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -79.75 113.04 17.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.5 mt -84.83 127.13 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 m -115.31 0.16 8.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.999 0.519 . . . . 0.0 110.379 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.95 145.52 10.32 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 41.8 t -152.45 148.08 27.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.635 0.718 . . . . 0.0 110.652 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 t -153.05 151.06 29.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 p -145.06 147.71 18.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-O 121.035 0.445 . . . . 0.0 110.345 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 52' ' ' PHE . 13.2 m-70 -140.0 -169.63 2.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.458 1.103 . . . . 0.0 108.265 -174.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -80.09 139.55 36.83 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.51 0.595 . . . . 0.0 109.561 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.36 -30.88 0.45 Allowed Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.754 1.169 . . . . 0.0 114.283 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.461 ' CE2' ' CD2' ' A' ' 49' ' ' HIS . 48.3 p90 -138.57 162.05 35.53 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.934 1.367 . . . . 0.0 111.42 -176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.34 169.0 21.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.235 0.614 . . . . 0.0 109.974 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -140.44 146.26 38.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.52 0.676 . . . . 0.0 111.857 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.7 138.37 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -117.72 111.44 19.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.28 -178.19 5.31 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.451 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -82.9 -26.98 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -152.79 175.7 12.59 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.795 0.438 . . . . 0.0 111.864 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.56 -35.94 75.85 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.724 0.81 . . . . 0.0 111.518 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -57.68 -39.83 78.03 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.07 0.548 . . . . 0.0 110.113 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.17 -35.57 78.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.453 0.301 . . . . 0.0 110.271 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.12 77.11 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.73 -0.606 . . . . 0.0 110.866 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -64.62 -26.45 68.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.6 75.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.374 0.27 . . . . 0.0 111.183 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.47 -28.16 18.77 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.31 -22.3 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.425 0.29 . . . . 0.0 110.532 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.61 -9.06 14.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -98.24 -20.83 19.27 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.415 -0.658 . . . . 0.0 113.989 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -127.16 -16.42 5.02 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.446 1.123 . . . . 0.0 111.813 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.86 132.75 54.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.971 0.805 . . . . 0.0 111.144 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.89 14.53 75.06 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.608 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -93.38 160.66 14.71 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 117.945 0.872 . . . . 0.0 111.069 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.1 ttm -98.77 139.31 34.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.884 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 59.8 mt -143.01 134.13 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 50.85 14.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.91 2.09 39.45 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.906 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -128.48 153.19 47.41 Favored 'General case' 0 C--N 1.337 0.048 0 CA-C-N 118.618 1.209 . . . . 0.0 109.592 174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.59 145.09 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.59 ' N ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -115.64 141.91 47.44 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.324 0.65 . . . . 0.0 110.119 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -94.47 100.74 12.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.83 137.73 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -156.87 163.49 39.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.81 153.03 41.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.02 52.3 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -127.01 13.03 7.27 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 79.3 mt-10 -130.87 45.53 1.81 Allowed Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 87' ' ' GLU . 83.6 Cg_endo -70.22 81.25 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.178 2.585 . . . . 0.0 110.678 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.53 -7.04 59.53 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.784 0.434 . . . . 0.0 110.76 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.1 p -90.33 155.48 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.316 0.646 . . . . 0.0 109.345 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -75.88 -8.02 55.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 43.05 66.38 0.79 Allowed 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.123 0.969 . . . . 0.0 111.168 -175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.97 -3.1 20.99 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.919 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HA ' ' C6 ' ' B' ' 3' ' ' ' U' . 44.1 mtmt 55.12 7.7 0.2 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.356 1.462 . . . . 0.0 113.991 -177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -159.34 -164.39 1.37 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.233 0.54 . . . . 0.0 110.976 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.07 -2.87 4.41 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.19 -24.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.74 0.816 . . . . 0.0 111.038 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -83.72 160.18 21.34 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.375 0.67 . . . . 0.0 111.024 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -98.45 164.48 12.26 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.835 0.854 . . . . 0.0 110.555 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 t -77.12 153.68 34.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.248 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.22 -3.32 10.32 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.36 -4.54 12.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.987 0.915 . . . . 0.0 111.36 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.05 8.32 8.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.316 0.646 . . . . 0.0 111.13 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 106' ' ' GLY . 8.2 ptm -115.14 -176.08 2.83 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.57 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.68 -15.21 51.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.741 0.816 . . . . 0.0 113.148 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.503 ' H ' ' HG3' ' A' ' 104' ' ' MET . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.859 1 O4'-C1'-N19 114.022 5.822 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 112.063 3.863 . 0.243 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.422 ' C2 ' ' HA ' ' A' ' 22' ' ' ASN . . . . . . . . 0 O4'--C4' 1.417 -2.962 4 O4'-C1'-N19 114.801 6.601 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.402 " H4'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.194 0 O5'-C5'-C4' 115.735 3.954 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.402 " H5'" " H4'" ' B' ' 4' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.008 0 O4'-C1'-N19 110.899 2.699 . 0.017 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.496 ' H3 ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.128 4.928 . 0.21 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 110.337 -3.442 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_